{"title": "David A. Hafler", "author": "David A Hafler", "url": "https://www.yalemedicine.org/specialists/david-hafler", "hostname": "yalemedicine.org", "description": "David Hafler, MD, is a world-renowned expert on multiple sclerosis (MS) and chair of the Department of Neurology, where he has presided over a major expansion in the last several years. He tells the neurologists who work for him to put patients first. \"If I sense that a doctor does not care deeply about patients, they don't belong at Yale,\" he says.Dr. Hafler knew from a young age that he wanted to be a doctor and study the immune system. In elementary school, he made slides of his own blood and studied them under a microscope. \"I took photographs. I still have them,\" he says. Because most neurologic diseases are chronic, he has been treating many of his patients for more than 30 years.\"Providing care for chronic disease is a very special part of being involved in someone'slife,\" he says. A professor of neurology and of immunobiology at Yale School of Medicine, Dr. Hafler is also a prolific researcher whose work has led to major advances in the understanding and treatment of MS, including identification of it as an autoimmune and genetic disease. He leads a lab at Yale that conducts cutting-edge research into MS and develops new treatments. Advances in treatment of MS have been remarkable, he says. \"Back in the 1970s when I was in medical school, there were no treatments,\" he says. \"From where we were in 1975, say, we've come a long way.\"", "sitename": "Yale Medicine", "date": "2023-08-28", "cleaned_text": "- Yale MS Center6 Devine StreetSte Suite [Learn about telehealth](/patient-tools/telehealth) Biography David Hafler, MD, is a world-renowned expert on multiple sclerosis (MS) and chair of the Department of Neurology, where he has presided over a major expansion in the last several years. He tells the neurologists who work for him to put patients first. \"If I sense that a doctor does not care deeply about patients, they don't belong at Yale,\" he says. Dr. Hafler knew from a young age that he wanted to be a doctor and study the immune system. In elementary school, he made slides of his own blood and studied them under a microscope. \"I took photographs. I still have them,\" he says. Because most neurologic diseases are chronic, he has been treating many of his patients for more than 30 years. \"Providing care for chronic disease is a very special part of being involved in someone's life,\" he says. A professor of neurology and of immunobiology at Yale School of Medicine, Dr. Hafler is also a prolific researcher whose work has led to major advances in the understanding and treatment of MS, including identification of it as an autoimmune and genetic disease. He leads a lab at Yale that conducts cutting-edge research into MS and develops new treatments. Advances in treatment of MS have been remarkable, he says. \"Back in the 1970s when I was in medical school, there were no treatments,\" he says. \"From where we were in 1975, say, we've come a long way.\" Titles - William S. and Lois Stiles Edgerly Professor of Neurology and Professor of Immunobiology - Chair, Neurology - Neurologist-in-Chief, Yale New Haven Hospital Education & Training - Post-Doctoral FellowshipHarvard Medical School (1986) - Chief ResidentThe New York Hospital-Cornell Medical Center, and Memorial Sloan Kettering Cancer Institute (1982) - Assistant ResidentThe New York Hospital-Cornell Medical Center, and Memorial Sloan Kettering Cancer Institute (1981) - MDUniversity of Miami School of Medicine (1978) - MSEmory University (1974) - BSEmory College, Chemistry (1974) - Visiting ScientistRockefeller University Additional Information - Elected Member of National Academy of Medicine: National Academy of Medicine (2018) - Raymond D. Adams Lectureship: American Neurological Association (2015) - John J. Dystel Prize for Multiple Sclerosis Research: American Academy of Neurology (2010) - Distinguished Alumni \"Hall of Fame\" Award: University of Miami (2010) - Best Doctors in Boston: Best of Boston (2008) - Honorary Member: Scandinavian Society for Immunology (2005) - Most Highly Cited List in the field of Immunology: ISI (2004) - The Jacobs Javits Merit Investigator Award: NIH (2004) - Best Doctors in America: (2000) - Elected Member: American Society for Clinical Investigation (1993) - AB of Psychiatry & Neurology, Neurology (1987) [Microfluidic ImmunoSerolomic Assay Reveals Systems Level Association with COVID19 Pathology and Vaccine Protection](http://www.ncbi.nlm.nih.gov/pubmed/37312418)Kim D, Biancon G, Bai Z, VanOudenhove J, Liu Y, Kothari S, Gowda L, Kwan J, BuitragoPocasangre N, Lele N, Asashima H, Racke M, Wilson J, Givens T, Tomayko M, Schulz W, Longbrake E, Hafler D, Halene S, Fan R. Microfluidic ImmunoSerolomic Assay Reveals Systems Level Association with COVID19 Pathology and Vaccine Protection Small Methods 2023, e2300594. [PMID: 37312418](https://pubmed.ncbi.nlm.nih.gov/37312418), [DOI: 10.1002/smtd.202300594](https://doi.org/10.1002/smtd.202300594). [Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients](http://www.ncbi.nlm.nih.gov/pubmed/37327781)Diray-Arce J, Fourati S, Jayavelu N, Patel R, Maguire C, Chang A, Dandekar R, Qi J, Lee B, van Zalm P, Schroeder A, Chen E, Konstorum A, Brito A, Gygi J, Kho A, Chen S, Gonzalez-Reiche A, Hoch A, Milliren C, Overton J, Westendorf K, Network I, Abraham J, Adkisson M, Albert M, Torres L, Alvarenga B, Anderson M, Anderson E, Arnett A, Asashima H, Atkinson M, Baden L, Barton B, Beach K, Beagle E, Becker P, Bell M, Bernui M, Bime C, Kumar A, Booth L, Borresen B, Brakenridge S, Bristow L, Bryant R, Calfee C, Manuel J, Carrillo S, Chak S, Chang I, Connors J, Conway M, Corry D, Cowan D, Croen B, Dela Cruz C, Cusimano G, Eaker L, Edwards C, Ehrlich L, Elashoff D, Erickson H, Erle D, Farhadian S, Farrugia K, Fatou B, Fernandes A, Fernandez-Sesma A, Fragiadakis G, Furukawa S, Geltman J, Ghale R, Berm\u00fadez M, Goonewardene M, Sanchez E, Guirgis F, Hafler D, Hamilton S, Harris P, Nemati A, Hendrickson C, Agudelo N, Hodder T, Holland S, Hough C, Huerta C, Hurley K, Hutton S, Iwasaki A, Jauregui A, Jha M, Johnson B, Joyner D, Kangelaris K, Kelly G, Khalil Z, Khan Z, Kheradmand F, Kim J, Kimura H, Ko A, Kohr B, Kraft M, Krummel M, Kutzler M, Lasky-Su J, Lee S, Lee D, Leipold M, Lentucci C, Leroux C, Lin E, Liu S, Love C, Lu Z, Maliskova L, Roth B, Manohar M, Martens M, McComsey G, McEnaney K, McLin R, Melamed E, Melnyk N, Mendez K, Messer S, Mosier J, Mulder L, Murphy M, Nadeau K, Nelson E, Nelson A, Nguyen V, Oberhaus J, Panganiban B, Pellegrini K, Pickering H, Powell D, Presnell S, Pulendran B, Rahman A, Sadeed A, Raskin A, Reed E, Pereira S, Rivera A, Rogers J, Rogers A, Rogowski B, Rooks R, Rosenberg-Hasson Y, Rothman J, Rousseau M, Samaha H, Schaenman R, Semenza N, Sen S, Sevransky J, Seyfert-Margolis V, Shaheen T, Shaw A, Sieg S, Siegel S, Sigal N, Siles N, Simmons B, Simon V, Singh G, Sinko L, Smith C, Smolen K, Song L, Srivastava K, Sullivan P, Syphurs C, Tcheou J, Tegos G, Tharp G, Ally A, Tsitsiklis A, Ungaro R, Vaysman T, Viode A, Vita R, Wang X, Ward A, Ward D, Willmore A, Woloszczuk K, Wong K, Woodruff P, Xu L, van Haren S, van de Guchte A, Zhao Y, Cairns C, Rouphael N, Bosinger S, Kim-Schulze S, Krammer F, Rosen L, Grubaugh N, van Bakel H, Wilson M, Rajan J, Steen H, Eckalbar W, Cotsapas C, Langelier C, Levy O, Altman M, Maecker H, Montgomery R, Haddad E, Sekaly R, Esserman D, Ozonoff A, Becker P, Augustine A, Guan L, Peters B, Kleinstein S. Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients Cell Reports Medicine 2023, 4: 101079. diseases 2023, 485-490. Sumida T. Regulatory T cells in peripheral tissue tolerance and diseases Frontiers In V, L. Cytokines in NewOnset Refractory 36871188](https://pubmed.ncbi.nlm.nih.gov/36871188), [DOI: 10.1002/ana.26627](https://doi.org/10.1002/ana.26627). - Liu Y, DiStasio M, Su G, Asashima H, Enninful A, Qin X, Deng Y, Nam J, Gao F, Bordignon P, Cassano M, Tomayko M, Xu M, Halene S, Craft J, Hafler D, Fan R. High-plex protein and whole transcriptome co-mapping at cellular resolution with CITE-seq 1-5. [PMID: 36823353](https://pubmed.ncbi.nlm.nih.gov/36823353), [DOI: Geisberger S, Roels J, Van Zeebroeck L, Dyczko A, van Gisbergen M, Kurniawan H, Wagner A, Yosef N, Weiss S, Schmetterer K, Schr\u00f6der A, Krampert L, Haase S, Bartolomaeus J, perturbs CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity](http://www.ncbi.nlm.nih.gov/pubmed/36634138)Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson K, Kakara M, Zuroff L, Bennett J, von B\u00fcdingen H, Carruthers R, Edwards K, Fallis R, Giacomini P, Greenberg B, Hafler D, Ionete C, Kaunzner U, Lock C, Longbrake E, Pardo G, Piehl F, Weber M, Ziemssen T, Jacobs D, Gelfand J, Cross A, Cameron B, Musch B, Winger R, Jia X, Harp C, Herman A, Bar-Or A. Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity Proceedings Of The National Academy Of Sciences Of The United States Of America in human acute viral infection](http://www.ncbi.nlm.nih.gov/pubmed/36596303)Asashima H, Mohanty S, Comi M, Ruff W, Hoehn K, Wong P, Klein J, Lucas C, Cohen I, Coffey S, Lele N, Greta L, Raddassi K, Chaudhary O, Unterman A, Emu B, Kleinstein S, Montgomery R, Iwasaki A, Dela Cruz C, Kaminski N, Shaw A, Hafler D, Sumida T. PD-1highCXCR5-CD4+ peripheral helper T cells promote CXCR3+ plasmablasts in human acute viral infection an essential role for HDAC7 in regulatory T cells](http://www.ncbi.nlm.nih.gov/pubmed/36516268)Axisa P, Yoshida T, Lucca L, Kasler H, Lincoln M, Pham G, Del Priore D, Carpier J, Lucas C, Verdin E, Sumida T, Hafler D. A multiple sclerosis-protective coding variant reveals an essential role for HDAC7 in regulatory T cells a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure](http://www.ncbi.nlm.nih.gov/pubmed/36514045)Qu R, Kluger Y, Yang J, Zhao J, Hafler D, Krause D, Bersenev A, Bosenberg M, Hurwitz M, Lucca L, Kluger H. Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure Molecular Cancer cells drives circulating follicular helper T cell expansion in multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/36250467)Asashima Pham Sumida TS, Hafler DA. Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis Journal Of limited diversity of protection against COVID-19 in patients with altered immunity.](http://www.ncbi.nlm.nih.gov/pubmed/36093346)Kim D, Biancon G, Bai Z, VanOudenhove J, Liu Y, Kothari S, Gowda L, NC, R. Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity. BioRxiv : The Preprint of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome](http://www.ncbi.nlm.nih.gov/pubmed/36031693)Longbrake EE, Hua LH, Mowry EM, Gauthier SA, Alvarez E, Cross AH, Pei J, Priest J, Raposo C, Hafler DA, Winger RC. The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome Multiple Sclerosis in a cohort of hospitalized COVID-19 patients: Results from the CB, M, LR, Shaw AC, Krammer F, van Bakel H, Esserman DA, Liu S, Sesma AF, Simon V, Hafler DA, Montgomery RR, Kleinstein SH, Levy O, Bime C, Haddad EK, Erle DJ, Pulendran B, Nadeau MM, Hough Corry D, Kheradmand F, Ehrlich LIR, Melamed E, McComsey GA, Sekaly R, Diray-Arce J, Peters B, Augustine AD, Reed EF, Altman MC, Becker PM, Rouphael N, Ozonoff A, Schaenman J, Jayavelu N, Milliren C, Calfee C, Cairns C, Kraft M, Baden L, Shaw A, Krammer F, van Bakel H, Esserman D, Liu S, Sesma A, Simon V, Hafler D, Montgomery R, Kleinstein S, Levy O, Bime C, Haddad E, Erle D, Pulendran B, Nadeau K, Davis M, Hough C, Messer W, Higuita N, Metcalf J, Atkinson M, Brakenridge S, Corry D, Kheradmand F, Ehrlich L, Melamed E, McComsey G, Sekaly R, Diray-Arce J, Peters B, Augustine A, Reed E, McEnaney K, Barton B, Lentucci C, Saluvan M, Chang A, Hoch A, Albert M, Shaheen T, Kho A, Thomas S, Chen J, Murphy M, Cooney M, Presnell S, Fragiadakis G, Patel R, Guan L, Gygi J, Pawar S, Brito A, Khalil Z, Maguire C, Fourati S, Overton J, Vita R, Westendorf K, Salehi-Rad R, Leligdowicz A, Matthay M, Singer J, Kangelaris K, Hendrickson C, Krummel M, Langelier C, Woodruff P, Powell D, Kim J, Simmons B, Goonewardene I, Smith C, Martens M, Mosier J, Kimura H, Sherman A, Walsh S, Issa N, Dela Cruz C, Farhadian S, Iwasaki A, Ko A, Chinthrajah S, Ahuja N, Rogers A, Artandi M, Siegel S, Lu Z, Drevets D, Brown B, Anderson M, Guirgis F, Thyagarajan R, Rousseau J, Wylie D, Busch J, Gandhi S, Triplett T, Yendewa G, Giddings O, Anderson E, Mehta A, Sevransky J, Khor B, Rahman A, Stadlbauer D, Dutta J, Xie H, Kim-Schulze S, Gonzalez-Reiche A, van de Guchte A, Farrugia K, Khan Z, Maecker H, Elashoff D, Brook J, Ramires-Sanchez E, Llamas M, Rivera A, Perdomo C, Ward D, Magyar C, Fulcher J, Abe-Jones Y, Asthana S, Beagle S, Carrillo S, Chak S, Fragiadakis G, Ghale R, Gonzalez A, Jauregui A, Jones N, Lea T, Lee D, Lota R, Milush J, Nguyen V, Pierce L, Prasad P, Rao A, Samad B, Shaw C, Sigman A, Sinha P, Ward A, Willmore A, Zhan J, Rashid S, Rodriguez N, Tang K, Altamirano L, Betancourt L, Curiel C, Sutter N, Paz M, Tietje-Ulrich G, Leroux C, Connors J, Bernui M, Kutzler M, Edwards C, Lee E, Lin E, Croen B, Semenza N, Rogowski B, Melnyk N, Woloszczuk K, Cusimano G, Bell M, Furukawa S, McLin R, Marrero P, Sheidy J, Tegos G, Nagle C, Mege N, Ulring K, Seyfert-Margolis V, Conway M, Francisco D, Molzahn A, Erickson H, Wilson C, Schunk R, Sierra B, Hughes T, Smolen K, Desjardins M, van Haren S, Mitre X, Cauley J, Li X, Tong A, Evans B, Montesano C, Licona J, Krauss J, Chang J, Izaguirre O, Coppi A, Fournier J, Mohanty M, Ruff W, Salahuddin S, Schulz W, Vijayakumar P, Wang H, Wunder E, Young H, Zhao Y, Saksena M, Altman D, Kojic E, Srivastava K, Eaker L, Berm\u00fadez-Gonz\u00e1lez M, Beach K, Sominsky L, Azad A, Carre\u00f1o J, Singh G, Raskin J, Bielak D, Kawabata H, Mulder L, Kleiner G, Lee A, E, Fernandes A, Manohar M, Hagan T, Blish C, Din H, Roque J, Yang S, Brunton A, Sullivan P, Strnad M, Lyski Z, Coulter F, Booth J, Sinko L, Moldawer L, Borresen B, Roth-Manning B, Song L, Nelson E, Lewis-Smith M, Smith J, Tipan P, Siles N, Bazzi S, Geltman J, Hurley K, Gabriele G, Sieg S, Vaysman T, Bristow L, Hussaini L, Hellmeister K, Samaha H, Cheng A, Spainhour C, Scherer E, Johnson B, Bechnak A, Ciric C, Hewitt L, Carter E, Mcnair N, Panganiban B, Huerta C, Usher J, Ribeiro S, Altman M, Becker P, Rouphael N. Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from M. Fatty Acid Metabolism and T Cells in Multiple DiStasio M, Su G, Asashima H, Enninful A, Qin X, Deng Y, Bordignon P, Cassano M, Tomayko M, Xu M, Halene S, Craft J, Hafler D. Spatial-CITE-seq: spatially resolved receptors in human T cells](http://www.ncbi.nlm.nih.gov/pubmed/35301508)Sumida TS, Dulberg VK, Hafler DA. Type I interferon transcriptional network regulates expression of coinhibitory receptors in human of mouse and human brain](http://www.ncbi.nlm.nih.gov/pubmed/35260865)Marsh SE, Walker AJ, Kamath T, Dissing-Olesen L, Hammond TR, de Soysa TY, Young AMH, Murphy S, Abdulraouf A, Nadaf N, Dufort C, Walker AC, Lucca LE, Kozareva V, Vanderburg C, Hong S, Bulstrode H, Hutchinson PJ, Gaffney DJ, Hafler DA, Franklin RJM, Macosko EZ, Stevens B. Dissection of artifactual and confounding glial signatures by single-cell sequencing Daud AI, Hafler DA, Kluger HM, Raychaudhuri S, Sharpe AH. TCR-sequencing in cancer and adaptive immune system in progressive COVID-19](http://www.ncbi.nlm.nih.gov/pubmed/35064122)Unterman A, Sumida TS, Nouri N, Yan X, Zhao AY, Gasque V, Schupp JC, Asashima H, Liu Y, Cosme C, Deng W, Chen M, Raredon MSB, Hoehn KB, Wang G, Wang Z, DeIuliis G, Ravindra NG, Li N, Castaldi C, Wong P, Minasyan M, Mohanty S, Ruff WE, Cohen I, Raddassi K, Niklason L, Ko A, Montgomery R, Farhadian S, Iwasaki A, Shaw A, van Dijk D, Zhao H, Kleinstein S, Hafler D, Kaminski N, Dela Cruz C. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19 Nature Communications Kissel JT, Wolfe GI, Burns TM, Freimer ML, Nations S, Granit V, Smith AG, Richman DP, Ciafaloni E, Al-Lozi MT, Sams LA, Quan D, Ubogu E, Pearson B, Sharma A, Yankey JW, Uribe L, Shy M, Amato AA, Conwit R, O'Connor KC, Hafler DA, Cudkowicz ME, Barohn RJ, Team O. Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive LE. The double-edged sword: Harnessing imaging: Worth its salt for understanding multiple sclerosis Proceedings Of The National Academy Of Sciences Of The United States Of J, Kleinstein S, Altman M, Bosinger S, Eckalbar W, Guan L, Hough C, Krammer F, Langelier C, Levy O, McEnaney K, Peters B, Rahman A, Rajan J, Sigelman S, Steen H, van Bakel H, Ward A, Wilson M, Woodruff P, Zamecnik C, Augustine A, Ozonoff A, Reed E, Becker P, Higuita N, Altman M, Atkinson M, Baden L, Becker P, Bime C, Brakenridge S, Calfee C, Cairns C, Corry D, Davis M, Augustine A, Ehrlich L, Haddad E, Erle D, Fernandez-Sesma A, Hafler D, Hough C, Kheradmand F, Kleinstein S, Kraft M, Levy O, McComsey G, Melamed E, Messer W, Metcalf J, Montgomery R, Nadeau K, Ozonoff A, Peters B, Pulendran B, Reed E, Rouphael N, Sarwal M, Schaenman J, Sekaly R, Shaw A, Simon V. Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective Fleming I, Hoehn KB, Dardick KR, Belperron of the skin lesion erythema SC, Bukreyev A, Kleinstein SH. Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19 The of Coinhibitory Receptors in Human T cells.](http://www.ncbi.nlm.nih.gov/pubmed/34127967)Hafler D, Sumida Schupp M, Unterman A, Kaminski N, Madi A, Kuchroo V. Type I Interferon Transcriptional Network Regulates Expression of Coinhibitory Receptors in Human T differential or co-expression analysis AM. NEBULA is a fast negative binomial mixed model for differential or co-expression analysis of large-scale with autoimmune disorders and advanced malignancies (AIM-NIVO).](https://doi.org/10.1200/jco.2021.39.15_suppl.tps2676)Dumbrava E, Dougan M, Gupta S, Cappelli L, Katsumoto T, Rahma O, Painter J, Wang Y, Suarez-Almazor M, Reid P, Wesley S, Hafler D, Bingham C, Warner B, Chung L, Ott P, Kluger H, Khosroshahi A, Tawbi H, Sharon E. A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies Cells from Patients with COVID-19 and Idiopathic Pulmonary Fibrosis Demonstrates Dissimilar Cell Shifts and Gene Expression Profiles](https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4361)Zhao A, Unterman A, Schupp J, Adams T, Sumida T, Ryu C, DeIuliis G, Yan X, Hafler D, Dela Cruz C, Herzog E, Kaminski N. Comparative scRNA-seq Analysis of Peripheral Blood Mononuclear Cells from Patients with COVID-19 and Idiopathic Pulmonary Fibrosis Demonstrates Dissimilar Cell Shifts and Gene [DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4361](https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4361). M, Asashima Liu Y, Shah A, Ravindra NG, Bishai J, Khan A, Lau W, Sellers B, Bansal N, Guerrerio P, Unterman A, Habet V, Rice AJ, Catanzaro J, Chandnani H, Lopez M, Kaminski N, Dela Cruz CS, Tsang JS, Wang Z, Yan X, Kleinstein SH, van Dijk D, Pierce RW, Hafler DA, Lucas CL. Immune autoreactivity correlate with disease severity in M, Asashima Liu Y, Shah A, Ravindra NG, Bishai J, Khan A, Lau W, Sellers B, Bansal N, Guerrerio P, Unterman A, Habet V, Rice AJ, Catanzaro J, Chandnani H, Lopez M, Kaminski N, Dela Cruz CS, Tsang JS, Wang Z, Yan X, Kleinstein SH, van Dijk D, Pierce RW, Hafler DA, Lucas CL. Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity. MedRxiv : The Preprint Jessel S, Zhang L, Raddassi K, Zhang L, Olino K, Clune J, Singer M, Kluger HM, Hafler DA. Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells Journal Of Tumor-Associated CK, Zito CR, in Melanoma by Subcellular FOXP3 regulatory T cells from patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/33170805)Pompura SL, Wagner A, Kitz A, Laperche J, Yosef N, Dominguez-Villar M, acid restores suppressive defects in tissue-resident FOXP3 regulatory T cells from patients with multiple sclerosis Journal Of Clinical Investigation 2021, 131 Receptors in Human T N, A, Kuchroo VK, Hafler DA. Type I Interferon Transcriptional Network Regulates Expression of Coinhibitory Receptors in Human T cells. BioRxiv : The Preprint [Two genetic variants explain the association of European ancestry with multiple sclerosis risk in African-Americans](http://www.ncbi.nlm.nih.gov/pubmed/33037294)Nakatsuka N, Patterson N, Patsopoulos NA, Altemose N, Tandon A, Beecham AH, McCauley JL, N, Hauser S, De Jager PL, Hafler DA, Oksenberg JR, Reich D. Two genetic variants explain the association of European ancestry with multiple sclerosis risk in African-Americans Scientific fine-mapping: identification of causal Dijk D, Hafler DA. Transcriptomic and clonal characterization of T cells in the human central nervous system Science Immunology patients with autoimmune disorders and advanced malignancies (AIM-NIVO)](https://doi.org/10.1158/1538-7445.am2020-ct249)Ileana Dumbrava E, Suarez-Almazor M, Painter J, Johanns T, Dougan M, Cappelli L, Wang Y, Bingham C, Gupta S, Warner B, Rahma O, Naidoo J, Ott P, Hafler D, Kluger H, Khosroshahi A, Naqash R, Chung L, Katsumoto T, Kummar S, Tawbi H, Sharon E. Abstract CT249: A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO) Research 2020, Ib study of autoimmune disorders and advanced malignancies (AIM-NIVO).](https://doi.org/10.1200/jco.2020.38.15_suppl.tps3158)Ileana Dumbrava E, Suarez-Almazor M, Painter J, Johanns T, Dougan M, Cappelli L, Bingham C, Wang Y, Gupta S, Warner B, Rahma O, Naidoo J, Ott P, Hafler D, Kluger H, Khosroshahi A, Katsumoto T, Kummar S, Sharon E, Tawbi H. A phase Ib study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO). Journal Of Clinical Oncology 2020, 38: tps3158-tps3158. Lucca Harnett B, Kumar VP, Ponath G, Raddassi K, Huttner A, Hafler DA, Pitt D. Differential expression of the T-cell inhibitor TIGIT in D, van Dijk D. Disease state prediction from single-cell data using graph attention networks 2020, 121-130. [DOI: 10.1145/3368555.3384449](https://doi.org/10.1145/3368555.3384449). - Wesley S, Hafler D. Chapter 51 Sclerosis 2020, 961-986. [DOI: 10.1016/b978-0-12-812102-3.00051-8](https://doi.org/10.1016/b978-0-12-812102-3.00051-8). - Consortium I, Mitrovi M, Patsopoulos N, Beecham A, Dankowski T, Goris A, Dubois B, D'hooghe M, Lemmens R, Van Damme P, S\u00f8ndergaard H, Sellebjerg Sorensen Ullum C, Bayas A, Heesen C, K\u00fcmpfel T, Linker J, R, Duijn C, Teunissen C, Bos S, Myhr K, Celius E, Lie B, Spurkland A, Comabella M, Piehl F, Jeli I, Martin R, Sospedra M, Ban M, Hawkins C, Hysi P, Kalra S, Karpe F, Khadake J, Lachance G, Neville M, Santaniello A, Caillier S, Calabresi P, Cree B, Cross A, Davis M, Haines J, de Bakker P, Delgado S, Dembele M, Edwards K, Fitzgerald K, Hakonarson H, Konidari I, Lathi E, Manrique C, Pericak-Vance M, Piccio L, Schaefer C, McCabe C, Weiner H, Goldstein J, Olsson T, Hadjigeorgiou G, Taylor B, Tajouri L, Charlesworth J, Booth D, Harbo H, Ivinson A, Hauser S, Compston A, Stewart G, Zipp F, Barcellos L, Baranzini Hafler D, Cotsapas C. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis EE. CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome Journal Shoostari P, Cotsapas C, Wong G, Beecham A, James T, Replogle J, Vlachos I, McCabe C, Pers T, Brandes A, White C, Keenan B, Cimpean M, Winn P, Panteliadis I, Robbins A, Andlauer T, Zarzycki O, Dubois B, Goris A, S\u00f8ndergaard C, Grummel V, Hemmer B, Hoshi A, S, Mancini N, Zuccal\u00e0 M, Mescheriakova J, van Duijn C, Bos S, Celius Spurkland Comabella M, Piehl F, Jeli I, Martin R, Sospedra M, Baker A, Ban M, Hawkins C, Hysi P, Kalra S, Karpe F, Khadake J, Lachance M, Thorpe J, Bradshaw E, Caillier S, Calabresi P, Cree B, Cross A, Davis M, de Bakker P, Delgado S, Dembele M, Edwards K, Fitzgerald K, Frohlich I, Gourraud P, Haines J, Hakonarson H, Kimbrough D, Isobe N, Konidari I, Lathi E, Lee M, Li T, An D, Zimmer A, Madireddy L, Manrique C, Mitrovic M, Olah M, Patrick E, Pericak-Vance M, Piccio L, Schaefer C, Weiner H, Lage K, Compston A, Hafler D, Harbo H, Hauser S, Stewart G, D'Alfonso S, Hadjigeorgiou G, Taylor B, Barcellos L, Booth D, Hintzen R, Kockum I, Martinelli-Boneschi J, Oksenberg J, A, Sawcer S, Ivinson A, Olsson T, De Jager P. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in [PMID: 31604244](https://pubmed.ncbi.nlm.nih.gov/31604244), Multiple 2019, Dominguez-Villar M. AKT isoforms modulate Th1like Treg generation and function in human T cells links inflammatory environments to autoimmunity](http://www.ncbi.nlm.nih.gov/pubmed/31175348)Sumida T, Lincoln MR, Ukeje CM, Rodriguez DM, Akazawa H, Noda T, Naito AT, I, DA. Author Correction: Activated -catenin in Foxp3+ regulatory T cells links inflammatory 2019, Beecham A, Dankowski T, Goris A, Dubois B, D'hooghe M, Lemmens R, Van Damme P, S\u00f8ndergaard H, Sellebjerg Sorensen Ullum C, Bayas A, Heesen C, K\u00fcmpfel T, Linker J, R, Duijn C, Theunissen C, Bos S, Myhr K, Celius E, Lie B, Spurkland A, Comabella M, Piehl F, Jeli I, Martin R, Sospedra M, Ban M, Hawkins C, Hysi P, Kalra S, Karpe F, Khadake J, Lachance G, Neville M, Santaniello A, Caillier S, Calabresi P, Cree B, Cross A, Davis M, Haines J, de Bakker P, Delgado S, Dembele M, Edwards K, Fitzgerald K, Hakonarson H, Konidari I, Lathi E, Manrique C, Pericak-Vance M, Piccio L, Schaefer C, McCabe C, Weiner H, Goldstein J, Olsson T, Hadjigeorgiou G, Taylor B, Tajouri L, Charlesworth J, Booth D, Harbo H, Ivinson A, Hauser S, Compston A, Stewart G, Zipp F, Barcellos L, Baranzini Hafler D, Cotsapas C. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis to modulates [Yjaut Neurologic Antigens relatives of SLE and RA patients](http://www.ncbi.nlm.nih.gov/pubmed/30952617)James JA, Chen H, Young KA, MH, Keating RM, Gaffney PM, Kelly JA, Langefeld CD, Harley JB, Robinson W, Hafler DA, O'Connor KC, J, Norris disease-specific boundaries in at-risk first-degree relatives of T, Takahashi T, Grover JR, Iwasaki DA, Montgomery RR, Fikrig E. Aedes aegypti AgBR1 antibodies modulate early Zika virus infection of 2019, S, Spreafico R, Hafler DA, McKinney EF. From Big Data to Precision Medicine Frontiers In Medicine 2019, 6: Dominguez-Villar M, signaling restores suppressor 2 Genetics of Multiple Sclerosis 2019, 33-54. [DOI: 10.1039/9781788016070-00033](https://doi.org/10.1039/9781788016070-00033). - Ponath G, Lincoln MR, Levine-Ritterman M, Park C, Dahlawi S, Mubarak M, Sumida T, Airas L, Zhang S, Isitan C, Nguyen TD, Raine CS, Hafler DA, Pitt D. Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis Nature cells using multi-directional magnetic ratcheting](http://www.ncbi.nlm.nih.gov/pubmed/30420988)Murray C, Miwa H, Dhar M, Park DE, Pao E, Martinez J, Kaanumale S, Loghin E, Graf J, Raddassi K, Kwok WW, Hafler D, Puleo C, Di Carlo D. Correction: Unsupervised capture and profiling of rare immune cells using multi-directional magnetic ratcheting Lab On A Chip 2018, 18: 3703. 30420988](https://pubmed.ncbi.nlm.nih.gov/30420988), [DOI: 10.1039/c8lc90095g](https://doi.org/10.1039/c8lc90095g). Akazawa H, Noda T, Naito AT, I, Dominguez-Villar M, Hafler DA. Activated -catenin in Foxp3+ regulatory T cells links inflammatory environments Beecham A, Dankowski T, Goris A, Dubois B, D'hooghe M, Lemmens R, Van Damme P, S\u00f8ndergaard H, Sellebjerg Sorensen Ullum C, Bayas A, Heesen C, K\u00fcmpfel T, Linker J, R, Duijn C, Theunissen C, Bos S, Myhr K, Celius E, Lie B, Spurkland A, Comabella M, Piehl F, Jeli I, Martin R, Sospedra M, Ban M, Hawkins C, Hysi P, Kalra S, Karpe F, Khadake J, Lachance G, Neville M, Santaniello A, Caillier S, Calabresi P, Cree B, Cross A, Davis M, Haines J, de Bakker P, Delgado S, Dembele M, Edwards K, Fitzgerald K, Hakonarson H, Konidari I, Lathi E, Manrique C, Pericak-Vance M, Piccio L, Schaefer C, McCabe C, Weiner H, Goldstein J, Olsson T, Hadjigeorgiou G, Taylor B, Tajouri L, Charlesworth J, Booth D, Harbo H, Ivinson A, Hauser S, Compston A, Stewart G, Zipp F, Barcellos L, Baranzini Hafler D, Cotsapas C. Low-Frequency and Rare-Coding Variation Contributes to during virologically suppressed HIV](http://www.ncbi.nlm.nih.gov/pubmed/30232286)Farhadian SF, Mehta SS, Zografou C, Robertson K, Price RW, Pappalardo J, Chiarella DA, reveals cells in cerebrospinal fluid during DA. modulates cell phenotype and regulatory T Dhar M, Park DE, Pao E, Martinez J, Kaanumale S, Loghin E, Graf J, Rhaddassi K, Kwok WW, Hafler D, Puleo C, Di Carlo D. Unsupervised capture and profiling of rare immune cells using multi-directional magnetic ratcheting Lab On A D. Regulatory T Cells: From Discovery to Autoimmunity Cold Spring Harbor Perspectives Hafler DA. Podoplanin is a negative cells in healthy donors and patients with glioblastoma multiforme](http://www.ncbi.nlm.nih.gov/pubmed/28880903)Goods BA, Hernandez AL, Lowther DE, Lucca LE, Lerner BA, Gunel M, Raddassi K, Coric V, Hafler DA, Love JC. Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy R, Gottardo R, Khatri S, Kotliarov Y, Meng H, Sauteraud R, Shen-Orr S, Tsang J, Vallania F, Anguiano E, Baisch J, Baldwin N, Belshe R, Blevins T, Chaussabel D, Davis M, Fikrig E, Grill D, Hafler D, Henrich E, Joshi S, Kaech S, Kennedy R, Mohanty S, Montgomery R, Oberg A, Obermoser G, Ovsyannikova I, Palucka A, Pascual V, Poland G, Pulendran B, Reinherz E, Shaw A, Siconolfi B, Stuart K, Tsang S, Ueda I, Wilson J, Zapata H. Multicohort analysis reveals baseline transcriptional predictors of a glioma oncometabolite prevents CD8+ T cell in Patients After Intracerebral Hemorrhage](https://doi.org/10.1161/str.48.suppl_1.213)Askenase M, Goods B, Steinschneider A, Raddassi K, Beatty H, Hafler D, Love J, Sansing L. Abstract 213: Hematoma-infiltrating Macrophages Transition From Inflammatory to Reparative Programs Intracerebral Hemorrhage Stroke 2017, 48 [DOI: 10.1161/str.48.suppl_1.213](https://doi.org/10.1161/str.48.suppl_1.213). - Vodovotz A, Read EL, Bassaganya-Riera J, Hafler DA, Sontag E, Wang J, Tsang JS, Day JD, Kleinstein SH, Butte AJ, Altman MC, Hammond Chang CF, Goods BA, Hammond MD, Grory B, Ai Y, Steinschneider promotes Cell 2016, 27814519](https://pubmed.ncbi.nlm.nih.gov/27814519), [DOI: 10.1016/j.cell.2016.10.040](https://doi.org/10.1016/j.cell.2016.10.040). Baranzini S, Barcellos L, Barizzone N, Beecham A, Berge T, Bernardinelli L, Booth D, Bos S, Buck D, Butkiewicz M, Celius E, Comabella M, Compston A, Dedham K, Cotsapas C, Alfonso S, De Jager P, Dubois B, Duquette P, Fontaine B, Gasperi C, Gil E, Goris C, Gyllenberg A, Hadjigeorgiou G, Hafler D, Hribko D, Haines J, Harbo H, Hauser S, Warto S, Hawkins C, Hemmer B, Henry R, Hintzen R, Horakova D, Ivinson A, Howard M, Jelcic I, Kaskow B, Kira J, Kleinova P, Kockum I, Kucerova K, Lill C, Luessi F, Malhotra S, Martin R, Martinelli F, Matsushita T, McCabe C, McCauley J, Mescheriakkova J, Mitrovic M, Moen S, Montalban H, Sorensen P, Sospedra M, Spurkland A, Stewart G, Taylor B, Uitterlinden A, Van Duijn C, Zipp F. NR1H3 p.Arg415Gln Is Not Associated to to Clinical Phenotype in Multiple Sclerosis: In Search He J, Hernandez AL, Joe B, Karumanchi SA, Maric-Bilkan C, Mattson D, Mehta NN, Randolph G, Ryan M, Sandberg K, Titze J, Tolunay E, Toney GM, Harrison DG. National Heart, Lung, and Blood Institute Working Group Report on Salt in Human Health and Sickness Hypertension 2016, Dominguez-Villar M. AKT isoforms modulate Th1like Treg generation and function in human Liver-Transplanted Recipients with De Novo Autoimmune Hepatitis Is Enhanced and Induces TH1-like Regulatory T Cells](http://www.ncbi.nlm.nih.gov/pubmed/27183637)Arterbery AS, Osafo-Addo A, Avitzur Y, Ciarleglio Deng Proinflammatory Cytokines by Monocytes in Liver-Transplanted Recipients with De Novo Autoimmune Hepatitis Is Enhanced and Induces TH1-like Regulatory T Cells The Journal Lucca LE, Lerner BA, Raddassi K, van Dijk D, Hernandez AL, Duan X, Gunel M, Coric V, Krishnaswamy S, Love JC, Hafler DA. PD-1 marks dysfunctional regulatory T cells in malignant O'Connor KC. Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis New England Journal Of Medicine 2016, AH, Papinutto N, Shinohara RT, Stern W, Amann M, Bakshi R, Bischof A, Carriero A, Comabella M, Crane JC, D'Alfonso S, Demaerel P, Dubois B, Filippi M, Fleischer V, Fontaine B, Gaetano L, Goris BMJ, Villoslada P, Wattjes MP, Weiner H, Wuerfel J, Zimmer C, Zipp F, Consortium I, Hauser SL, Oksenberg JR, Henry RG. Power estimation Ponath G, Zabad R, VL, Vortmeyer AO, Hafler DA, D. demyelination Hafler DA. The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations. Current 17: 651-65. [PMID: 26844569](https://pubmed.ncbi.nlm.nih.gov/26844569), [DOI: 10.2174/1389450117666160201105934](https://doi.org/10.2174/1389450117666160201105934). [Investigating Nervous System-Derived Immunoglobulins](http://www.ncbi.nlm.nih.gov/pubmed/26648933)Willis SN, Stathopoulos P, Chastre A, Compton SD, Hafler DA, O'Connor K. Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins Frontiers IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE-143](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638710)Lowther Reap E, Vlahovic Sahebjam S, Baehring J, Voloschin A, Cloughesy T, Lim M, Coric V, Latek R, Simon J, Lerner B, Raddassi K, Hafler D, Sampson J. CBM-06IMMUNE BIOMARKER RESULTS FROM A TRIAL OF NIVOLUMAB \u00b1 IN COMBINATION WITH IPILIMUMAB IN RECURRENT GLIOBLASTOMA: UPDATED RESULTS FROM CHECKMATE-143](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638899)Sampson J, Omuro Vlahovic G, Sahebjam S, Baehring A, Simon J, Latek R, Coric V, Cloughesy T, Lim M, Reardon D. IMCT-03SAFETY AND ACTIVITY OF NIVOLUMAB MONOTHERAPY AND NIVOLUMAB IN COMBINATION WITH IPILIMUMAB IN Goods Lowther D, Hernandez A, Lerner B, Gunel M, Raddassi K, Simon J, Latek R, Coric V, Love J, Hafler D. CBM-04PD-1 EXPRESSION IDENTIFIES EXHAUSTED TUMOR INFILTRATING REGULATORY T EFFECTOR CELLS IN HEALTHY DONORS AND PATIENTS WITH GLIOBLASTOMA](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638709)Goods B, Lowther D, Lucca L, Hernandez A, Lerner B, Gunel M, Raddassi K, Simon J, Coric V, Love J, Hafler D. CBM-05FUNCTIONAL DIFFERENCES BETWEEN PD-1+ AND PD-1- CD4+ T EFFECTOR CELLS IN HEALTHY Kitz A, Wu C, Lowther DE, Rodriguez DM, Vudattu N, Deng S, Herold KC, Kuchroo VK, Kleinewietfeld M, DA. Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells Journal Of Reardon DA, Sampson JH. Prospects of immune checkpoint modulators in the treatment of to inflammatory stimuli](http://www.ncbi.nlm.nih.gov/pubmed/26062845)Housley WJ, Fernandez SD, Vera K, Murikinati SR, Mitrovic Cotsapas Hafler DA. Genetic variants associated with autoimmunity drive NFB signaling and responses to inflammatory stimuli with ipilimumab in recurrent glioblastoma J, Coric V, Cloughesy T, Lim M, Reardon D. Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma Hafler DA, Astier AL. Editorial: T Cell Regulation by the Environment Frontiers T cells from patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/25972006)Cao Y, Goods BA, Raddassi K, Nepom GT, Kwok WW, Love JC, Hafler DA. Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis Science Bilenky M, Yen A, Heravi-Moussavi A, Kheradpour P, Zhang Z, Wang J, Ziller M, Amin V, Whitaker J, Schultz M, Ward L, Sarkar A, Quon G, Sandstrom R, Eaton M, Wu Y, Pfenning A, Wang X, ClaussnitzerYaping Liu M, Coarfa C, Alan Harris R, Shoresh N, Epstein C, Gjoneska E, Leung D, Xie W, David Hawkins R, Lister R, Hong C, Gascard P, Mungall A, Moore R, Chuah E, Tam A, Canfield T, Scott Hansen R, Kaul R, Sabo P, Bansal M, Carles A, Dixon J, Farh K, Feizi S, Karlic R, Kim A, Kulkarni A, Li D, Lowdon R, Elliott G, Mercer T, Neph S, Onuchic V, Polak P, Rajagopal N, Ray P, Sallari R, Siebenthall K, Sinnott-Armstrong N, Stevens M, Thurman R, Wu J, Zhang B, Zhou X, Abdennur N, Adli M, Akerman M, Barrera L, Antosiewicz-Bourget J, Ballinger T, Barnes M, Bates D, Bell R, Bennett D, Bianco K, Bock C, Boyle P, Brinchmann J, Caballero-Campo P, Camahort R, Carrasco-Alfonso M, Charnecki T, Chen H, Chen Z, Cheng J, Cho S, Chu A, Chung W, Cowan C, Athena Deng Q, Deshpande V, Diegel M, Ding B, Durham T, Echipare L, Edsall L, Flowers D, Genbacev-Krtolica O, Gifford C, Gillespie S, Giste E, Glass I, Gnirke A, Gormley M, Gu H, Gu J, Hafler D, Hangauer M, Hariharan M, Hatan M, Haugen E, He Y, Heimfeld S, Herlofsen S, Hou Z, Humbert R, Issner R, Jackson A, Jia H, Jiang P, Johnson A, Kadlecek T, Kamoh B, Kapidzic M, Kent J, Kim A, Kleinewietfeld M, Klugman S, Krishnan J, Kuan S, Kutyavin T, Lee A, Lee K, Li J, Li N, Li Y, Ligon K, Lin S, Lin Y, Liu J, Liu Y, Luckey C, Ma Y, Maire C, Marson A, Mattick J, Mayo M, McMaster M, Metsky H, Mikkelsen T, Miller D, Miri M, Mukame E, Nagarajan R, Neri F, Nery J, Nguyen T, O'Geen H, Paithankar S, Papayannopoulou N, Raghuraman S, Raney B, Raubitschek A, Reynolds A, Richards H, Riehle K, Rinaudo P, Robinson J, Rockweiler N, Rosen E, Rynes E, Schein J, Sears R, Sejnowski T, Shafer A, Shen L, Shoemaker R, Sigaroudinia M, Slukvin I, Stehling-Sun S, Stewart R, Subramanian S, Suknuntha K, Swanson S, Tian S, Tilden H, Tsai L, Urich M, Vaughn I, Vierstra J, Vong S, Wagner U, Wang H, Wang T, Wang Y, Weiss A, Whitton H, Wildberg A, Witt H, Won K, Xie M, Xing X, Xu I, Xuan Z, Ye Z, Yen C, Yu P, Zhang X, Zhang X, Zhao J, Zhou Y, Zhu J, Zhu Y, Ziegler S, Beaudet A, Boyer L, De Jager P, Farnham P, Fisher S, Haussler D, Jones S, Li W, Marra M, McManus M, Sunyaev S, Thomson J, Tlsty T, Tsai L, Wang W, Waterland R, Zhang M, Chadwick L, Bernstein B, Costello J, Ecker J, Hirst M, Meissner A, Milosavljevic A, Ren B, Stamatoyannopoulos J, Wang T, Kellis M. Integrative analysis of 111 DA, Gimelbrant A, Chess A. Monoallelic expression of the human FOXP2 speech gene Proceedings Of The National Academy Of Sciences Of The United States Of America 2014, Hafler DA. TLR7 induces anergy Interleukin 10 After Influenza Vaccination in Older Adults](http://www.ncbi.nlm.nih.gov/pubmed/25367297)Mohanty S, Joshi SR, Ueda I, Wilson J, Blevins TP, Siconolfi B, Meng H, Devine L, SM, Proinflammatory Cytokine Production in Monocytes Modulated by Interleukin 10 After Influenza Vaccination in Older Adults The Journal Of Infectious Diseases 2014, 211: 1174-1184. Meng H, Wang X, You F, Devine L, Raddassi K, Garcia MN, Murray KO, Bolen SS, Hafler D, Fikrig E, Xavier R, Kleinstein SH, Montgomery RR. Systems Immunology Reveals Markers of Susceptibility to West Nile Virus MJ, Hafler DA, Bernstein BE. Genetic and epigenetic fine mapping of causal autoimmune disease BA, Vigneault F, Kleinstein SH, Hafler DA, O'Connor KC. B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes Science Translational C, Levkovich T, Perrotta A, Bhela S, Varian B, Ibrahim Y, Lakritz J, Kearney S, Chatzigiagkos A, Hafler D, Alm E, Obesity 2014, 17-43. [DOI: 10.1201/b17254-6](https://doi.org/10.1201/b17254-6). [Joint Modeling and Registration of Cell Populations in Cohorts of High-Dimensional Flow Cytometric Data](http://www.ncbi.nlm.nih.gov/pubmed/24983991)Pyne S, Lee SX, Wang K, Irish Tamayo P, Nazaire MD, Duong T, Ng SK, Hafler D, Levy R, Nolan GP, Mesirov J, McLachlan GJ. Joint Modeling and Registration of Cell Populations in Cohorts of High-Dimensional Flow Cytometric in Patients With De Novo Autoimmune Hepatitis.](https://doi.org/10.1097/00007890-201407151-02977)Ekong U, Hill M, Edmunds C, Han G, Bhela S, Hafler D, Kleinewietfeld M. Identification of Pathogenic IL-17 Producing FOXP3+ Tregs in Patients With De Novo Autoimmune Hepatitis. Transplantation 2014, 98: 872-873. [DOI: 10.1097/00007890-201407151-02977](https://doi.org/10.1097/00007890-201407151-02977). - Gautron A, Dominguez-Villar M, M, Hafler DA. Enhanced suppressor function of TIM3+FoxP3+ regulatory T cells European Journal Molecular Basis of Autoimmune Disease Annals Of The Rheumatic Diseases 2014, 73: 27. or in combination with ipilimumab versus bevacizumab in patients (pts) with recurrent glioblastoma (GBM).](https://doi.org/10.1200/jco.2014.32.15_suppl.tps2101)Sampson J, Vlahovic G, Desjardins A, Friedman H, Baehring J, Hafler D, Rollin L, Coric V, Perez S, phase IIb study of nivolumab (anti-PD-1; alone or in combination with ipilimumab versus bevacizumab in patients (pts) with recurrent glioblastoma Kuchroo VK, Hafler DA. Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cells Journal Of S, Ye C, Lee MN, Replogle JM, Feng T, Lee M, Asinovski N, Frohlich I, Imboywa S, Von Korff A, Okada Y, Patsopoulos NA, Davis S, McCabe C, Paik HI, Srivastava GP, Raychaudhuri S, Hafler A, N, Mathis D, Benoist C, Stranger BE, De Jager PL. Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles TW, Hafler DA, Toes RE. TLRmediated STAT3 and ERK activation controls IL10 secretion by human B cells European and Th17 Cell Responses](http://www.ncbi.nlm.nih.gov/pubmed/24745333)Joller N, Lozano E, Burkett PR, Patel B, Xiao S, Zhu C, Xia J, Tan TG, Sefik E, Yajnik V, Sharpe AH, Selectively Cell Transcriptional Network by Divergent Mechanisms](http://www.ncbi.nlm.nih.gov/pubmed/24745332)Xiao S, Yosef N, Yang J, Wang Y, Zhou L, Zhu C, Wu C, Baloglu E, Schmidt D, Ramesh R, Lobera M, Sundrud MS, Tsai PY, Xiang Z, Wang J, Xu Y, Lin X, Kretschmer K, Rahl PB, Young RA, Zhong Z, Hafler DA, A, Ghosh S, Marson A, Kuchroo VK. Small-Molecule RORt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms Heiden Uduman DA, SH. pRESTO: toolkit Raj T, Li W, Eisenhaure TM, Imboywa SH, Chipendo PI, Ran FA, Slowikowski K, Ward LD, Raddassi K, McCabe C, Lee MH, Frohlich IY, Hafler DA, Kellis M, Raychaudhuri S, Zhang F, BE, Benoist CO, De Jager PL, Regev A, Hacohen N. Common Genetic Variants Modulate Pathogen-Sensing Responses D. Chapter 52 Multiple Sclerosis 2014, 735-756. [DOI: 10.1016/b978-0-12-384929-8.00052-6](https://doi.org/10.1016/b978-0-12-384929-8.00052-6). - Bailey M, Hafler D, Pelletier D. and Acute Disseminated M. Role of \"Western Diet\" in Inflammatory Autoimmune Diseases Current Allergy And Asthma 14: 404. [PMID: 24338487](https://pubmed.ncbi.nlm.nih.gov/24338487), [PMCID: PMC4034518](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034518), Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA LF, Hintzen RQ, Noble Raj T, , , Gourraud PA, Stranger BE, Oksenberg J, Olsson T, BV, Sawcer S, Hafler DA, Carrington M, De Jager PL, de Bakker PI. Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and of human Treg and Th17 cells and its role Healy BC, Keenan BT, Xia Z, Chitnis T, Guttmann CR, Khoury SJ, Weiner HL, Hafler DA, De Jager PL. Clinical relevance and functional consequences of the TNFRSF1A CD226/CD155 Interaction Regulates the Proinflammatory (Th1/Th17)/Anti-Inflammatory (Th2) Balance in in MS 2013, 27-47. [DOI: 10.1007/978-1-4614-7953-6_2](https://doi.org/10.1007/978-1-4614-7953-6_2). - Querol L, Clark PL, Bailey MA, Cotsapas C, Cross AH, Hafler DA, Kleinstein SH, Lee JY, Yaari G, Willis SN, O'Connor KC. Protein array-based profiling of CSF identifies RBPJ as an autoantigen with GWAS Data from 15,000 Cases and 30,000 Controls](http://www.ncbi.nlm.nih.gov/pubmed/23731539)Consortium I, Baranzini S, Khankhanian P, Patsopoulos N, Li M, Stankovich J, Cotsapas C, S\u00f8ndergaard H, Ban M, Barizzone N, Bergamaschi L, Booth D, Buck D, Cavalla P, Celius E, Comabella M, Comi G, Compston A, Cournu-Rebeix I, D'alfonso S, Damotte V, Din L, Dubois B, Elovaara I, Esposito F, Fontaine B, Franke V, Martinelli-Boneschi F, McCauley J, Myhr K, Naldi M, Sellebjerg F, S\u00f8rensen P, Spurkland A, Stewart G, Taylor B, Tienari P, Winkelmann J, Consortium W, Zipp F, Ivinson A, Haines J, Sawcer S, DeJager P, Hauser S, Oksenberg J. Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls American Journal Of Human Genetics 2013, T, Lynch M, Preston-Hurlburt P, Herold KC, Hafler DA, O'Connor K, Meffre E. Specific peripheral B cell tolerance defects in patients with multiple sclerosis Journal Of Clinical Investigation lyoplate flow cytometry data (P3374)](https://doi.org/10.4049/jimmunol.190.supp.135.13)Scheuermann R, Finak G, Ramey J, Taghiyar J, Stanton R, Brandes A, De Jager P, Qiu P, McCoy J, Hafler D, Maecker H, Mosmann T, Brinkman R, Gottardo R. FlowCAP: comparison of automated and manual gating of standardized lyoplate flow cytometry data multiple Haren L, Robinson WH. Serum to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing- remitting multiple sclerosis Multiple sclerosis, type 1 diabetes and rheumatoid arthritis](http://www.ncbi.nlm.nih.gov/pubmed/23497938)Larman HB, Nigrovic PA, De Jager O'Connor KC, Elledge SJ. PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis Journal DN, DA. Sodium chloride drives autoimmune disease by the induction of pathogenic from Immunoglobulin Sequencing Data](http://www.ncbi.nlm.nih.gov/pubmed/24298272)Yaari G, Heiden J, Uduman Stern JN, O'Connor K, Hafler DA, Laserson U, Vigneault F, Kleinstein SH. Models of Somatic Hypermutation Targeting and Substitution Based on Synonymous Mutations from High-Throughput Immunoglobulin Sequencing Data JP, GJ, Khoury SJ, Hafler DA, Weiner HL, De Jager PL. An RNA Profile Identifies Two Subsets of Multiple Sclerosis Patients Differing in Disease Activity Science Translational Medicine 2012, 4: 153ra131. Yosef N, Quintana FJ, Xiao S, Peters A, Wu C, Kleinewietfeld M, Kunder S, Hafler DA, Sobel RA, Regev A, Kuchroo VK. Induction and molecular signature R, Hafler D, Muller D. Abstract 456: High Salt Induces Pathogenic Th17 Cells and Exacerbates Autoimmune Diseases Hypertension 2012, 60 [DOI: 10.1161/hyp.60.suppl_1.a456](https://doi.org/10.1161/hyp.60.suppl_1.a456). [Correction: The CD6 Multiple Sclerosis Susceptibility Allele Is Associated with Alterations in CD4+T Cell Proliferation](https://doi.org/10.4049/jimmunol.1290044)Kofler D, Severson C, Mousissian N, De Jager Hafler D. Correction: The CD6 Multiple Sclerosis Susceptibility Allele Is Associated with Alterations in CD4+T Cell Proliferation The Journal Of Immunology 2012, 189: 2063-2063. [DOI: 10.4049/jimmunol.1290044](https://doi.org/10.4049/jimmunol.1290044). [Erratum: Interferon regulatory factor gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis](https://doi.org/10.1038/gene.2012.18)Vosslamber S, van der Voort L, van den Elskamp I, Heijmans R, Aubin C, B, Killestein J, Polman C, Verweij C. Erratum: Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis Genes & Immunity 2012, 13: 443-443. [DOI: 10.1038/gene.2012.18](https://doi.org/10.1038/gene.2012.18). - Lowther DE, Hafler DA. Regulatory T cells in the central nervous system Immunological Reviews 2012, S, Hafler DA, Jabbour HN, Astier AL. Prostaglandin E2 Affects T Cell Responses through Modulation of CD46 Expression Stephen J, Hafler D, Jabbour H. Prostaglandin E2 affects T cell responses through modulation of CD46 expression. (178.8) The Journal Of 178.8-178.8. 10.4049/jimmunol.188.supp.178.8](https://doi.org/10.4049/jimmunol.188.supp.178.8). Kuchroo V, Linker R, Muller D, Hafler D. High salt induces pathogenic Th17 cells and exacerbates autoimmune diseases (60.13) The Journal Of 2012, Hafler DA. The TIGIT/CD226 Axis Regulates Human T Cell Function The Journal - Nylander A, Class II Self-Antigen Presentation in Fingolimod for Multiple Sclerosis New England Of Medicine 2012, 366: 339-347. [PMID: 22276823](https://pubmed.ncbi.nlm.nih.gov/22276823), [DOI: Hafler D, von Herrath M, Nestle FO. Unraveling the autoimmune translational research process layer by layer Nature J, Sandbrink R, Pohl C, Edan G, Kappos L, Miller D, Montalb\u00e1n J, Polman C, Freedman M, Hartung H, Arnason B, Comi G, Cook S, Filippi M, Goodin D, Jeffery D, O'Connor P, Ebers G, Langdon D, Reder A, Traboulsee A, Zipp S, Hillert J, Bahlo M, Booth D, Broadley S, Brown M, Browning B, Browning S, Butzkueven H, Carroll W, Chapman C, Foote S, Griffiths L, Kermode A, Kilpatrick T, Lechner-Scott J, Marriott M, Mason D, Moscato P, Heard R, Pender M, Perreau V, Perera D, Rubio J, Scott R, Slee M, Stankovich J, Stewart G, Taylor B, Tubridy N, Willoughby E, Wiley J, Matthews P, Boneschi F, Compston A, Haines J, Hauser S, McCauley J, Ivinson A, Oksenberg J, Pericak-Vance M, Sawcer S, Jager P, Hafler D, de Bakker P. Genomewide metaanalysis identifies novel multiple sclerosis susceptibility Hafler DA, Lauffenburger DA, Love JC. Polyfunctional responses by human T cells result from sequential release of cytokines Proceedings Of The National Academy Of Sciences Of The United States Of America Associated with Ventricular Dysfunction after Primary Coronary Artery Bypass Graft Surgery](http://www.ncbi.nlm.nih.gov/pubmed/21980348)Fox AA, Pretorius M, Liu KY, Collard CD, Perry TE, Shernan SK, De Jager PL, Hafler DA, Herman DS, DePalma SR, Roden DM, Muehlschlegel JD, Donahue BS, Darbar D, Seidman JG, Body SC, Seidman CE. Genome-Wide Assessment for Genetic Variants Associated with Ventricular Dysfunction after Primary Coronary Artery Bypass Graft Surgery with Alterations in CD4+ T Cell Proliferation](http://www.ncbi.nlm.nih.gov/pubmed/21849685)Kofler DM, Severson CA, Mousissian N, De Jager PL, Hafler DA. The CD6 Multiple Sclerosis Susceptibility Allele Is Associated with Alterations in CD4+ T Cell Proliferation The Journal Of BM, Wallace C, Abecasis GR, Barrett JC, Behrens T, Cho J, De Jager PL, Elder JT, Graham RR, Gregersen P, Klareskog L, Siminovitch KA, van Heel DA, Wijmenga C, Worthington J, Todd JA, Hafler DA, Rich SS, Daly MJ, . Pervasive Sharing of Genetic Effects in Autoimmune in Patients with Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/21653833)Raddassi K, Kent SC, Yang J, Bourcier V, Glycoprotein/MHC Class II-Binding CD4 Cells in Patients with chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex](http://www.ncbi.nlm.nih.gov/pubmed/21653641)Zuvich RL, WS, Hafler D, Hauser S, Sawcer S, Pericak-Vance M, Barcellos L, Mortlock D, Haines J. Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex Human Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease variants and pharmacological and clinical outcome of Interferon therapy in multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/21471993)Vosslamber S, van der Voort LF, Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferon therapy in multiple sclerosis Genes & Immunity 2011, 12: 466-472. [PMID: 21471993](https://pubmed.ncbi.nlm.nih.gov/21471993), [DOI: 10.1038/gene.2011.18](https://doi.org/10.1038/gene.2011.18). Human CD4+CD25hi Regulatory Cells in Patients with Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/21300823)Baecher-Allan CM, Costantino CM, Cvetanovich GL, M, DA. CD2 Costimulation Reveals Defective Activity by Human CD4+CD25hi Regulatory Cells in Patients with Multiple Sclerosis The Journal that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin](http://www.ncbi.nlm.nih.gov/pubmed/21353315)Obermeier B, Lovato L, Mentele R, Br\u00fcck W, H, Hohlfeld R, Hafler DA, O'Connor KC, Dornmair K. Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin L, Y, Polman CH, Hauser SL, Oksenberg J, Haines JL, Ritchie MD. A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility Genes & D, de Bakker PI, Kappos L, Polman CH, Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Chibnik LB, Hafler DA, Matthews PM, Hauser SL, Baranzini SE, Oksenberg JR. Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data Genome Medicine 2011, SE, Howell OW, Reynolds R, O'Connor K, Hafler DA. Related B cell clones populate the meninges and parenchyma of patients with multiple DRB1*1501 in the response of subjects with multiple sclerosis to first-line treatments](http://www.ncbi.nlm.nih.gov/pubmed/21115201)Gross R, Healy BC, Cepok B, Weiner HL, DA, De Jager PL. Population structure and HLA DRB1*1501 in the response of subjects with multiple sclerosis to first-line treatments Journal Of Amos M, Elliott J, Gaigalas A, Wang L, Aranda R, Banchereau J, Boshoff C, Braun J, Korin Y, Reed E, Cho J, Hafler D, Davis M, Fathman CG, Robinson W, Denny T, Weinhold K, Desai B, Diamond B, Gregersen P, Di Meglio P, Nestle FO, Peakman M, Villanova F, Ferbas J, Field E, Kantor A, Kawabata T, Komocsar H, O'Lone R, Phippard D, Plevy S, Rich S, Roederer M, Rotrosen D, Yeh JH. A model for harmonizing flow cytometry Human regulatory T cells in autoimmune diseases Current Opinion In ML. Droplet-based microfluidic With Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/20837847)Khoury SJ, Healy BC, Kivis\u00e4kk P, Viglietta V, CR, Wedgwood JF, Hafler DA, Weiner HL, Buckle G, Cook S, Reddy S. A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Glanz B, Wolfish L, R, sclerosis using supervised machine learning and meta-analysis in 12 566 individuals](http://www.ncbi.nlm.nih.gov/pubmed/20699326)Briggs FB, Bartlett SE, Goldstein BA, MA, Haines JL, Barcellos L. Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12 566 individuals Human Molecular gene signature is prevalent in the central nervous system of patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/20655601)Ligocki AJ, Lovato L, Xiang D, O'Connor KC, Monson NL. A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis Journal Of Independently HLA-DRB1*15:01](http://www.ncbi.nlm.nih.gov/pubmed/20593013)Cree BA, Rioux JD, McCauley JL, . A Major Histocompatibility Class I Locus Contributes to Multiple Sclerosis Susceptibility Independently from HLA-DRB1*15:01 sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/20574445)Ban M, McCauley JL, Zuvich R, Baker A, S, Guerini FR, J, Barcellos Ivinson AJ, Sexton SL, Haines J, Compston A, Sawcer S. A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis Genes Hafler DA. FOXP3+ regulatory T cells in the human immune system Nature Reviews Immunology 2010, DW, Driscoll Diederichs S, Haider K, Netravali I, Le S, Elia R, Dow E, Lee A, Freudenberg J, De Jager PL, Chretien Y, Varki A, MacDonald ME, Gillis T, Behrens TW, Bloch D, Collier D, Korzenik J, Podolsky DK, MA, Haines JL, Barcellos LF. Variation Within DNA Repair Pathway Genes and Risk of Multiple Sclerosis American Journal Of Epidemiology 2010, 172: 217-224. [PMID: M, Scott RJ, Lechner-Scott J, Goris Dobosi Dubois J, Kockum I, Olsson T, Hillert J, Ban M, Baker A, Kemppinen A, Sawcer S, Compston A, Robertson NP, JR, Hauser SL, Sexton D, Haines J. Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis. Nature Genetics and rates of cytokine secretion from single cells by quantitative microengraving](http://www.ncbi.nlm.nih.gov/pubmed/20376398)Han Q, Bradshaw EM, Nilsson B, Hafler DA, Love JC. Multidimensional analysis of the frequencies and rates of cytokine secretion from single cells by quantitative microengraving Lab and IL-10 and a Baecher-Allan C. CD4+CD45RA-CD25hiCD127low/neg regulatory T cells to secrete IFN and IL-10 and acquire a non-regulatory S, Oksenberg J, Barcellos L. CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis Human Molecular a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene](http://www.ncbi.nlm.nih.gov/pubmed/20159113)Jakkula E, Lepp\u00e4 Palotie A, Saarela J, Peltonen L. Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene American Journal Of Multiple Sclerosis Genetics Consortium, Aubin C, Cross AH, Piccio L, Aggarwal NT, Evans D, Hafler DA, Compston A, Hauser SL, Pericak-Vance MA, Haines JL. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility Human D, O'Connor K. Characterization of the Myelin Specific Autoantibodies in Acute 10.1016/j.clim.2010.03.243](https://doi.org/10.1016/j.clim.2010.03.243). T IFN and IL-10 and Acquire a Non-regulatory Effector D, Baecher-Allan C. IL-12 Induces CD4+CD45RA-CD25hiCD127low/neg Regulatory T Cells to Secrete IFN and IL-10 and Baecher-Allan C, Hafler D. IL-1 Receptor Expression on Human Regulatory T Cells and IL-1's Role in Reducing Suppression Clinical Immunology 2010, 135: s131. 10.1016/j.clim.2010.03.395](https://doi.org/10.1016/j.clim.2010.03.395). - Schubert Seth N, Raddassi K, Hafler D, Dustin M, Wucherpfennig K. Altered Synapse Formation by Self-reactive T Cells from MS Patients Clinical 2010, [DOI: 10.1016/j.clim.2010.03.227](https://doi.org/10.1016/j.clim.2010.03.227). Banwell B, Bates A, Ben-Hur T, Bowling A, Davis S, De Jager P, Dutta R, Edan G, Frohman E, Frohman T, Gold R, Hafler D, Jacob A, jeli I, Kaplin A, Kerr D, Kleinschnitz C, Kozubal D, Lemack G, Linker R, lucchinetti C, Marriott J, Martin R, Matiello M, Melzer N, Meuth S, Morrissey S, Munger K, O'Connor P, Amato M, Pirko I, Pittock S, Schr\u00f6der A, Shah A, Trapp B, Trecker C, Venkateswaran S, Voskuhl R, Weinshenker B, Wiendl H, Wingerchuk D, AUTHORS 2010, 35: xi-xvii. [DOI: 10.1016/b978-1-4160-6068-0.00024-3](https://doi.org/10.1016/b978-1-4160-6068-0.00024-3). [Monocytes from Patients with Type 1 Diabetes Have Increased Gene Expression of Pro-inflammatory Cytokines or IL-10](https://doi.org/10.1016/j.clim.2010.03.061)Bradshaw E, Elyaman W, Raddassi K, Mousissian N, Greer A, Orban T, Gottlieb P, Kent S, Hafler D. Monocytes from Patients with Type 1 Diabetes Have Increased Gene Expression of Pro-inflammatory Cytokines or Pyne S, Hu X, Wang K, Rossin E, Lin T, Maier L, Baecher-Allan C, McLachlan G, Tamayo P, Hafler D, De Jager P, Mesirov J. Automated C, Moya J, Bell D, Haider K, Taylor K, De Jager P, Behrens T, Hafler D, Sands B, Murali M, Gregersen P, Pillai S. Regulation of Immunological [Dissecting Functional Consequences of the Validated Multiple Sclerosis Susceptibility Allele in TNFRSF1A](https://doi.org/10.1016/j.clim.2010.03.351)Ottoboni L, Mousissian N, Castillo I, Hafler D, De Jager P. Dissecting the Functional Consequences of the Validated Multiple Sclerosis Susceptibility Allele in TNFRSF1A Clinical Immunology 2010, Pyrdol J, Raddassi K, Hafler D, Dustin M, Wucherpfennig K. Efficient Activation of Self-reactive T Cells from MS Patients with Altered Synapse Human Genetic and Immunologic Variation](https://doi.org/10.1016/j.clim.2010.03.355)Castillo I, Lui Q, Ottoboni L, Briskin R, Hafler D, De Jager P. The PhenoGenetic Project: A Living Biobank Enabling the Study of Human Genetic and Immunologic Immunology and Proinflammatory Cytokines and is Increased in Diabetes](https://doi.org/10.1016/j.clim.2010.03.089)Beriou Lozano E, Baecher-Allan C, Inducible by TGF- and Proinflammatory Cytokines and is Increased Diabetes Immunology 135: s29. [DOI: 10.1016/j.clim.2010.03.089](https://doi.org/10.1016/j.clim.2010.03.089). - De Jager P, Hafler D. Chapter 3 Uncovering the Genetic Architecture of Multiple Sclerosis 2010, 35: 43-56. [DOI: Hafler DA, Hacohen N. RNA Interference Screen in Primary Human T Cells Reveals FLT3 as a Modulator of IL-10 Levels Raddassi K, Nilsson B, Nepom GT, Hafler DA, Love JC. On-Chip Activation and Subsequent Detection of Individual Antigen-Specific T Cells study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci](http://www.ncbi.nlm.nih.gov/pubmed/20007504), , McCauley J, Zuvich R, Beecham A, De Jager P, Konidari I, Whitehead P, Aubin C, Ban M, Pobywajlo S, Briskin R, Romano S, Aggarwal N, Piccio L, McArdle W, Strachan D, Evans D, Cross A, Cree B, Rioux J, Barcellos L, Ivinson A, Compston A, Hafler D, Hauser S, Oksenberg J, Sawcer S, Pericak-Vance M, Haines J. Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci A-Chain of Human Insulin Using NMR Spectroscopy, Quantum Chemical Calculations, and Mass Spectrometry](http://www.ncbi.nlm.nih.gov/pubmed/19954153)Sharma AK, Ling Y, Greer AB, Hafler DA, Kent SC, Zhang Y, Rigby AC. Evaluating the Intrinsic Cysteine Redox-Dependent States of the A-Chain of Human Insulin Using NMR Spectroscopy, Quantum Chemical Calculations, and Mass Spectrometry The Journal Of Physical Chemistry L, Fernando M, Green T, De Jager P, Foisy S, Wang J, de Bakker P, Leslie S, McVean G, Padyukov L, Alfredsson L, Annese R, Sawcer S, Compston A, Cree B, Mirel D, Daly M, Behrens T, Klareskog L, Gregersen P, Oksenberg J, Hauser S. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases Proceedings Of The National Academy Of Sciences Of The United States Of America 2009, 106: KD. Engineered Interleukin-2 Antagonists for the Inhibition of Regulatory T Cells Journal into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score](http://www.ncbi.nlm.nih.gov/pubmed/19879194)De Jager PL, Chibnik LB, Cui J, Reischl J, Bauer D, Heubach JF, Sandbrink R, Tyblova M, Lelkova P, the steering committees of the BENEFIT B, Havrdova E, Pohl C, Horakova D, Ascherio A, Hafler D, Karlson E. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score Proinflammatory Cytokines Inducing Th17 Cells](http://www.ncbi.nlm.nih.gov/pubmed/19748982)Bradshaw EM, Raddassi Gottlieb PA, Kent SC, Hafler DA. Monocytes from Patients with Type 1 Diabetes Spontaneously Secrete Proinflammatory Cytokines Inducing Th17 Cells Franz B, Kennedy J, McArdel S, Kuhle J, Kappos L, Rostasy K, Pohl D, S, KC, V, Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis The Journal Greenfield EA, TB, Hafler DA, Kuchroo VK. TIM3 is expressed on activated CD4+ T cells and regulates Th1 and Th17 MM, Br\u00fcck W, Hafler DA, O'Connor K. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain Brain 2009, ME, De Jager PL, Hafler DA, Breitbart RE, Seidman JG, Seidman CE. De novo copy number variants identify new genes and loci in isolated sporadic Class II MHC Processing in Human CD4+ HLA-DR+ T Cells and TNFRSF1A as new multiple sclerosis susceptibility loci](http://www.ncbi.nlm.nih.gov/pubmed/19525953)De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Baranzini S, McCauley J, Pericak-Vance M, Haines J, Gibson R, Naeglin Y, Uitdehaag B, Matthews P, Kappos L, Polman C, McArdle W, Strachan D, Evans D, Cross A, Daly M, Compston A, Sawcer S, Weiner H, Hauser S, Hafler D, Oksenberg J. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis Lin TI, Maier LM, Baecher-Allan C, McLachlan GJ, Tamayo P, Hafler PL, Mesirov JP. Automated high-dimensional flow cytometric data analysis Proceedings Of The National Academy Of Sciences Of The United States Of America 2009, 106: J, Yelensky R, Price A, Leppa V, Patterson N, de Bakker PI, Tran D, Aubin C, Pobywajlo S, Rossin E, Hu CW, Choy E, Rioux JD, Pericak-Vance MA, Ivinson A, Booth DR, GJ, Peltonen L, Dubois B, Haines JL, Weiner HL, Compston A, Hauser SL, Daly MJ, Reich D, Oksenberg JR, Hafler DA. The role of the CD58 locus in multiple sclerosis Proceedings Of The National Academy Of Sciences Of The United States Of America 2009, 106: 5264-5269. [PMID: JL, Lassmann H, O'Connor KC, Ritchie AM, Shearer A, Lam C, Yu X, Birlea M, DuPree C, Williamson RA, Hafler DA, Burgoon MP, Gilden D. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid \u00c5, Baker A, Mihalova T, Ingram G, Booth DR, Heard RN, Stewart E, Dubois B, Harbo HF, Celius Spurkland Strange R, Hawkins C, NP, Dudbridge F, Wason J, De SL, Sexton D, Haines J, Sawcer S. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor European Journal Of Human Genetics 2009, A, Peltonen L, Saarela J. Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS Sclerosis Subjects and the Effect of Soluble IL-2RA on Immune Responses](http://www.ncbi.nlm.nih.gov/pubmed/19155502)Maier LM, Anderson DE, Severson CA, Wittrup KD, De Jager PL, Hafler DA. Soluble IL-2RA Levels in Multiple Sclerosis Subjects and the Effect of Soluble IL-2RA on Immune Responses The Journal Kuchroo VK, Baecher-Allan C, Hafler DA. IL-17-producing human peripheral regulatory Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production](http://www.ncbi.nlm.nih.gov/pubmed/19119414)Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE, Severson C, Clark PM, Healy B, Walker N, Aubin C, Oksenberg JR, Hauser SL, Compston A, Sawcer S, , De Jager PL, Wicker LS, Todd JA, Hafler DA. IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production PLOS Genetics Acute Necrotizing Encephalopathy Caused by Mutations in a Component of the Nuclear Pore, RANBP2](http://www.ncbi.nlm.nih.gov/pubmed/19118815)Neilson DE, Adams MD, Orr CM, Schelling DK, Eiben RM, Kerr DS, Anderson J, Bassuk AG, Bye AM, Childs AM, Clarke A, Crow YJ, Di Rocco M, Dohna-Schwake C, Dueckers G, Fasano A, Lentschig MG, Lopez-Laso J, Schmitt-Mechelke T, Servidei S, Skardoutsou Uldall P, van der MS, KC, Tefft DL, Aubin C, de Jager P, Hafler D, Warman ML. Infection-Triggered Familial or Recurrent Cases of Acute Necrotizing Encephalopathy Caused by Mutations in a Component of the Nuclear Pore, RANBP2 American Journal Of B Cell Repertoires Among Lesions and Normal Appearing White Matter in the Multiple Sclerosis Central Nervous System](https://doi.org/10.1016/j.clim.2009.03.055)Lovato L, Almendinger S, Willis S, Rodig S, Hafler D, O'Connor K. OR.43. Comparative Analysis of B Cell Repertoires Among Lesions and Normal Appearing White Matter in the Multiple Sclerosis Central Nervous System Clinical Immunology 2009, 131: s20-s21. [DOI: 10.1016/j.clim.2009.03.055](https://doi.org/10.1016/j.clim.2009.03.055). [F.89. Elucidating the Antigen Specificity of B Cells Present within the CNS Lesions of Patients with MS](https://doi.org/10.1016/j.clim.2009.03.346)Willis S, Almendinger S, Lovato L, Hafler D, O'Connor K. F.89. Elucidating the Antigen Specificity of B Cells Present within the CNS Lesions of Patients with MS Clinical Immunology 2009, 131: s117. [DOI: 10.1016/j.clim.2009.03.346](https://doi.org/10.1016/j.clim.2009.03.346). - Hastings Human S Regulates MHC Class II Processing Clinical Autoreactive B Cells in Pancreatic Draining Lymph Nodes from Type 1 Diabetes Subjects](https://doi.org/10.1016/j.clim.2009.03.051)Kent S, Bradshaw E, Han Q, Varadarajan N, Greer A, Love J, Hafler D. OR.39. Enumeration and Phenotype of Autoreactive B Cells in Pancreatic Draining Lymph Nodes from Type 1 Diabetes Subjects Clinical Immunology 2009, 131: s19. Differs Significantly Between Functionally Distinct Subpopulations of CD4+CD25high Human Regulatory T Cells](https://doi.org/10.1016/j.clim.2009.03.361)Cvetanovich G, Ashley C, Hafler D, Baecher-Allan C. F.108. DNA Methylation of the Human FoxP3 Locus Differs Significantly Between Functionally Distinct Subpopulations of CD4+CD25high Human Regulatory T Cells s122. Cells](https://doi.org/10.1016/j.clim.2009.03.011)Costantino Beriou D, Baecher-Allan C. Cellular Senescence in Terminally Differentiated and TNFRSF1A as Novel Multiple Sclerosis Susceptibility Loci](https://doi.org/10.1016/j.clim.2009.03.294)De Jager P, de Bakker P, Wang J, Ottoboni L, Consortium I, Hauser S, Oksenberg J, Hafler D. F.27. Meta-analysis of Genome Scans and Replication Identify CD6, ICSBP1, and TNFRSF1A as Novel Multiple CD4+Cells in the Peripheral Blood of Patients with Multiple Sclerosis using MHC Class II Tetramers](https://doi.org/10.1016/j.clim.2009.03.444)Raddassi K, Yang J, Kent S, Bradshaw E, Bourcier K, Seyfert-Margolis V, Detection of Myelin Reactive CD4+Cells in the Peripheral Blood of Patients with Multiple Sclerosis using MHC Class II Define Functionally Distinct Human Tregs- One Subsets Exhibits Decreased Activity in Multiple Sclerosis](https://doi.org/10.1016/j.clim.2009.03.487)Ashley C, Hafler D, Baecher-Allan C. S.119. CD127 and HLA DR Define Functionally Distinct Human Tregs- One Subsets Exhibits Decreased Activity in Multiple 2009, 131: s164-s165. [DOI: 10.1016/j.clim.2009.03.487](https://doi.org/10.1016/j.clim.2009.03.487). [T.22. Monocytes Pro-inflammatory Cytokines Inducing Th17 Cells](https://doi.org/10.1016/j.clim.2009.03.163)Bradshaw E, Raddassi K, Elyaman Gottlieb P, Kent S, Hafler D. T.22. Monocytes from Patients with Type 1 Diabetes Spontaneously Secrete Pro-inflammatory Cytokines Inducing [OR.55. Transforming Growth Factor-beta is Crucial for the Differentiation and Regulation of Interleukin 9-producing Human CD4+T Cells](https://doi.org/10.1016/j.clim.2009.03.067)Beriou G, Costantino C, Baecher-Allan C, Hafler D. OR.55. Transforming Growth Factor-beta is Crucial for the Differentiation and Regulation of Interleukin 9-producing Human CD4+T Cells Clinical D, Kuchroo V. TIMs: central regulators of immune responses Journal Of Cell Biology 2008, 183: i12-i12. [DOI: 10.1083/jcb1835oia12](https://doi.org/10.1083/jcb1835oia12). [Genetic Analysis of Human Traits In Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines](http://www.ncbi.nlm.nih.gov/pubmed/19043577)Choy E, Yelensky R, Bonakdar S, Hafler D, Daly MJ, Altshuler D. Genetic Analysis of Human Traits In Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines TIMs: central regulators of immune responses Journal Of Hafler DA, Love JC. Concurrent detection of secreted products from human lymphocytes by microengraving: Rusche JR, Hafler DA. Multiple Sclerosis and Regulatory T Cells Journal Of Hastings W, Anderson D, Kuchroo V, Hafler D. SY-23 Human CD4+CD25high natural [DOI: 10.1016/j.cyto.2008.07.340](https://doi.org/10.1016/j.cyto.2008.07.340). - Hutton J, Baecher-Allan C, Hafler D. Multiple Sclerosis and Regulatory T Cells 2008, 265-277. [DOI: 10.1007/978-0-387-77909-6_13](https://doi.org/10.1007/978-0-387-77909-6_13). [Pathology of an Islet Transplant for a Nonimmunological Loss](http://www.ncbi.nlm.nih.gov/pubmed/18622278)Smith RN, Kent Hafler DA, Auchincloss H, Orban T, Cagliero E. Pathology of an Islet Transplant 2 Years After Transplantation: Evidence for a Transplantation 2008, 86: 54-62. 18622278](https://pubmed.ncbi.nlm.nih.gov/18622278), [DOI: DA. TGF- are required for population structure and a reduction of CD8low cells](http://www.ncbi.nlm.nih.gov/pubmed/18567923)De Jager PL, Rossin E, Pyne V, Weiner M, Soler D, Izmailova E, Faron-Yowe L, O'Brien C, Freeman S, Granados S, Parker A, Roubenoff R, Mesirov JP, Khoury SJ, Hafler DA, Weiner HL. Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low DA. Human regulatory T cells and autoimmunity J, Hafler DA. Lack of TIM-3 Immunoregulation in Multiple Kassam N, Dardalhon V, Greenfield RA, DA, Strom TB, Kuchroo VK. TIM-4 Expressed on APCs Induces T Cell Expansion and Survival The Journal \"MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells\"](https://doi.org/10.4049/jimmunol.180.6.3626)Baecher-Allan C, Hafler D. Response to Comment on \"MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells\" The Journal Of to Initiate Invariant Chain Act Redundantly to Initiate Human Invariant Chain Degradation The cells upon CD46 activation in patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/18403025)Vaknin-Dembinsky A, Murugaiyan G, Hafler DA, Astier AL, Weiner IL-23 and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis Hafler DA. The developing mosaic of autoimmune disease risk Nature Genetics 2008, 40: 131-132. [PMID: 18227869](https://pubmed.ncbi.nlm.nih.gov/18227869), Kuhle J, Kappos K, Pohl D, Wong S, Tavakoli N, Tenembaum S, Franz B, O'Connor K, K. F.14. Autoantibodies to 10.1016/j.clim.2008.03.126](https://doi.org/10.1016/j.clim.2008.03.126). - Hastings W, Anderson D, Kuchroo V, Hafler D. Sa.102. Discovery and Characterization of Immunology 2008, M, Kuchroo V, Hafler D. OR.41. IL-21 and TGF- are Required for Differentiation Clinical 2008, Hacohen N. Flt3, a New Regulator of IL-10 Production by Human T Cells, Identified Using an RNAi Library Clinical Immunology 2008, 127: s29. [DOI: Sawcer S, Goris A, Saarela J, Barcellos L, Dubois B, Peltonen L, Palotie A, Weiner H, Booth D, Stewart G, Pericak-Vance M, Haines J, Rioux J, Hauser S, Daly M, Waliszewska A, Oksenberg J, Hafler D. OR.102. The CD58 Pathway is Implicated MS Clinical Immunology 2008, 127: s40-s41. [DOI: 10.1016/j.clim.2008.03.109](https://doi.org/10.1016/j.clim.2008.03.109). - Bradshaw E, Kent Greer Elyaman W, Raddassi K, Love J, Orban T, Hafler D. Sa.77. Ex Vivo Activated State of Immunology 2008, 127: s106. Baecher-Allan C. Differentiation of D. Sa.109. in the CD8dimCD4- Cell Population Parallel Disease Activity in Treated Multiple Sclerosis Subjects](https://doi.org/10.1016/j.clim.2008.03.146)De Jager P, Kivis\u00e4kk P, Hu X, Soler-Ferran D, Izmailova E, O'Brien C, Hafler D, Weiner H, Khoury S. F.34. Changes in the CD8dimCD4- Cell Population Parallel Disease Activity in Treated Multiple Sclerosis Subjects Clinical Immunology 2008, 127: s54. [DOI: 10.1016/j.clim.2008.03.146](https://doi.org/10.1016/j.clim.2008.03.146). P, Hafler D, Mesirov J, De Jager P. Su.86. Automated High-dimensional Granzyme Inhibits that Control the Expression of MHC Genes Do Not Affect Susceptibility to Multiple Sclerosis](https://doi.org/10.1016/j.clim.2008.03.145)Ottoboni L, Young E, Yelensky R, Hafler D, Daly M, De Jager P. F.33. Genetic Variants that Control the Expression of MHC Genes Do Not Affect Susceptibility to Multiple Sclerosis Clinical 2008, 127: (nTregs) Represent Effector nTregs, Precursor nTregs, and Induced nTregs](https://doi.org/10.1016/j.clim.2008.03.336)Baecher-Allan C, L, G, Ashley C, Hafler D. Sa.115. IL7R and HLA-Class II selected FoxP3+ T (nTregs) Represent Effector nTregs, - De Wicker LS, Hafler DA. Allelic variant in CTLA4 alters T cell phosphorylation patterns Proceedings Of The National Academy Of Sciences Of The United States Of America 2007, 104: 18607-18612. [PMID: 18000051](https://pubmed.ncbi.nlm.nih.gov/18000051), Hastings WD, Kassam N, Lei C, Chandwaskar R, Karman J, Su Hirashima M, Bruce JN, Kane LP, Kuchroo VK, Hafler DA. Promotion of Tissue Inflammation by the Immune Receptor Tim-3 Expressed on Innate Immune Cells Science 2007, 18006747](https://pubmed.ncbi.nlm.nih.gov/18006747), [DOI: 10.1126/science.1148536](https://doi.org/10.1126/science.1148536). - Plenge RM, L, Price AL, de Bakker PI, Maller J, Pe'er I, Burtt NP, Blumenstiel B, DeFelice M, Parkin M, Barry R, Winslow W, Healy C, Graham RR, Neale BM, Izmailova E, Roubenoff R, Parker AN, Glass R, Karlson EW, Maher N, Hafler DA, Lee DM, Seldin MF, Remmers EF, Lee AT, D. independent alleles at 6q23 associated with risk of rheumatoid Abnormal Tr1 differentiation in multiple sclerosis S, Lander E, Daly M, De Jager P, de Bakker P, Gabriel S, Mirel D, Ivinson A, Pericak-Vance M, Gregory S, Rioux J, McCauley J, Haines J, Barcellos L, Cree B, Oksenberg J, Hauser S. Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study New England Journal Of Medicine 2007, Sobel RA, Robinson WH, Steinman L. Protective and therapeutic role for B-crystallin Cohen C, RH, Podolsky DK, Louis E, Hafler DA, Rioux JD. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases Genes & Immunity 2007, 8: 387-397. F, Cohen IR, De Boer R, Garcia KC, Goldstein B, Greenspan R, Hafler D, Hodgkin P, Huseby ES, Krakauer DC, Nemazee AS, Pinilla C, Strong RK, Sercarz EE. Polyspecificity of T cell and B cell receptor recognition Seminars responses by T cells expanded by endogenous selfpeptide/MHC complexes PL, Hafler DA. New Therapeutic Approaches for Multiple Sclerosis Annual Review Of Medicine 2007, 58: 417-432. [PMID: 17217332](https://pubmed.ncbi.nlm.nih.gov/17217332), [DOI: 10.1146/annurev.med.58.071105.111552](https://doi.org/10.1146/annurev.med.58.071105.111552). - McLaughlin K. Detection of autoantibodies with self-assembling tetramers Exchange 2007 [DOI: TW, De Jager PL, Gregory SG, Barcellos LF, Walton A, Goris A, Fenoglio C, Ban M, Taylor CJ, Goodman RS, Walsh E, Wolfish CS, Horton R, Traherne J, Beck S, Trowsdale J, Caillier SJ, Ivinson AJ, Green T, Pobywajlo ES, Pericak-Vance MA, Haines JL, Daly MJ, S, . A second major histocompatibility complex susceptibility locus for multiple De Jager PL, Chitnis T, Bettelli E, Xu C, Robinson A, K, M, Amato AA, Hafler DA, Greenberg SA, O'Connor K. A Local Antigen-Driven Humoral Response Is Present in the Inflammatory Myopathies K, Anderson R, Anderson D, Bruce J, Hafler D, O'Connor K. Characterization of the B Cell Infiltrate Within Intracranial Germinomas Clinical Immunology 2007, Single B Cell Immunoglobulin Variable Region Genes Derived from Infiltrated Muscle Tissue of Subjects with Inflammatory Myopathies](https://doi.org/10.1016/j.clim.2007.03.072)Bradshaw E, Orihuela A, McArdel S, Hafler D, Amato A, O'Connor K. Characterization of Single B Cell Immunoglobulin Variable Region Genes Derived from Infiltrated Muscle Tissue of Subjects with Inflammatory Myopathies Clinical Immunology 2007, 123: s152. [DOI: 10.1016/j.clim.2007.03.072](https://doi.org/10.1016/j.clim.2007.03.072). - O'Connor K, Cherry S, Hafler D. How B Cells Contribute to Multiple Sclerosis Pathology 2007, 66-86. [DOI: 10.1007/978-0-387-36003-4_5](https://doi.org/10.1007/978-0-387-36003-4_5). - Manzanet R, Hartt-Meyers J, Slavik J, Dardalhon V, Kassam N, Greenfield E, Sobel R, Strom T, Hafler D, Kuchroo V. Tim-4 Expressed on Antigen-presenting Cells Induces T Cell Expansion and Survival Clinical Immunology 2007, 123: s124-s125. [DOI: 10.1016/j.clim.2007.03.533](https://doi.org/10.1016/j.clim.2007.03.533). - Yang L, Anderson D, Kuchroo V, Hafler D. Defect in TIM-3 Regulation of CD4+ T Cells in a Human Autoimmune Disease Clinical Immunology 2007, 123: s139-s140. [DOI: 10.1016/j.clim.2007.03.035](https://doi.org/10.1016/j.clim.2007.03.035). - Hastings W, Greer A, Kuchroo V, Hafler D, Kent S, Anderson D. Dysregulation of the TIM-3-Galectin-9 Pathway in Type I Diabetic T Cells Clinical Immunology 123: s21. [DOI: 10.1016/j.clim.2007.03.228](https://doi.org/10.1016/j.clim.2007.03.228). [Haplotype-specific the Class II MHC Peptide Repertoire but Does Not Impair Invariant Chain Degradation in Human Antigen Presenting Cells](https://doi.org/10.1016/j.clim.2007.03.330)Costanti-England C, Hang H, Hafler D, Ploegh H. Haplotype-specific Use of Lysosomal Proteases Can Modulate the Class II MHC Peptide Repertoire but Does Not Impair Invariant Chain Degradation in Human Antigen Presenting Cells Clinical Immunology 2007, 123: s53. [DOI: 10.1016/j.clim.2007.03.330](https://doi.org/10.1016/j.clim.2007.03.330). - IL-10 Both Inhibits Treg Suppressive Activity and is a Survival Factor for Human Natural Tregs Clinical Immunology 2007, 123: P, Hafler D, Reich D. Admixture Mapping, a New Tool for Disease Gene Finding in Autoimmune and Other Diseases Clinical Immunology 2007, 123: s122. [DOI: 10.1016/j.clim.2007.03.526](https://doi.org/10.1016/j.clim.2007.03.526). - J, O'Conner K, Wawrousek E, Hafler D, Sobel R, Robinson W, Steinman L. Protective and Therapeutic Role for B-Crystallin in Autoimmune Clinical V, Hafler D. Improving Elispot to Detect Antigen Specific Immunology 2007, s154. [DOI: 10.1016/j.clim.2007.03.078](https://doi.org/10.1016/j.clim.2007.03.078). [A of Immunologically Relevant Cell Surface Markers](https://doi.org/10.1016/j.clim.2007.03.076)De Jager P, Yelensky R, Rossin Bonadkar S, Daly M, Altshuler D, Hafler D. A Genome-wide Screen for Genetic Variants Affecting the Expression of Immunologically Relevant Cell Surface Markers Clinical Immunology 2007, D. Elifacs: A Multiplex Assay to Detect Antigen Specific T Cells and to Monitor the Immune Response Clinical Immunology 2007, 123: s126. [DOI: 10.1016/j.clim.2007.03.538](https://doi.org/10.1016/j.clim.2007.03.538). - Mesirov J, Tamayo P, Hafler D. Novel Computational Methods to Enhance the Uncovers Population Structure in Untreated MS Subjects and Highlights the Role of NK Cells](https://doi.org/10.1016/j.clim.2007.03.068)Rossin E, Viglietta V, Soler-Ferran D, Parker A, Weiner M, Buckle G, Khoury S, Hafler D, Weiner H, De Jager P. Large Scale Immunoprofiling Uncovers Population Structure in Untreated MS Subjects and Highlights the Role of NK Cells Apoptosis Resistant, DR+ Tregs](https://doi.org/10.1016/j.clim.2007.03.507)Ashley C, Anderson R, Bruce J, D, Hafler D, Baecher-Allan C. Human Glioblastoma Multiforme (GBM) Kassam N, Hafler D. TIM-3 is a Negative Regulator of Clinical Immunology 2007, 123: s154. Susceptibility Locus CTLA4 and Alterations in Proximal TCR Signaling in Healthy Human Volunteers](https://doi.org/10.1016/j.clim.2007.03.023)Maier L, Anderson D, de Jager P, Hafler D, Wicker L. An Association Between the Autoimmune Susceptibility Locus CTLA4 and Alterations in Proximal TCR Signaling in Healthy Clinical Immunology s135. the Current Understanding of Putative Biomarkers](http://www.ncbi.nlm.nih.gov/pubmed/17124343)O'Connor K, Roy SM, Becker CH, Hafler DA, Comprehensive Phenotyping in Multiple Sclerosis: Discovery Based Proteomics and the Current Understanding of S, Hafler DA. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis Journal Of Clinical Investigation for disease association studies in the extended human MHC](http://www.ncbi.nlm.nih.gov/pubmed/16998491)de Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J, Ke X, Monsuur AJ, Whittaker P, Delgado M, Morrison J, Richardson A, Walsh EC, Gao X, Galver L, Hart J, Hafler DA, Pericak-Vance M, Todd JA, Daly MJ, Trowsdale J, Wijmenga C, Vyse TJ, Beck S, Murray SS, Carrington M, Gregory S, Deloukas P, Rioux JD. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC Nature Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response](http://www.ncbi.nlm.nih.gov/pubmed/16951385)Karni A, Abraham M, Monsonego A, Cai G, Freeman GJ, Hafler D, Khoury HL. Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response The Journal Of Hafler DA. Human regulatory T cells and their role in autoimmune disease Immunological Reviews 2006, 212: 203-216. [PMID: 16903916](https://pubmed.ncbi.nlm.nih.gov/16903916), [DOI: 10.1111/j.0105-2896.2006.00417.x](https://doi.org/10.1111/j.0105-2896.2006.00417.x). O'Connor KC, Kuchroo VK, Hafler DA. Dysregulated T cell expression of TIM3 in multiple sclerosis Journal Of Experimental loci in multiple sclerosis and systemic lupus erythematosus](http://www.ncbi.nlm.nih.gov/pubmed/16642031)De Jager PL, Graham R, Farwell L, Sawcer Behrens TW, DA, Kere J, Vyse TJ, Rioux JD. The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus Hafler DA. MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells The Journal Of Immunology 2006, The Purification and Functional Analysis of Human CD4+CD25high Regulatory T Cells Current Protocols Variable Region Genes Derived from Muscle Tissue of Subjects with Inflammatory Myopathies](https://doi.org/10.1016/j.clim.2006.04.262)Bradshaw E, Orihuela A, Amato A, Hafler D, Greenberg S, O'Connor K. Sa.30. Characterization of B-Cell Immunoglobulin Variable Region Genes Derived from Muscle Tissue of Subjects with Inflammatory Myopathies Clinical Immunology 2006, 119: s115. [DOI: 10.1016/j.clim.2006.04.262](https://doi.org/10.1016/j.clim.2006.04.262). - O'Connor K, McArdel S, Bradshaw E, Anderson D, Moore N, Brady M, Hafler D. Sa.9. Examination of the B-Cell Repertoire in the CNS of Patients with MS Clinical Immunology 2006, 119: s108. [DOI: 10.1016/j.clim.2006.04.241](https://doi.org/10.1016/j.clim.2006.04.241). - Hastings W, Kuchroo V, Hafler D. Analysis of Autoreactive T-Cells in Khoury S, D. Sa.25. In Vitro Correlates of in Vivo Rapamycin Therapy in Patients with Multiple Sclerosis Clinical Immunology 2006, 119: s113. [DOI: 10.1016/j.clim.2006.04.257](https://doi.org/10.1016/j.clim.2006.04.257). - BRASS S, WEINER H, HAFLER CHAPTER 46 Multiple Sclerosis 2006, 615-632. [DOI: 10.1016/b978-012595961-2/50049-4](https://doi.org/10.1016/b978-012595961-2/50049-4). [Sa.13. Function of TIM3 May Be Compromised in Human CD4 T-Cells of Untreated Patients with Multiple Sclerosis](https://doi.org/10.1016/j.clim.2006.04.245)Yang L, Anderson D, Hafler D. Sa.13. Function of TIM3 May Be Compromised in Human CD4 T-Cells of Untreated Patients with Multiple Sclerosis Clinical Immunology 119: s109. [DOI: 10.1016/j.clim.2006.04.245](https://doi.org/10.1016/j.clim.2006.04.245). [OR.80. Identifying Regulators Using a Lentiviral N. OR.80. Identifying Regulators of Cytokine Production in Primary Human T-Cells Using a Il-10 Plays a Contrasting Role in Suppression By Functionally Distinct, Dr+ and Dr Human Natural Regulatory T-Cells](https://doi.org/10.1016/j.clim.2006.04.011)Baecher-Allan C, Ashley C, Hafler D. OR.9. Il-10 Plays a Contrasting Role in Suppression By Functionally Distinct, Dr+ and Dr Human Natural Regulatory T-Cells Clinical Immunology 2006, 119: s7. [DOI: 10.1016/j.clim.2006.04.011](https://doi.org/10.1016/j.clim.2006.04.011). [OR.72. of Insulin a Chain 1-15 By Expanded T-Cell Clones from Human Type 1 Diabetic (T1D) Pancreatic Draining Lymph Nodes](https://doi.org/10.1016/j.clim.2006.04.228)Kent S, Hafler D. OR.72. Enhanced Recognition of Insulin a Chain 1-15 By Expanded T-Cell Clones from Human Type 1 Diabetic (T1D) Pancreatic Draining Nodes Clinical Immunology 2006, [Sa.43. Role of the HLA DRB1*1501 Haplotype in the Expression of Clinical and Radiographic Phenotypes of Multiple Sclerosis](https://doi.org/10.1016/j.clim.2006.04.275)De Jager P, Charles G, Wolfish C, Holland C, Alkasab T, Parker A, Roubenoff R, Khoury S, Hafler D, Weiner H. Sa.43. Role of the HLA DRB1*1501 Risk Haplotype in the Expression of Clinical and Radiographic Phenotypes of Pathway Alleles Associated with Risk of Inflammatory Bowel Disease](https://doi.org/10.1016/j.clim.2006.04.259)Waliszewska A, De Jager P, Franchimont D, Hafler Epistasis Analyses of Toll-Like Receptor Pathway Alleles Associated with Risk of Inflammatory Bowel Disease Clinical Immunology 2006, 119: s114. [DOI: 10.1016/j.clim.2006.04.259](https://doi.org/10.1016/j.clim.2006.04.259). [OR.22. Dissection of the Admixture Multiple Locus On Chromosome 1 in An African-American Population](https://doi.org/10.1016/j.clim.2006.04.024)De Jager P, Patterson N, McDonald G, Waliszewska A, Cree B, Wolfish C, Hauser S, Oksenberg J, Reich D, Hafler D. OR.22. Dissection of the Admixture Multiple Sclerosis Susceptibility Locus On Chromosome 1 in An African-American Population Clinical Immunology 119: Cohen L, Goris A, Libioulle C, Jani N, Dassopoulos T, Gillian B, Dubois B, Cho J, Brant S, Duerr R, Yang H, Rotter J, Silverberg M, Steinhart H, Daly M, Louis E, Hafler D, Rioux J. Sa.137. Toll-Like Receptor Pathway Polymorphisms and Association to Inflammatory Bowel Disease Clinical Immunology 2006, 119: s154. 2006, 119: s151. [DOI: 10.1016/j.clim.2006.04.362](https://doi.org/10.1016/j.clim.2006.04.362). [Sa.128. Comparison of Two Methods to Isolate Mononuclear Cells from Peripheral Blood On Viability and Function of Freshly and Cryopreserved PBMCS](https://doi.org/10.1016/j.clim.2006.04.360)Raddassi K, Estevam J, Bourcier K, Gisler T, Hafler D, Seyfert-Margolis V. Sa.128. Comparison of Two Methods to Isolate Mononuclear Cells from Peripheral Blood On Viability and Function of Freshly and Cryopreserved PBMCS Clinical Immunology 2006, Sawcer S, Waliszewska A, Farwell L, Wild Cohen A, D, Bitton A, Compston A, Hafler DA, Rioux JD. of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosis European Human Genetics 2005, 14: 317-321. [PMID: 16391555](https://pubmed.ncbi.nlm.nih.gov/16391555), [DOI: 10.1038/sj.ejhg.5201548](https://doi.org/10.1038/sj.ejhg.5201548). Bregoli L, Clemmings S, Hering B, Kenyon N, Ricordi C. Insulin auto-antigenicity in type 1 diabetes (Reply) Nature 2005, 438: e5-e6. [DOI: 10.1038/nature04424](https://doi.org/10.1038/nature04424). - Baecher-Allan CM, Hafler DA. Immunology 117: 192. [PMID: Kenyon NS, Ricordi C, Hering B, Hafler DA. Loss of IL-4 Secretion from Human Type 1a Diabetic Pancreatic Draining Lymph Node NKT Cells 175: 4458-4464. [DOI: McDonald GJ, Waliszewska A, Tandon A, Lincoln C, Fruhan SA, Cabre P, Bera O, Semana G, Kelly MA, Francis DA, Ardlie K, Khan O, Cree BA, Hauser SL, Oksenberg JR, Hafler DA. A whole-genome admixture scan finds a candidate locus for multiple sclerosis Genetics 16186815](https://pubmed.ncbi.nlm.nih.gov/16186815), [DOI: Myelin Oligodendrocyte Glycoprotein](http://www.ncbi.nlm.nih.gov/pubmed/16034142)O'Connor K, Appel H, Bregoli L, Call ME, Catz I, Chan JA, Moore NH, Warren KG, Wong SJ, Hafler DA, Wucherpfennig KW. Antibodies from Inflamed Central Nervous Tissue Recognize Compston A, Kirby A, Daly MJ, Jager Walsh Lander ES, Rioux JD, Hafler DA, Ivinson A, Rimmler J, Gregory Pericak-Vance MA, Akesson E, Hillert J, Datta HF, Spurkland A, Myhr KM, Laaksonen M, Booth D, Heard R, Stewart G, Lincoln R, Barcellos LF, Hauser SL, Oksenberg JR, Kenealy SJ, Haines JL. A High-Density Screen for Linkage in Multiple Sclerosis American Journal Of Trollmo C, Kessler B, Hekking B, Merritt D, Meyer AL, Kwok B, Ploegh H, Huber BT, Hafler DA. Characterization of in vivo expanded OspA-specific from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope](http://www.ncbi.nlm.nih.gov/pubmed/15889096)Kent SC, Chen Y, Bregoli Hering BJ, Hafler DA. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope Nature 2005, 435: 224-228. populations of human regulatory CD4+CD25+ T cells](http://www.ncbi.nlm.nih.gov/pubmed/15870015)Baecher-Allan C, Wolf E, Hafler DA. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T KC, De Jager P, BaecherAllan Jutton M, Price DA, Hafler DA, Kuchroo VK, Altmann DM. High Incidence of Spontaneous Disease in an HLA-DR15 and TCR Transgenic Multiple Sclerosis Model The Journal Of 2005, Jager P. Applying a new generation of genetic maps to understand human inflammatory disease Nature Reviews Immunology 2005, 5: 83-91. [PMID: 15630431](https://pubmed.ncbi.nlm.nih.gov/15630431), [DOI: 10.1038/nri1532](https://doi.org/10.1038/nri1532). [The potential for targeting CD4+CD25+ regulatory T cells in the treatment of multiple sclerosis in humans](https://doi.org/10.1007/3-7643-7301-6_8)Baecher-Allan C, Viglietta V, Hafler D. The potential for targeting CD4+CD25+ regulatory T cells in the treatment of multiple sclerosis in humans 2005, 133-151. [DOI: 10.1007/3-7643-7301-6_8](https://doi.org/10.1007/3-7643-7301-6_8). [PD-1 ligands, negative regulators for activation of na\u00efve, memory, and recently activated human CD4+ T cells](http://www.ncbi.nlm.nih.gov/pubmed/15598424)Cai G, Karni A, Oliveira EM, Weiner HL, Hafler DA, Freeman GJ. PD-1 ligands, negative regulators for activation of na\u00efve, memory, and recently activated human CD4+ T Self Antigens Presented by Different MHC Class II Molecules The Immunology [PMID: Hafler DA. Re: GAMES issue study: Are 5-6. [PMID: 15334748](https://pubmed.ncbi.nlm.nih.gov/15334748). - Baecher-Allan C, Hafler DA. Suppressor T Cells in Human Diseases Journal Of Experimental Medicine 2004, De Jager PL, Gabriel S, Hafler DA, Ivinson AJ, Lander ES, Rioux JD, Walsh E, Gregory SG, Schmidt S, Pericak-Vance MA, Barcellos L, Hauser SL, Oksenberg JR, Kenealy SJ, Haines JL. Enhancing linkage analysis of complex disorders: an evaluation of cell receptor transgenic model of multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/15214032)Ellmerich S, Takacs K, Mycko M, Waldner H, Wahid Altmann DM. Diseaserelated epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis European Journal Of Immunology Differentially and Th2 Cells and in Cerebrospinal Fluid-Derived Mononuclear M, Takazawa N, Baecher-Allan C, Brundin L, J, Martin C, Harris RA, Hafler DA, Kuchroo VK, Olsson T, Piehl Mucin-Domain-Containing Molecule-3 and Molecules Are Differentially and Th2 Cells and in Cerebrospinal Fluid-Derived Mononuclear Cells in Multiple Signals Negatively in T Cells](http://www.ncbi.nlm.nih.gov/pubmed/15142525)Vijayakrishnan L, Slavik JM, Ill\u00e9s Z, Greenwald RJ, Rainbow D, Greve B, Peterson LB, Hafler DA, Freeman GJ, Sharpe AH, Wicker LS, Kuchroo An Autoimmune Disease-Associated CTLA-4 Splice Variant Lacking the B7 Binding Domain Signals Negatively in T Cells Immunity 2004, 20: 563-575. [PMID: 15142525](https://pubmed.ncbi.nlm.nih.gov/15142525), [DOI: 10.1016/s1074-7613(04)00110-4](https://doi.org/10.1016/s1074-7613(04)00110-4). - DA. Gene expression profiling in MS: what is the clinical relevance? The Lancet Neurology 2004, 269. [PMID: 15099539](https://pubmed.ncbi.nlm.nih.gov/15099539), B, Lohmueller KE, Hafler DA, Oksenberg JR, Hauser SL, Smith MW, O'Brien S, Altshuler D, Daly MJ, Reich D. Methods for High-Density Admixture Mapping of Disease Genes American Journal Of 74: Jager PL, Mignault AA, Yi Z, de Th\u00e9 G, Essex M, Sankal\u00e9 J, Moore JH, Poku D, Williams Tishkoff SA, Winkler CA, De La Vega FM, Woodage T, Sninsky JJ, Hafler DA, Altshuler D, Gilbert DA, O'Brien S, Reich D. A High-Density Admixture Map for Disease Gene Discovery in African Americans American Journal Of Human Genetics 2004, Hafler DA. Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis Journal Of Experimental Medicine 2004, Hafler A, Gottlieb P. Regulatory T cells in type 1 diabetes mellitus Current Opinion In Endocrinology Diabetes And Obesity 2004, 11: 85-90. [DOI: 10.1097/01.med.0000129641.34639.2e](https://doi.org/10.1097/01.med.0000129641.34639.2e). - Hafler D. Multiple 113: 1070-1070. [PMCID: PMC380239](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC380239), [DOI: 10.1172/jci200421357c](https://doi.org/10.1172/jci200421357c). - Hafler in Multiple Sclerosis kip1 Down-regulation and bcl-xL p27 kip1 Down-regulation and bcl-xL Inhibitor of Phosphoinositide Hafler DA, Rioux JD. Genetic analysis Induce Atypical Partial Agonistic CD8+ T and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions](http://www.ncbi.nlm.nih.gov/pubmed/12620653)O'Connor KC, Chitnis T, Griffin the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions Journal of glatiramer acetate induces hyporesponsive T cells in patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/12706402)Schmied M, Duda PW, Krieger JI, Trollmo C, Hafler DA. In vitro evidence that subcutaneous administration of glatiramer acetate induces hyporesponsive T cells in patients with multiple Clinical Immunology DA. Activated CD8+ T cells in myelin basic protein reactive T cells may distinguish patients with multiple sclerosis from healthy controls](http://www.ncbi.nlm.nih.gov/pubmed/12604314)Oliveira EM, Bar-Or A, Waliszewska AI, Cai G, Anderson DE, Krieger JI, Hafler DA. CTLA-4 dysregulation in the activation of myelin basic protein reactive T cells may distinguish patients with multiple sclerosis from healthy controls Journal Of Autoimmunity 2003, 20: 71-81. [PMID: characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis](http://www.ncbi.nlm.nih.gov/pubmed/12594850)Cao D, Malmstr\u00f6m V, BaecherAllan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis European Journal Of DA, Weinshenker BG. CTLA4 is associated with susceptibility to 2003, 134: 133-141. [PMID: GJ, Hafler DA. CD4+CD25+ Regulatory Cells from Human Peripheral Blood Express Very High Levels of CD25 Ex DA. Inhibition of Human CD4+CD25+high Regulatory T Cell Function 6210-6217. T, Hafler D. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes Journal Of Clinical Investigation 2002, 109: 1511-1511. [DOI: 10.1172/jci14114c1](https://doi.org/10.1172/jci14114c1). - Lim DG, H\u00f6llsberg P, Hafler DA. Strength of prior stimuli determines the magnitude of secondary responsiveness in CD8+ T cells Cellular Hafler DA. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes Journal Of Clinical opposed to specificity, in immunotherapy Journal Expressing Costimulatory Molecules in the Resting State](http://www.ncbi.nlm.nih.gov/pubmed/11698439)Bar-Or A, Oliveira E, Anderson D, Krieger J, Duddy M, O'Connor K, Hafler D. Immunological Memory: Contribution of Memory B Cells Expressing Costimulatory Molecules in the Resting State The Journal Of Immunology 2001, 167: 5669-5677. [Conserved CDR3 Regions CD8+T Cells That Recognize the Tax11-19/HLA-A*0201 Complex in a Subject Infected with Human T-Cell Leukemia Virus Type 1: Relationship of T-Cell Fine Specificity and Major Histocompatibility Complex/Peptide/TCR Crystal Structure](http://www.ncbi.nlm.nih.gov/pubmed/11559817)Bourcier K, Lim D, Ding Y, Smith K, Wucherpfennig K, Hafler D. Conserved CDR3 Regions in T-Cell Receptor (TCR) CD8+T Cells That Recognize the Tax11-19/HLA-A*0201 Complex in a Subject Infected with Human T-Cell Leukemia Virus Type 1: Relationship of T-Cell Fine Specificity and Major Histocompatibility Complex/Peptide/TCR Crystal Structure of contaminating mouse IgG; techniques for producing Ig-free MOG](http://www.ncbi.nlm.nih.gov/pubmed/11498254)Ohashi T, Yukitake M, Slavin A, Krieger J, Hafler D. In vitro evidence that immunuaffinity-purified MOG contains immunogenic quantities of contaminating mouse IgG; techniques for producing Freeman G, Hafler D. CD4+CD25high Regulatory Cells in Human Peripheral Blood The the Single Cell Level: LFA-1L Is a Partial Agonist for Outer Surface Protein A-Reactive T Cells](http://www.ncbi.nlm.nih.gov/pubmed/11290815)Trollmo C, Meyer A, Steere A, Hafler D, Huber B. Molecular Mimicry in Lyme Arthritis Demonstrated at the Single Cell Level: LFA-1L Is a Partial Agonist for Outer Surface Protein A-Reactive T Cells The and B Lymphocytes in Immunopathogenesis](http://www.ncbi.nlm.nih.gov/pubmed/11332657)O'connor K, Bar-Or A, Hafler D. The Neuroimmunology of Multiple Sclerosis: Possible Roles of T and B Lymphocytes in Immunopathogenesis Hafler D, Hartung H. Enhanced B7 Costimulatory Molecule Expression In Inflammatory Human Sural Nerve Biopsies Journal Of The Peripheral Nervous System 2001, 6: 64-64. [DOI: 10.1046/j.1529-8027.2001.01008-15.x](https://doi.org/10.1046/j.1529-8027.2001.01008-15.x). [Decreases in Interleukin-4 Secretion by Invariant T Cells in Peripheral Blood of Patients with Relapsing-Remitting Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/11141321)Gausling R, Trollmo C, Hafler D. Decreases in Interleukin-4 Secretion by Invariant CD4CD8V24JQ T Cells in Peripheral Blood of Patients with Relapsing-Remitting Multiple Sclerosis in Human Type 1 Diabetes Mellitus Before Clinical Onset](http://www.ncbi.nlm.nih.gov/pubmed/11905851)Orban T, Kent SC, Malik P, Milner JD, Schuster K, Jackson RA, Hafler DA. Heterophile Antibodies Indicate Progression of Autoimmunity in Human Type 1 Diabetes Mellitus Before 2001, 10.3109/08916930109014694](https://doi.org/10.3109/08916930109014694). - Anderson D, Hafler System Antigen: Recognition of the Synthetic Random Polypeptide Glatiramer Acetate](http://www.ncbi.nlm.nih.gov/pubmed/11120865)Duda P, Krieger J, Human and Murine CD4 T Cell Reactivity to a Complex Antigen: Recognition of the Synthetic Random Polypeptide Glatiramer Acetate Hafler Antigen-specific therapy for autoimmune disease Current Humans Using MHC Class I Tetramers: Similar Cytotoxicity but Variable Proliferation and Cytokine Production Among Different Clonal CD8+ T Cells Specific to a Single Viral Epitope](http://www.ncbi.nlm.nih.gov/pubmed/11086055)Lim D, Bourcier K, Freeman G, Hafler D. Examination of CD8+ T Cell Function in Humans Using MHC Class I Tetramers: Similar Cytotoxicity but Variable Proliferation and Cytokine Production Among Different Clonal CD8+ T Cells Specific to a Single Viral Epitope Of Immunology 2000, Marrack P, Steere A, Huber B, Kappler J, Hafler D. Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers Proceedings Of The National Academy Of Sciences Of The United States Of America 2000, Hafler DA, Hartung HP. Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies Journal Of Neurology Neurosurgery cells producing intracellular IL4 is decreased in patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/10940899)Kipp B, BarOr A, Gausling R, Oliveira E, Fruhan S, Stuart W, Hafler D. A novel population of B71+ T cells producing intracellular IL4 is decreased in patients with multiple sclerosis European Immunology 2000, 30: 2092-2100. [PMID: 10940899](https://pubmed.ncbi.nlm.nih.gov/10940899), gene expression in regulatory V24JQ T cells from identical twins discordant for type I diabetes](http://www.ncbi.nlm.nih.gov/pubmed/10840051)Wilson S, Kent S, Horton H, Hill A, Bollyky P, Hafler D, Strominger J, Byrne M. Multiple differences in gene expression in regulatory V24JQ T cells from identical twins discordant for type I diabetes Proceedings Of The National Academy Of Sciences Of The United States Of America in patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/10749576)Duda PW, Schmied MC, Cook SL, Krieger JI, Hafler DA. Glatiramer acetate (Copaxone\u00ae) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis Journal Of Clinical Investigation M, Hafler D. T-cell function in response to CTLA-4 blockade; heterogeneity within the [PMID: 10655112](https://pubmed.ncbi.nlm.nih.gov/10655112), with pulse cyclophosphamidel methylprednisolone: Response to therapy is linked to the duration of progressive disease](http://www.ncbi.nlm.nih.gov/pubmed/10618696)Hohol M, Olek M, Orav E, Stazzone L, Hafler D, Khoury S, Dawson D, Weiner H. Treatment of progressive multiple sclerosis with pulse cyclophosphamidel methylprednisolone: Response to therapy is linked to the duration of progressive disease Multiple Sclerosis Journal 1999, 5: 403-409. [PMID: 10618696](https://pubmed.ncbi.nlm.nih.gov/10618696), [DOI: 10.1177/135245859900500i606](https://doi.org/10.1177/135245859900500i606). - What is the turning point? Editorial overview Immunology 1999, 11: 635-637. 10631547](https://pubmed.ncbi.nlm.nih.gov/10631547), [DOI: D. The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system Current Opinion In Immunology 1999, D, Hafler D. Molecular pathogenesis of multiple CDR3 region amino acid substitutions are restricted by CD1d](http://www.ncbi.nlm.nih.gov/pubmed/10600006)Kent S, Hafler D, Strominger J, Wilson S. Noncanonical V24JQ T cells with conservative chain CDR3 region amino acid substitutions are restricted Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.](http://www.ncbi.nlm.nih.gov/pubmed/10452989)Milner J, Kent S, Ashley T, Wilson S, Strominger J, Hafler D. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to blurs between an autoimmune versus microbial hypothesis in multiple sclerosis Journal Of Clinical in families and are associated with protection from type 1 diabetes](http://www.ncbi.nlm.nih.gov/pubmed/10393957)She J, Ellis T, Wilson S, Wasserfall C, Marron M, Reimsneider S, Kent S, Hafler D, Neuberg D, Muir A, Strominger J, Atkinson M. Heterophile antibodies segregate in families and are associated with protection from type 1 diabetes Proceedings Of The National Academy Of Sciences Of The United States Of America 1999, D. T cell Autoreactivity to Proinsulin Epitopes in Diabetic Patients and Healthy 12: 259-267. [PMID: 10330297](https://pubmed.ncbi.nlm.nih.gov/10330297), multiple sclerosis with pulse cyclophosphamide/methylprednisolone: Response to therapy is linked to the duration of progressive disease](https://doi.org/10.1191/135245899678846492)Hohol M, Olek M, John Orav E, Stazzone L, Hafler D, Khoury S, Dawson D, Weiner H. Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: Response to therapy is linked to the duration of progressive disease Multiple Sclerosis Journal 1999, 5: 403-409. [DOI: 10.1191/135245899678846492](https://doi.org/10.1191/135245899678846492). - Wilson S, Kent S, Patton K, Orban T, Jackson R, Exley M, Porcelli S, Schatz D, Atkinson M, Balk S, Strominger J, Hafler D. Erratum: Extreme Th1 bias of invariant V24JQ T cells in type 1 diabetes Nature 1999, 399: 84-84. [DOI: 10.1038/20007](https://doi.org/10.1038/20007). - Smith D, Buckle G, Hafler D, Frank D, H\u00f6llsberg P. HTLV-I-Infected T Cells Evade the Antiproliferative Not in Borrelial Encephalomyelitis](http://www.ncbi.nlm.nih.gov/pubmed/10357888)Pohl-Koppe A, E, burgdorferi and Myelin Protein-Specific Cells Clones Specific for Altered Peptide with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy.](http://www.ncbi.nlm.nih.gov/pubmed/9973440)Bieganowska K, Hollsberg P, Buckle G, Lim D, Greten T, Schneck J, Altman J, Jacobson S, Ledis S, Hanchard B, Chin J, Morgan O, Roth P, Hafler D. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic Reingold S, Hafler D. T helper cell differentiation in multiple sclerosis and autoimmunity Trends In DA. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis Journal Of 1998, Myelin basic protein reactive Th2 T cells are found in acute disseminated Neuroimmunology 1998, P. Increased expression of CDIIb (mac-1) on CD8+ T cells in patients with Of Neuroimmunology 1998, 90: IL-4 secretion by invariant V24JQT cells in peripheral blood of patients with multiple sclerosis (MS)](https://doi.org/10.1016/s0165-5728(98)91612-5)Gausling R, Trollmo T, Hafler D. Decreases in IL-4 secretion by invariant V24JQT cells in peripheral blood of patients with multiple sclerosis (MS) Journal Of Neuroimmunology 1998, 90: 72. [DOI: 10.1016/s0165-5728(98)91612-5](https://doi.org/10.1016/s0165-5728(98)91612-5). - Anderson D, Bieganowska K, Bar-Or A, Hafler D. CTLA4 engagement can have both positive and negative effects on human T cell activation Journal Of Neuroimmunology 1998, 90: 14. [DOI: 10.1016/s0165-5728(98)91262-0](https://doi.org/10.1016/s0165-5728(98)91262-0). - Bieganowska K, Anderson D, Bar-Or A, Hafler D. Effect of CD28/CTLA4 signaling on function of MBP reactive T cells Journal Of Neuroimmunology 1998, 90: 15. 10.1016/s0165-5728(98)91267-x](https://doi.org/10.1016/s0165-5728(98)91267-x). - Bar-Or A, CTLA4 blockade B7-2 dependent Duda P, Krieger J, Hafler D. In vitro analysis of T-cell responses to Copaxone\u00ae Of Multiple Sclerosis Patients](http://www.ncbi.nlm.nih.gov/pubmed/9683547)Takashima H, Smith D, Fukaura H, Khoury S, Hafler D, Weiner H. Pulse Cyclophosphamide Plus Methylprednisolone Induces Myelin-Antigen-Specific IL-4-Secreting T Cells in 28-34. [PMID: receptors interferon secretion from T cells and natural killer cells](http://www.ncbi.nlm.nih.gov/pubmed/9520447)Mandelboim O, Kent S, Davis D, Wilson S, Okazaki T, Jackson R, Hafler D, Strominger J. Natural killer activating receptors trigger interferon secretion from T cells and natural killer cells Proceedings Of The National Academy Of Sciences Of The United States Of America of both IFN-gamma and IL-10 secretion in K, Steere A, Logigian E, Hafler D. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia is independent of exogenous B7 costimulation.](http://www.ncbi.nlm.nih.gov/pubmed/9570577)Scholz C, Patton K, Anderson D, Freeman G, Hafler D. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. from PHA-Activated Immune Cells](http://www.ncbi.nlm.nih.gov/pubmed/9464271)Dangond J, Randall J, Kojima R, Utku N, Gullans S. Differential Display Cloning Novel Histone (HDAC3) cDNA from Wilson K, Orban T, Jackson R, Exley M, Porcelli S, Schatz D, Atkinson M, Balk S, Strominger J, Hafler D. Extreme Th1 bias of invariant V24JQ T cells in type T Cells in Patients with Multiple Sclerosisa](http://www.ncbi.nlm.nih.gov/pubmed/9616767)HAFLER D, KENT S, PIETRUSEWICZ M, KHOURY S, WEINER H, FUKAURA H. Oral Administration of Myelin Induces Antigenspecific TGF1 Secreting T Cells in Patients with Multiple Sclerosisa Annals Of The New York Academy Of Sciences 1997, 120-131. [PMID: CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4.](http://www.ncbi.nlm.nih.gov/pubmed/9366404)H\u00f6llsberg P, Scholz C, Anderson DE, Greenfield EA, VK, Freeman GJ, DA. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4. The enhanced agonist response induced by altered ligands.](http://www.ncbi.nlm.nih.gov/pubmed/9366420)Dressel A, Gausling DA. by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands of myelin sclerosis: Increased interleukin4 production and associated eosinophilia](http://www.ncbi.nlm.nih.gov/pubmed/9307252)Smith D, Balashov K, Hafler D, Khoury S, Weiner H. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin4 production and T cell reveal functional differences in B7-1 and B7-2 costimulation of human T cell clones. and its relevance to CNS autoimmunity](http://www.ncbi.nlm.nih.gov/pubmed/9184642)Dangond F, Windhagen A, Groves C, Hafler D. Constitutive expression of costimulatory molecules by human microglia and its relevance to Cells in Human Autoimmune Disease](http://www.ncbi.nlm.nih.gov/pubmed/9151896)Bieganowska K, Ausubel L, Modabber Y, Slovik E, Messersmith W, D. Direct Ex Vivo Analysis of Activated, Fas-sensitive Autoreactive T Cells in Human Autoimmune Disease Journal Of blood-derived T-cell clones infected with human T-cell leukemia virus type I.](http://www.ncbi.nlm.nih.gov/pubmed/9129036)Richardson JH, Hollsberg P, Windhagen A, Child LA, Hafler DA, Lever A. Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia [DOI: Antigens: Results of a Phase I/II Randomized Masked Trial](http://www.ncbi.nlm.nih.gov/pubmed/9152063)Nussenblatt R, Gery I, Weiner H, Ferris F, Shiloach J, Remaley N, Perry C, Caspi R, Hafler D, Foster C, Whitcup S. Treatment of Uveitis by Oral Administration of Retinal Antigens: Results of a Phase I/II Randomized Masked Trial Multiple Sclerosis Patientsa](http://www.ncbi.nlm.nih.gov/pubmed/9186687)KENT S, FUKAURA H, PIETRUSEWICZ M, KHOURY S, WEINER H, HAFLER D. Oral Administration of Myelin Induces Antigenspecific TGF1secreting T Cells in Multiple Sclerosis Patientsa Annals Of The New York Academy Of Sciences 1997, 815: 412-422. [PMID: 9186687](https://pubmed.ncbi.nlm.nih.gov/9186687), [DOI: 10.1111/j.1749-6632.1997.tb52092.x](https://doi.org/10.1111/j.1749-6632.1997.tb52092.x). induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.](http://www.ncbi.nlm.nih.gov/pubmed/9036945)Greenfield EA, Howard E, Paradis T, Nguyen K, Benazzo F, McLean P, H\u00f6llsberg P, Davis G, Hafler DA, Sharpe AH, Freeman GJ, Kuchroo VK. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors. The 158: 2025-34. [PMID: 9036945](https://pubmed.ncbi.nlm.nih.gov/9036945), Induction by activated CD4+ T cells via CD40 ligand](http://www.ncbi.nlm.nih.gov/pubmed/9012830)Balashov K, Smith D, Khoury S, Hafler D, Weiner H. Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4+ T cells via CD40 ligand Proceedings Of The National Academy Of Sciences Of The United States Of America C, Sette A, V, Hafler D. Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones Proceedings Of The National Academy Of Sciences Of The United States Of America 1996, Induction of anergy in CD8 T cells by B cell presentation of antigen. The Journal Of Immunology 1996, How to know thy self CD4+ T cells via CD40 ligand](https://doi.org/10.1177/135245859600200519)Weiner H, Balashov K, Smith D, Khoury S, Hafler D. Increased IL-12 production in progressive multiple sclerosis: Induction by activated CD4+ T cells via CD40 Sclerosis Journal 1996, 2: 253-253. [DOI: 10.1177/135245859600200519](https://doi.org/10.1177/135245859600200519). [Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation.](http://www.ncbi.nlm.nih.gov/pubmed/8816399)Scholz C, Freeman GJ, Greenfield EA, Hafler DA, H\u00f6llsberg P. Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 of C, Hafler H\u00f6llsberg P. of IL10 secretion and enhanced antigenpresenting abilities following HTLVI infection of T cells Journal Characterization of Autoreactive T-cells in Acute Disseminated Encephalomyelitis 199 Pediatric Research 1996, 548-548. [DOI: 10.1203/00006450-199609000-00222](https://doi.org/10.1203/00006450-199609000-00222). - Windhagen A, Anderson DE, Carrizosa A, Williams RE, Hafler DA. IL-12 induces human T cells secreting IL-10 protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in sclerosis patients.](http://www.ncbi.nlm.nih.gov/pubmed/8690806)Fukaura and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. Journal Of Clinical Milford E, Steinman L. TCR usage in human and experimental demyelinating disease In V, Hafler D. Role of Th1 and 10.1159/000319485](https://doi.org/10.1159/000319485). - MATSUI M, HAFLER D, WEINER Pilot Study of Oral Tolerance to Keyhole Limpet Hemocyanin in Humans. Annals Of The New York Sciences 1996, 778: 398-404. [PMID: 8611003](https://pubmed.ncbi.nlm.nih.gov/8611003), [DOI: 10.1111/j.1749-6632.1996.tb21156.x](https://doi.org/10.1111/j.1749-6632.1996.tb21156.x). Oral Tolerization with Myelin Antigens in Multiple Sclerosis and Design of a Phase III Pivotal Trial](http://www.ncbi.nlm.nih.gov/pubmed/8610977)HOHOL M, KHOURY S, COOK S, ORAV E, HAFLER D, WEINER H. Threeyear Open Protocol Continuation Study of Oral Tolerization with Myelin Antigens in Multiple Sclerosis and Design of a Phase III Pivotal Trial Annals Of The New York Academy Of Sciences 1996, 778: 243-250. [PMID: 8610977](https://pubmed.ncbi.nlm.nih.gov/8610977), H, D. Antigenspecific TGF1 Secretion with Bovine Myelin Oral Tolerization in Multiple Sclerosis Annals Of The New York Academy Of Sciences 1996, 778: 251-257. activation. JAIDS Journal D, Weiner H. Antigen-specific therapies for the treatment of autoimmune diseases 1996, B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. Journal Of Experimental McNeely B, Hafler D, Hedley-Whyte E. Case 37-1995 \u2014 A 6-year-old boy with a rash, meningismus, and diplegia New England [DOI: immunodominant myelin basic protein Strominger specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes. Proceedings Of The National Academy Of Sciences Of The United States Of America 1995, S, Sette A, Kuchroo VK, of immunodominant and cryptic proteolipid protein epitopes in Sclerosis: Clonal Expansion and Persistence of Human TCells Specific for an Immunodominant Myelin Basic Protein Peptidea](http://www.ncbi.nlm.nih.gov/pubmed/7544075)WUCHERPFENNIG K, HAFLER D. A Review of TCell Receptors in Multiple Sclerosis: Clonal Expansion and Persistence of Human TCells Specific for an Immunodominant Myelin Basic Protein Peptidea Annals Of The New York Of Sciences 1995, 756: 241-258. [PMID: 7544075](https://pubmed.ncbi.nlm.nih.gov/7544075), [DOI: 10.1111/j.1749-6632.1995.tb44522.x](https://doi.org/10.1111/j.1749-6632.1995.tb44522.x). - Hafler D, Weiner H. Antigen-specific therapies for the treatment of autoimmune diseases Seminars 1995, 17: 61-76. [PMID: 7482227](https://pubmed.ncbi.nlm.nih.gov/7482227), [DOI: 10.1007/bf00194100](https://doi.org/10.1007/bf00194100). [Correlation of Magnetic Resonance Imaging With Immune and Clinical Measures in 45 MS Patients Receiving 20 to 24 MRI Scans Each Over a 1 -Year Period: 1](https://doi.org/10.1212/wnl.45.7.1416)Weiner H, Guttman C, Khoury S, Hohol M, Hafler D, Orav E, Hsu L, Ahn S, Kikinis R, Jolesz F. Correlation of Magnetic Resonance Imaging With Immune and Clinical Measures in 45 MS Patients Receiving 20 to 24 MRI Scans Each Over a 1 -Year Period: 1 Neurology 1995, 45: 1416-1416. [DOI: 10.1212/wnl.45.7.1416](https://doi.org/10.1212/wnl.45.7.1416). [Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis.](http://www.ncbi.nlm.nih.gov/pubmed/7769110)Balashov KE, Khoury SJ, Hafler DA, Weiner HL. Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis. Journal Of Clinical Investigation delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements.](http://www.ncbi.nlm.nih.gov/pubmed/7722338)Stinissen P, Vandevyver C, Medaer R, Vandegaer L, Nies J, Tuyls L, Hafler DA, Raus J, Zhang J. Increased frequency of gamma delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements. T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand.](http://www.ncbi.nlm.nih.gov/pubmed/7732026)H\u00f6llsberg P, Weber WE, Dangond F, Batra V, Sette A, Hafler DA. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proceedings Of The National Academy Of Sciences Of The United States Of America human autoreactive T cell clones by a single amino acid substitution of their peptide ligand](http://www.ncbi.nlm.nih.gov/pubmed/7536622)Windhagen A, Schooz C, H\u00f6llsberg D. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand Immunity 1995, 2: 373-380. HAFLER D, WEINER H. Immunologic Mechanisms and Therapy in Multiple Immunological Hafler DA. Tropical spastic paraparesis on the Caribbean coast of Colombia. American Journal Of Tropical Medicine And Hygiene 1995, 52: 155-8. of normal T-cell lines to MBP isolated from normal and multiple sclerosis white matter Journal Of The Neurological Sciences 1995, 128: 205-211. [PMID: 7537795](https://pubmed.ncbi.nlm.nih.gov/7537795), [DOI: 10.1016/0022-510x(94)00224-c](https://doi.org/10.1016/0022-510x(94)00224-c). Khoury S, Dawson D, Hafler D. Therapy for Weiner HL. Antigen specific therapies for the treatment of autoimmune diseases. 1995, 47: 59-77. Immunosuppression: Oral Tolerance for the 1995, 60: 126-149. [PMID: 7857525](https://pubmed.ncbi.nlm.nih.gov/7857525), [DOI: 10.1159/000423974](https://doi.org/10.1159/000423974). Kent S, Orav J, Khoury S, Hafler D. Treatment of multiple sclerosis and other autoimmune diseases by oral tolerance to autoantigens Journal Of Neuroimmunology 1995, 56: 14. Scholz C, Fukaura H, H\u00f6llsberg P. Modification of immune responses to myelin basic protein (MBP) using altered peptide ligands Journal Of T-cell receptors. Proceedings Of The National Academy Of Sciences Of The United States Of America the Treatment of Autoimmune Disease (Part 2 of 2)](https://doi.org/10.1159/000319270)Hafler D, Weiner H. Antigen-Specific Immunosuppression: Oral Tolerance for the Treatment of Autoimmune Disease (Part 2 of 2) 1994, 60: 138-149. [DOI: 10.1159/000319270](https://doi.org/10.1159/000319270). [Antigen-Specific Immunosuppression: Oral Tolerance for the Treatment of Autoimmune Disease (Part 1 of 2)](https://doi.org/10.1159/000319269)Hafler D, Weiner H. Antigen-Specific Immunosuppression: Oral Tolerance for the Treatment of Autoimmune Disease (Part 1 of 2) 1994, 60: 126-137. [DOI: 10.1159/000319269](https://doi.org/10.1159/000319269). Kuchroo V, D. cell recognition of immunodominant and cryptic proteolipid protein epitopes in 179. [DOI: proliferation in HTLV-I tax-reactive CD8 T cells by a single amino acid substitution in a T cell receptor contact residue of the peptide antigen](https://doi.org/10.1016/0165-5728(94)90360-3)H\u00f6llsberg P, Weber W, Dangond F, Batra V, Sette A, Hafler D. Differential activation of cytolysis and proliferation in HTLV-I tax-reactive CD8 T cells by a single amino acid substitution in a T cell receptor contact residue of the peptide antigen Journal Of Neuroimmunology 1994, 54: 168. [DOI: 10.1016/0165-5728(94)90360-3](https://doi.org/10.1016/0165-5728(94)90360-3). Zhang J, Hafler Raus J. In vivo clonal depletion of human myelin basic protein-reactive T cells by T cell vaccination Journal Of Neuroimmunology 1994, 54: 208. [DOI: 10.1016/0165-5728(94)90597-5](https://doi.org/10.1016/0165-5728(94)90597-5). [Switch of autoreactive human from a TH2 to a TGF1 secreting phenotype with low Scholz C, Fukaura H, Sette A, Hafler D. Switch of autoreactive human T cell clones from a TH2 to a TGF1 secreting phenotype with low affinity T-cell receptor stimulating Journal Of Neuroimmunology 1994, 54: 206. [DOI: 10.1016/0165-5728(94)90586-x](https://doi.org/10.1016/0165-5728(94)90586-x). - Chen Y, Kuchroo V, Inobe J, Hafler D, Weiner H. Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune to TGF-beta 1-induced suppression.](http://www.ncbi.nlm.nih.gov/pubmed/8021495)H\u00f6llsberg P, Ausubel LJ, Hafler DA. Human T cell lymphotropic virus type I-induced T cell activation. Resistance to TGF-beta 1-induced suppression. Hafler DA, Boeri E, Lever A, Bernardi G. Regional specificity of HTLV-I pro viral integration in the human 155-163. [PMID: 8206368](https://pubmed.ncbi.nlm.nih.gov/8206368), [DOI: 10.1016/0378-1119(94)90091-4](https://doi.org/10.1016/0378-1119(94)90091-4). [Clonal expansion and human T cells specific for an immunodominant myelin basic protein peptide.](http://www.ncbi.nlm.nih.gov/pubmed/7514641)Wucherpfennig KW, Zhang J, Witek M, Modabber Y, Ota K, Hafler DA. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. [T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR V beta 8.2 transgenic mice.](http://www.ncbi.nlm.nih.gov/pubmed/8163944)Kuchroo VK, Collins M, al-Sabbagh A, Sobel RA, Whitters MJ, SS, Dorf ME, Hafler DA, Seidman JG, Weiner HL. T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR V beta 8.2 transgenic mice. Journal Of Experimental Medicine of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens](http://www.ncbi.nlm.nih.gov/pubmed/8011298)Weiner HL, Friedman A, Miller A, Khoury SJ, al-Sabbagh L, Sayegh DE, Hafler DA. Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens Annual cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.](http://www.ncbi.nlm.nih.gov/pubmed/7509366)Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. Journal Of Experimental 1994, 179: 973-984. basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.](http://www.ncbi.nlm.nih.gov/pubmed/7505801)Wucherpfennig KW, Sette DA. Structural requirements for binding an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. Journal Of Experimental Medicine 1994, D, Lorenzo C, Sewell K, Hafler D, Weiner H. Effects of Oral Administration of Type II Collagen on Rheumatoid Arthritis Science 1993, 261: 1727-1730. Raus J. MHC-Restricted Depletion of Human Myelin Basic Protein-Reactive T Cells by T Cell 261: 1451-1454. [PMID: 7690157](https://pubmed.ncbi.nlm.nih.gov/7690157), [DOI: 10.1126/science.7690157](https://doi.org/10.1126/science.7690157). [T-cell proliferation and anergy induction. Differential superantigen and autoantigen.](http://www.ncbi.nlm.nih.gov/pubmed/7687620)LaSalle Saadeh M, Golan DE, Taber R, Hafler DA. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen D, Hafler D. Increased Protein Kinase C Activity in Human Memory T Cells progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.](http://www.ncbi.nlm.nih.gov/pubmed/8388090)Weiner HL, Mackin GA, Orav Herndon R, Lehrich JR, Hauser SL, Turel A, Fisher M, Birnbaum G, McArthur J, Butler R, Moore M, Sigsbee B, Safran A. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group. Neurology 1993, Z, LaSalle J, Weiner H, Hafler D. Biological activity of recombinant human myelin basic protein Of Neuroimmunology 1993, Hafler D. Pathogenesis of Diseases Induced by Human Lymphotropic Virus Type I Infection New England Journal Of Medicine 1993, 328: 1173-1182. [PMID: 8455685](https://pubmed.ncbi.nlm.nih.gov/8455685), E, Khoury S, Dawson D, Hafler D. Double-Blind Pilot Trial of Oral Tolerization with Myelin 10.1126/science.7680493](https://doi.org/10.1126/science.7680493). cells predominantly use unusual rearrangements of the T cell receptor delta and gamma loci expressed on both CD4+CD8- and JL. Human fetal liver gamma/delta T cells predominantly use unusual rearrangements of the T cell receptor delta and gamma loci expressed on both CD4+CD8- and CD4-CD8- gamma/delta T cells. specific therapies for autoimmune diseases; investigations in multiple sclerosis as a paradigm for rheumatoid arthritis.](http://www.ncbi.nlm.nih.gov/pubmed/7686832)Hafler DA, Zhang JW, LaSalle J, Donnelly C, Weiner HL, Wucherpfeffnig K. The development of antigen specific therapies for autoimmune diseases; investigations in multiple sclerosis as a paradigm for rheumatoid arthritis. Clinical And Experimental Rheumatology 1993, 11 Suppl 8: s39-40. [PMID: 7686832](https://pubmed.ncbi.nlm.nih.gov/7686832). - Weiner Miller S, Zhang Z, Al-Sabbagh A, Brod S, Lider O, Higgins P, Sobel R, Matsui M, Sayegh M, Carpenter C, Eisenbarth G, Nussenblatt R, Hafler D. Suppression of Organ-Specific Autoimmune Diseases by Oral Administration Autoantigens 10.1007/978-3-642-51479-1_81](https://doi.org/10.1007/978-3-642-51479-1_81). [CTLA-4 and CD28 mRNA are in cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate Lombard and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine Thrombolytic Streptokinase in Elderly Patients with Suspected Acute Myocardial Infarction](http://www.ncbi.nlm.nih.gov/pubmed/1598117)Krumholz H, Pasternak R, Weinstein M, Friesinger G, Ridker P, Tosteson A, Goldman L. Cost Effectiveness of Thrombolytic Therapy with Streptokinase in Elderly Patients with Suspected Acute Myocardial Infarction New England Journal Of Medicine LM, Hafler DA. Early signaling defects in human T cells anergized by T cell presentation of autoantigen. Journal Of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells. The Cuzner ML, Hafler DA. Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. Proceedings Of The National Academy Of Sciences Of The United States Of America beta repertoire and cytokine gene expression in active multiple sclerosis lesions.](http://www.ncbi.nlm.nih.gov/pubmed/1348083)Wucherpfennig KW, Newcombe J, Li H, Keddy C, Cuzner ML, Hafler DA. T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions. Journal Of Experimental Medicine 1992, DA. by autologous human T-cell leukemia virus type I-infected T-cell clones. Proceedings Of The National Academy Of Sciences Of The United States Of America 1992, Cohen I, Benjamin D, Weiner H. T cell vaccination in multiple sclerosis: A preliminary report Clinical Immunology 1992, Hafler D, Weiner H. Immunotherapy in autoimmune diseases Current Biology 1992, 2: 74. [DOI: 10.1016/0960-9822(92)90205-o](https://doi.org/10.1016/0960-9822(92)90205-o). - Zhang J, Weiner H, Hafler D. Autoreactive T Cells in Multiple Sclerosis International Weiner H. Experimental Approaches to Specific Immunotherapy in Multiple Sclerosis 1992, 301-307. [DOI: 10.1007/978-1-4471-3184-7_15](https://doi.org/10.1007/978-1-4471-3184-7_15). - Mackin G, Dawson D, Hafler D, Weiner H. Treatment of Multiple Sclerosis with Cyclophosphamide 1992, 199-216. [DOI: 10.1007/978-1-4471-3184-7_9](https://doi.org/10.1007/978-1-4471-3184-7_9). [The Potential of Restricted T Cell Recognition of Myelin Basic Protein Epitopes in the Therapy of Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/1724362)HAFLER D, MATSUI M, WUCHERPFENNIG K, OTA K, WEINER H. The Potential of Restricted T Cell Recognition of Myelin Basic Protein Epitopes in the Therapy of Multiple Sclerosis Annals Of The New York Academy Of Sciences 1991, 636: 251-265. [PMID: 1724362](https://pubmed.ncbi.nlm.nih.gov/1724362), [DOI: 10.1111/j.1749-6632.1991.tb33456.x](https://doi.org/10.1111/j.1749-6632.1991.tb33456.x). - Miller A, Hafler D, Weiner H. Immunotherapy in autoimmune diseases Current Opinion In Immunology 1991, 3: 936-940. [PMID: 1793539](https://pubmed.ncbi.nlm.nih.gov/1793539), [DOI: 10.1016/s0952-7915(05)80017-2](https://doi.org/10.1016/s0952-7915(05)80017-2). - WEINER ZHANG S, MILLER A, ALSABBAGH A, BROD S, LIDER O, HIGGINS P, SOBEL R, NUSSENBLATT R, HAFLER D. AntigenDriven Peripheral Immune Tolerance Annals Of The New York Academy Of Sciences 1991, 636: 227-232. [PMID: 1793212](https://pubmed.ncbi.nlm.nih.gov/1793212), [DOI: of CD45RA and CD45RO isoforms on T cells during the S/G2/M stages of Cellular Annals Neurology 1991, 30: 624-624. [DOI: 10.1002/ana.410300422](https://doi.org/10.1002/ana.410300422). - LaSalle JM, Ota K, Hafler DA. Presentation of autoantigen by human T cells. The Of 774-80. DA. Restricted T cell expression of IL-2/IFN-gamma mRNA in human inflammatory disease. The 810-5. T-cell recognition of myelin autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases](http://www.ncbi.nlm.nih.gov/pubmed/1868980)Miller A, Hafler D, Weiner H. Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases The 1991, 5: [PMID: 1868980](https://pubmed.ncbi.nlm.nih.gov/1868980), [DOI: 10.1096/fasebj.5.11.1868980](https://doi.org/10.1096/fasebj.5.11.1868980). administration of myelin antigens: IV. Suppression of chronic relapsing disease in the lewis rat and strain 13 guinea pig](http://www.ncbi.nlm.nih.gov/pubmed/1716432)Brod S, alSabbagh A, Sobel R, Hafler D, Weiner H. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the lewis rat and strain 13 guinea pig Annals Of Neurology 1991, progressive multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/1672870)Hafler D, Orav J, Gertz R, Stazzone L, Weiner H. Immunologic effects of cyclophosphamide/ACTH in patients with chronic progressive multiple sclerosis Journal Of 1991, Mcquillen Hoffmann R, Weiner H, Hauser S, Dawson D, Hafler D, Mackin G, Orav E, Currier R, Haerer A, Files J, Morrison F. Cyclophosphamide and plasma exchange in multiple sclerosis The 1033-1034. [PMID: T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/1847614)Lee S, Wucherpfennig K, Brod S, Benjamin D, Weiner H, Hafler D. Common Tcell receptor V usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis Annals Of Neurology 1991, H. Interleukin-1 corrects the defective autologous mixed lymphocyte response in HTLV-1 induced spontaneous T cell clonal proliferation is rapamycin sensitive Journal Of Neuroimmunology 1991, [DOI: 10.1016/0165-5728(91)91225-2](https://doi.org/10.1016/0165-5728(91)91225-2). Wucherpfennig Cuzner L, Li H, Keddy C, Hafler D. Analysis of and T cell receptors in multiple sclerosis plaques Journal Of Neuroimmunology 1991, 35: 28. [DOI: 10.1016/0165-5728(91)90882-8](https://doi.org/10.1016/0165-5728(91)90882-8). - Matsui M, Miller Weiner H. Oral toleralization to keyhole limpet hemocyanin 10.1016/0165-5728(91)90995-j](https://doi.org/10.1016/0165-5728(91)90995-j). [Case 42-1990 \u2014 A Previously Healthy 41-Year-Old Man with Meningoencephalitis and the Rapid Development of Coma](http://www.ncbi.nlm.nih.gov/pubmed/2215581)Cabot R, Scully R, Mark E, McNeely W, McNeely B, Hafler D, Sobel R. Case 42-1990 \u2014 A Previously Healthy 41-Year-Old Man with Meningoencephalitis and the Rapid Development of Coma New England Journal Of Medicine 1990, 323: 1123-1135. [PMID: 2215581](https://pubmed.ncbi.nlm.nih.gov/2215581), Benjamin D, Hafler D. TT cell interactions are mediated by adhesion molecules European Journal Of Immunology 1990, Mackin G, Weiner H, Hafler D. T-cell recognition of an immuno-dominant myelin basic protein 10.1038/346183a0](https://doi.org/10.1038/346183a0). N, Seidman JG, Rosenzweig A, Weiner H, Hafler D. Shared Human T Cell Receptor V Usage to Immunodominant Regions of Myelin Basic Protein 1693015](https://pubmed.ncbi.nlm.nih.gov/1693015), [DOI: - 27: 447-448. [DOI: 10.1002/ana.410270417](https://doi.org/10.1002/ana.410270417). - Brod S, Benjamin D, Hafler D. Frequency analysis of CD4+CD8+ T cells cloned with Cellular Immunology 1990, FcR-mediated crosslinking of Ta1 Review of immunology. Proceedings Of The Association For Research In Nervous And Mental Disease 1990, 68: 23-35. [PMID: 2183313](https://pubmed.ncbi.nlm.nih.gov/2183313). DA. Lymphokine regulation of CD45R expression on human T cell clones. Journal Of Experimental 1989, 170: 2147-2152. Dalgleish A, Hafler D. In Reply: PCR Analysis of DNA from Multiple Sclerosis Patients for the Presence of HTLV-I Science 1989, 246: 821-823. [DOI: 10.1126/science.246.4931.821-a](https://doi.org/10.1126/science.246.4931.821-a). P, Dalgleish A, Hafler D. PCR Analysis of DNA from Multiple Sclerosis Patients for the Presence of HTLV-I Science 1989, 246: 821-823. [DOI: 10.1126/science.246.4931.821.b](https://doi.org/10.1126/science.246.4931.821.b). - Hafler D. Book Review Medicine 1989, 321: 1347-1347. [DOI: 10.1056/nejm198911093211921](https://doi.org/10.1056/nejm198911093211921). [Inflammatory cerebrospinal fluid t cells requirements characteristic of cd4+cd45ra t cells](http://www.ncbi.nlm.nih.gov/pubmed/2479560)Chofflon M, Gonz\u00e1lez V, Weiner H, Hafler D. Inflammatory cerebrospinal fluid t cells have activation requirements characteristic of cd4+cd45ra t cells European Journal Of D. Decrease of suppressor inducer (cd4+ 2h4+) t cells in multiple sclerosis CD3 phosphorylation correlates with Ta1 (CDw26) expression.](http://www.ncbi.nlm.nih.gov/pubmed/2564857)Hafler DA, Chofflon M, Benjamin D, Dang NH, Breitmeyer J. Mechanisms of immune memory. T cell activation and CD3 phosphorylation correlates with Ta1 (CDw26) expression. fluid of a patient with varicella zoster viral meningoencephalitis](http://www.ncbi.nlm.nih.gov/pubmed/2465314)Duby A, Weiner H, Benjamin D, Seidman JG, Hafler D. Sequestration of virus-specific T cells in the cerebrospinal fluid of a patient with varicella zoster a CNS and systematic autoimmune Borst J, Ang S, Hafler D, Seidman J. Cytolytic Potential of CD3+4-8- T Cells with Differently Organized T Cell Receptor Y Chains 1988, 493-498. [DOI: 10.1515/9783110850253-073](https://doi.org/10.1515/9783110850253-073). [Immunohistochemical Analysis of SuppressorInducer and HelperInducer T Cells in Multiple Sclerosis Brain Tissue](http://www.ncbi.nlm.nih.gov/pubmed/2905121)SOBEL R, HAFLER D, CASTRO E, MORIMOTO C, WEINER H. Immunohistochemical Analysis of SuppressorInducer and HelperInducer T Cells in Multiple Sclerosis Brain Tissue Annals Of The New York Academy Of Sciences 1988, 540: 306-308. [PMID: 2905121](https://pubmed.ncbi.nlm.nih.gov/2905121), [DOI: 10.1111/j.1749-6632.1988.tb27082.x](https://doi.org/10.1111/j.1749-6632.1988.tb27082.x). [Loss of Linked to Decreases in Circulating SuppressorInducer (CD4+2H4+) T Cells in Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/2905122)CHOFFLON M, WEINER H, HAFLER D. Loss of Functional Suppression Is Linked to Decreases in Circulating SuppressorInducer (CD4+2H4+) T Cells in Multiple Sclerosis Annals Of The New York Academy Of Sciences 1988, Multiple Sclerosis Immunosuppressive Effects and Human Antimouse Responses](http://www.ncbi.nlm.nih.gov/pubmed/2905125)HAFLER D, WEINER H. AntiCD4 and AntiCD2 Monoclonal Antibody Infusions in Subjects with Multiple Sclerosis Immunosuppressive Effects and Human Antimouse Responses Annals Of The New York Academy Of Sciences 1988, 540: in Chronic Progressive Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/2849902)CARTER J, DAWSON D, HAFLER D, FALLIS R, STAZZONE L, ORAV J, WEINER H. Cumulative Experience with HighDose Intravenous Cyclophosphamide and ACTH Therapy in Chronic Progressive Multiple Sclerosis Annals Of The New York Academy Of Sciences 1988, 540: 535-536. [PMID: 2849902](https://pubmed.ncbi.nlm.nih.gov/2849902), [DOI: 10.1111/j.1749-6632.1988.tb27163.x](https://doi.org/10.1111/j.1749-6632.1988.tb27163.x). [Loss of functional to decreases in circulating suppressor inducer (CD4 + 2H4 +) T Cells in multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/2972249)Chofflon M, Weiner H, Morimoto C, Hafler D. Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4 + 2H4 +) T Cells in multiple multiple sclerosis. Immunosuppressive effects and human anti-mouse responses.](http://www.ncbi.nlm.nih.gov/pubmed/2454256)Hafler DA, Ritz J, Weiner HL. Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses. The in 164 patients.](http://www.ncbi.nlm.nih.gov/pubmed/2838768)Carter JL, Hafler in Neurology 42-7. [PMID: 3260356](https://pubmed.ncbi.nlm.nih.gov/3260356). [Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody.](http://www.ncbi.nlm.nih.gov/pubmed/2966845)Borst J, van Dongen JJ, Bolhuis RL, Peters PJ, Hafler DA, de Vries E, van de Griend RJ. Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody. Journal Of Experimental Morimoto C, Weiner HL. The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions. The Journal Of Immunology 1988, D, Seidman JG, Weiner HL. Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis. Journal Of Experimental 1988, 167: 1313-1322. CD8 molecules. Anti-CD4 can mediate two distinct inhibitory activities.](http://www.ncbi.nlm.nih.gov/pubmed/2891768)Blue ML, Hafler DA, Daley JF, Levine H, Craig KA, Breitmeyer JB, Schlossman SF. Regulation of T cell clone function via CD4 and CD8 molecules. Anti-CD4 can mediate two distinct inhibitory ISBN O + 531 pages) ISBN O 9: 243-244. [DOI: 10.1016/0167-5699(88)91225-x](https://doi.org/10.1016/0167-5699(88)91225-x). - Blue ML, Hafler Craig Levine H, Schlossman SF. Phosphorylation of CD4 and CD8 molecules following T cell triggering. 139: 3949-54. [PMID: 2961801](https://pubmed.ncbi.nlm.nih.gov/2961801), [DOI: 10.4049/jimmunol.139.12.3949](https://doi.org/10.4049/jimmunol.139.12.3949). - Hafler D, Weiner H. T Cells in Multiple Sclerosis and Inflammatory Central Nervous System Diseases Immunological Reviews 1987, 100: 307-332. [PMID: 3326824](https://pubmed.ncbi.nlm.nih.gov/3326824), [DOI: 10.1111/j.1600-065x.1987.tb00537.x](https://doi.org/10.1111/j.1600-065x.1987.tb00537.x). - Hafler D, Fox D, Benjamin D, Blue M, Weiner H. Secondary immune amplification following live poliovirus immunization in [DOI: 10.1016/0090-1229(87)90076-6](https://doi.org/10.1016/0090-1229(87)90076-6). [Loss linked to decreases in circulating suppressor-inducer (CD4+2H4+) T cells in multiple sclerosis](https://doi.org/10.1016/0165-5728(87)90177-9)Chofflon M, Weiner H, Hafler D. Loss of functional suppression is linked to decreases in circulating suppressor-inducer (CD4+2H4+) T cells in multiple sclerosis Journal Of Neuroimmunology 1987, 16: 33. [DOI: 10.1016/0165-5728(87)90177-9](https://doi.org/10.1016/0165-5728(87)90177-9). [Oligocllonal T lymphocytes in the cerebrospinal fluid (CSF) of patients with chronic progressive multiple sclerosis](https://doi.org/10.1016/0165-5728(87)90234-7)Hafler D, Duby A, Lee S, Seidman D, Weiner H. Oligocllonal T lymphocytes in the cerebrospinal fluid (CSF) of patients with chronic progressive multiple sclerosis Journal Of Neuroimmunology 1987, 16: and in multiple sclerosis Cumulative experience in 100 patients](https://doi.org/10.1016/0165-5728(87)90173-1)Carter J, Az S, Dawson D, Fallis R, Hafler H. Immunosuppression with high-dose I.V. cyclophosphamide and acth in progressive multiple sclerosis Cumulative experience in 100 patients Journal Of Neuroimmunology 1987, 16: 29. [DOI: 10.1016/0165-5728(87)90173-1](https://doi.org/10.1016/0165-5728(87)90173-1). - Lee S, Benjamin D, Duby A, Ang S, Seidman J, Hafler D. T-cell receptor--chain clones with natural killer-like activity in the cerebrospinal Journal Of Neuroimmunology 1987, 103. [DOI: 10.1016/0165-5728(87)90287-6](https://doi.org/10.1016/0165-5728(87)90287-6). [Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue](https://doi.org/10.1016/0165-5728(87)90382-1)Sobel R, Castro E, Hafler D, Morimoto C, Schlossman S, Weiner H. Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue Journal Of 1987, infusions in multiple Immunosuppressive and Of Neuroimmunology 16: 180. [DOI: of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis.](http://www.ncbi.nlm.nih.gov/pubmed/2438352)Hafler DA, Benjamin DS, Burks J, Weiner HL. Myelin and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious In vivo labeling of blood T cells: Rapid traffic into cerebrospinal fluid in multiple sclerosis natural killer-like T cell clones.](http://www.ncbi.nlm.nih.gov/pubmed/3106557)Ang SL, Seidman JG, Peterman GM, Duby AD, Benjamin D, Lee SJ, Hafler DA. Functional gamma chain-associated T cell receptors on cerebrospinal fluid-derived natural killer-like T cell clones. Journal Letvin N, Hagan M, Daley J, Schlossman S. Selective Loss of the Suppressor-Inducer T-Cell Subset in Progressive Multiple Sclerosis New England 1987, 316: 67-72. [PMID: 2946956](https://pubmed.ncbi.nlm.nih.gov/2946956), [DOI: 10.1056/nejm198701083160202](https://doi.org/10.1056/nejm198701083160202). cyclophosphamide and monoclonal antibodies.](http://www.ncbi.nlm.nih.gov/pubmed/3039645)Dawson DM, Carter JL, Hafler DA, Weiner HL. Immunosuppression in progressive multiple sclerosis high dose intravenous in Cerebrospinal Fluid and Blood of Patients with Multiple Sclerosis](https://doi.org/10.1007/978-1-4899-5348-3_31)Hafler D, Weiner H. Activated T-Cells and Antigen Reactivity in the Cerebrospinal Fluid and Blood of Patients with Multiple Sclerosis 1987, 261-272. [DOI: 10.1007/978-1-4899-5348-3_31](https://doi.org/10.1007/978-1-4899-5348-3_31). [Cell-mediated immunity to myelin-associated protein in multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/2428837)Johnson D, Hafler D, Fallis R, Lees M, Brady R, Quarles R, Weiner H. Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in 99-108. [PMID: 2428837](https://pubmed.ncbi.nlm.nih.gov/2428837), [DOI: Benjamin D, Weiner HL. Antigen reactive memory T cells are defined by Ta1. The Journal Immunology 1986, 137: 414-8. [PMID: 3013990](https://pubmed.ncbi.nlm.nih.gov/3013990), [DOI: 10.4049/jimmunol.137.2.414](https://doi.org/10.4049/jimmunol.137.2.414). [Immunologic with an anti-T-cell monoclonal antibody, anti-T12.](http://www.ncbi.nlm.nih.gov/pubmed/3486383)Hafler DA, Fallis Reinherz EL, Weiner HL. Immunologic responses of progressive multiple sclerosis patients treated with DA, Johnson D, JJ, Panitch H, Kyle HL. Monoclonal vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases](http://www.ncbi.nlm.nih.gov/pubmed/3930113)Hafler DA, Hemler ME, Christenson L, Williams JM, Shapiro HM, TB, Strominger JL, Weiner HL. Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases Clinical Immunology 1985, 37: 163-171. [PMID: 3930113](https://pubmed.ncbi.nlm.nih.gov/3930113), [DOI: 10.1016/0090-1229(85)90147-3](https://doi.org/10.1016/0090-1229(85)90147-3). [Phenotypic and functional analysis of T cells cloned directly from the blood and cerebrospinal fluid of patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/2416267)Hafler D, Buchsbaum M, Johnson D, Weiner H. Phenotypic and functional analysis of T cells cloned directly from the blood and cerebrospinal fluid of patients with multiple sclerosis Annals the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/2985995)Hafler D, Fox D, Manning M, Schlossman S, Reinherz E, Weiner H. In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple Sclerosis New England Journal Of Medicine 1985, 312: 1405-1411. [PMID: 2985995](https://pubmed.ncbi.nlm.nih.gov/2985995), [DOI: H. Decreased autologous mixed lymphocyte reaction in multiple sclerosis 9: 339-347. [PMID: 2931449](https://pubmed.ncbi.nlm.nih.gov/2931449), HAFLER D, FALLIS R, LEHRICH J, DAWSON D. The Use of Cyclophosphamide in the Treatment of Multiple Sclerosisa Annals Of The New York Academy Of Sciences 1984, 436: 373-381. [PMID: 6099707](https://pubmed.ncbi.nlm.nih.gov/6099707), [DOI: 10.1111/j.1749-6632.1984.tb14808.x](https://doi.org/10.1111/j.1749-6632.1984.tb14808.x). FALLIS R, JOHNSON D, AULT K, HAUSER S. T Cell Subsets in Patients with Multiple Sclerosis: An Overviewa Annals Of The New York Academy Of Sciences 1984, 436: 281-290. [PMID: 6152384](https://pubmed.ncbi.nlm.nih.gov/6152384), [DOI: 10.1111/j.1749-6632.1984.tb14800.x](https://doi.org/10.1111/j.1749-6632.1984.tb14800.x). Fallis R, Johnson D, Ault K, Hauser S. Altered blood T-cell subsets in patients with multiple sclerosis of monoclonal antibodies against normal tissue following infection of mice with reovirus and demonstration of shared antigenicity between virus and lymphocytes](http://www.ncbi.nlm.nih.gov/pubmed/6329771)Tardieu M, Powers M, Hafler D, Hauser S, Weiner H. Autoimmunity following viral infection: demonstration of monoclonal antibodies against normal tissue following infection of mice with reovirus and demonstration of shared antigenicity between virus and lymphocytes Hafler DA, Victor J. Embarrassment as the aura of a complex partial seizure. Neurology 1982, R, Reichert W. Spinal Subarachnoid Hematoma \u2014 A Hazard of Lumbar Puncture Resulting in Reversible Paraplegia New England Journal Of Prolonged benzodiazepine coma. New State Journal Of Medicine 1981, 81: 776-7. [PMID: 6111773](https://pubmed.ncbi.nlm.nih.gov/6111773). - Panitch H, Hafler D, Johnson K. Antibodies to Myelin Basic Protein in Cerebrospinal Fluid of Patients with Multiple Sclerosis 1980, 98-105. [DOI: 10.1007/978-3-642-67554-6_17](https://doi.org/10.1007/978-3-642-67554-6_17). - 06473 Biography David Hafler, MD, is a world-renowned expert on multiple sclerosis (MS) and chair of the Department of Neurology, where he has presided over a major expansion in the last several years. He tells the neurologists who work for him to put patients first. \"If I sense that a doctor does not care deeply about patients, they don't belong at Yale,\" he says. Dr. Hafler knew from a young age that he wanted to be a doctor and study the immune system. In elementary school, he made slides of his own blood and studied them under a microscope. \"I took photographs. I still have them,\" he says. Because most neurologic diseases are chronic, he has been treating many of his patients for more than 30 years. \"Providing care for chronic disease is a very special part of being involved in someone's life,\" he says. A professor of neurology and of immunobiology at Yale School of Medicine, Dr. Hafler is also a prolific researcher whose work has led to major advances in the understanding and treatment of MS, including identification of it as an autoimmune and genetic disease. He leads a lab at Yale that conducts cutting-edge research into MS and develops new treatments. Advances in treatment of MS have been remarkable, he says. \"Back in the 1970s when I was in medical school, there were no treatments,\" he says. \"From where we were in 1975, say, we've come a long way.\" Titles - William S. and Lois Stiles Edgerly Professor of Neurology and Professor of Immunobiology - Chair, Neurology - Neurologist-in-Chief, Yale New Haven Hospital Education & Training - Post-Doctoral FellowshipHarvard Medical School (1986) - Chief ResidentThe New York Hospital-Cornell Medical Center, and Memorial Sloan Kettering Cancer Institute (1982) - Assistant ResidentThe New York Hospital-Cornell Medical Center, and Memorial Sloan Kettering Cancer Institute (1981) - MDUniversity of Miami School of Medicine (1978) - MSEmory University (1974) - BSEmory College, Chemistry (1974) - Visiting ScientistRockefeller University Additional Information - Elected Member of National Academy of Medicine: National Academy of Medicine (2018) - Raymond D. Adams Lectureship: American Neurological Association (2015) - John J. Dystel Prize for Multiple Sclerosis Research: American Academy of Neurology (2010) - Distinguished Alumni \"Hall of Fame\" Award: University of Miami (2010) - Best Doctors in Boston: Best of Boston (2008) - Honorary Member: Scandinavian Society for Immunology (2005) - Most Highly Cited List in the field of Immunology: ISI (2004) - The Jacobs Javits Merit Investigator Award: NIH (2004) - Best Doctors in America: (2000) - Elected Member: American Society for Clinical Investigation (1993) - AB of Psychiatry & Neurology, Neurology (1987) [Microfluidic ImmunoSerolomic Assay Reveals Systems Level Association with COVID19 Pathology and Vaccine Protection](http://www.ncbi.nlm.nih.gov/pubmed/37312418)Kim D, Biancon G, Bai Z, VanOudenhove J, Liu Y, Kothari S, Gowda L, Kwan J, BuitragoPocasangre N, Lele N, Asashima H, Racke M, Wilson J, Givens T, Tomayko M, Schulz W, Longbrake E, Hafler D, Halene S, Fan R. Microfluidic ImmunoSerolomic Assay Reveals Systems Level Association with COVID19 Pathology and Vaccine Protection Small Methods 2023, e2300594. [PMID: 37312418](https://pubmed.ncbi.nlm.nih.gov/37312418), [DOI: 10.1002/smtd.202300594](https://doi.org/10.1002/smtd.202300594). [Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients](http://www.ncbi.nlm.nih.gov/pubmed/37327781)Diray-Arce J, Fourati S, Jayavelu N, Patel R, Maguire C, Chang A, Dandekar R, Qi J, Lee B, van Zalm P, Schroeder A, Chen E, Konstorum A, Brito A, Gygi J, Kho A, Chen S, Gonzalez-Reiche A, Hoch A, Milliren C, Overton J, Westendorf K, Network I, Abraham J, Adkisson M, Albert M, Torres L, Alvarenga B, Anderson M, Anderson E, Arnett A, Asashima H, Atkinson M, Baden L, Barton B, Beach K, Beagle E, Becker P, Bell M, Bernui M, Bime C, Kumar A, Booth L, Borresen B, Brakenridge S, Bristow L, Bryant R, Calfee C, Manuel J, Carrillo S, Chak S, Chang I, Connors J, Conway M, Corry D, Cowan D, Croen B, Dela Cruz C, Cusimano G, Eaker L, Edwards C, Ehrlich L, Elashoff D, Erickson H, Erle D, Farhadian S, Farrugia K, Fatou B, Fernandes A, Fernandez-Sesma A, Fragiadakis G, Furukawa S, Geltman J, Ghale R, Berm\u00fadez M, Goonewardene M, Sanchez E, Guirgis F, Hafler D, Hamilton S, Harris P, Nemati A, Hendrickson C, Agudelo N, Hodder T, Holland S, Hough C, Huerta C, Hurley K, Hutton S, Iwasaki A, Jauregui A, Jha M, Johnson B, Joyner D, Kangelaris K, Kelly G, Khalil Z, Khan Z, Kheradmand F, Kim J, Kimura H, Ko A, Kohr B, Kraft M, Krummel M, Kutzler M, Lasky-Su J, Lee S, Lee D, Leipold M, Lentucci C, Leroux C, Lin E, Liu S, Love C, Lu Z, Maliskova L, Roth B, Manohar M, Martens M, McComsey G, McEnaney K, McLin R, Melamed E, Melnyk N, Mendez K, Messer S, Mosier J, Mulder L, Murphy M, Nadeau K, Nelson E, Nelson A, Nguyen V, Oberhaus J, Panganiban B, Pellegrini K, Pickering H, Powell D, Presnell S, Pulendran B, Rahman A, Sadeed A, Raskin A, Reed E, Pereira S, Rivera A, Rogers J, Rogers A, Rogowski B, Rooks R, Rosenberg-Hasson Y, Rothman J, Rousseau M, Samaha H, Schaenman R, Semenza N, Sen S, Sevransky J, Seyfert-Margolis V, Shaheen T, Shaw A, Sieg S, Siegel S, Sigal N, Siles N, Simmons B, Simon V, Singh G, Sinko L, Smith C, Smolen K, Song L, Srivastava K, Sullivan P, Syphurs C, Tcheou J, Tegos G, Tharp G, Ally A, Tsitsiklis A, Ungaro R, Vaysman T, Viode A, Vita R, Wang X, Ward A, Ward D, Willmore A, Woloszczuk K, Wong K, Woodruff P, Xu L, van Haren S, van de Guchte A, Zhao Y, Cairns C, Rouphael N, Bosinger S, Kim-Schulze S, Krammer F, Rosen L, Grubaugh N, van Bakel H, Wilson M, Rajan J, Steen H, Eckalbar W, Cotsapas C, Langelier C, Levy O, Altman M, Maecker H, Montgomery R, Haddad E, Sekaly R, Esserman D, Ozonoff A, Becker P, Augustine A, Guan L, Peters B, Kleinstein S. Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients Cell Reports Medicine 2023, 4: 101079. diseases 2023, 485-490. Sumida T. Regulatory T cells in peripheral tissue tolerance and diseases Frontiers In V, L. Cytokines in NewOnset Refractory 36871188](https://pubmed.ncbi.nlm.nih.gov/36871188), [DOI: 10.1002/ana.26627](https://doi.org/10.1002/ana.26627). - Liu Y, DiStasio M, Su G, Asashima H, Enninful A, Qin X, Deng Y, Nam J, Gao F, Bordignon P, Cassano M, Tomayko M, Xu M, Halene S, Craft J, Hafler D, Fan R. High-plex protein and whole transcriptome co-mapping at cellular resolution with CITE-seq 1-5. [PMID: 36823353](https://pubmed.ncbi.nlm.nih.gov/36823353), [DOI: Geisberger S, Roels J, Van Zeebroeck L, Dyczko A, van Gisbergen M, Kurniawan H, Wagner A, Yosef N, Weiss S, Schmetterer K, Schr\u00f6der A, Krampert L, Haase S, Bartolomaeus J, perturbs CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity](http://www.ncbi.nlm.nih.gov/pubmed/36634138)Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson K, Kakara M, Zuroff L, Bennett J, von B\u00fcdingen H, Carruthers R, Edwards K, Fallis R, Giacomini P, Greenberg B, Hafler D, Ionete C, Kaunzner U, Lock C, Longbrake E, Pardo G, Piehl F, Weber M, Ziemssen T, Jacobs D, Gelfand J, Cross A, Cameron B, Musch B, Winger R, Jia X, Harp C, Herman A, Bar-Or A. Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity Proceedings Of The National Academy Of Sciences Of The United States Of America in human acute viral infection](http://www.ncbi.nlm.nih.gov/pubmed/36596303)Asashima H, Mohanty S, Comi M, Ruff W, Hoehn K, Wong P, Klein J, Lucas C, Cohen I, Coffey S, Lele N, Greta L, Raddassi K, Chaudhary O, Unterman A, Emu B, Kleinstein S, Montgomery R, Iwasaki A, Dela Cruz C, Kaminski N, Shaw A, Hafler D, Sumida T. PD-1highCXCR5-CD4+ peripheral helper T cells promote CXCR3+ plasmablasts in human acute viral infection an essential role for HDAC7 in regulatory T cells](http://www.ncbi.nlm.nih.gov/pubmed/36516268)Axisa P, Yoshida T, Lucca L, Kasler H, Lincoln M, Pham G, Del Priore D, Carpier J, Lucas C, Verdin E, Sumida T, Hafler D. A multiple sclerosis-protective coding variant reveals an essential role for HDAC7 in regulatory T cells a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure](http://www.ncbi.nlm.nih.gov/pubmed/36514045)Qu R, Kluger Y, Yang J, Zhao J, Hafler D, Krause D, Bersenev A, Bosenberg M, Hurwitz M, Lucca L, Kluger H. Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure Molecular Cancer cells drives circulating follicular helper T cell expansion in multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/36250467)Asashima Pham Sumida TS, Hafler DA. Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis Journal Of limited diversity of protection against COVID-19 in patients with altered immunity.](http://www.ncbi.nlm.nih.gov/pubmed/36093346)Kim D, Biancon G, Bai Z, VanOudenhove J, Liu Y, Kothari S, Gowda L, NC, R. Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity. BioRxiv : The Preprint of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome](http://www.ncbi.nlm.nih.gov/pubmed/36031693)Longbrake EE, Hua LH, Mowry EM, Gauthier SA, Alvarez E, Cross AH, Pei J, Priest J, Raposo C, Hafler DA, Winger RC. The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome Multiple Sclerosis in a cohort of hospitalized COVID-19 patients: Results from the CB, M, LR, Shaw AC, Krammer F, van Bakel H, Esserman DA, Liu S, Sesma AF, Simon V, Hafler DA, Montgomery RR, Kleinstein SH, Levy O, Bime C, Haddad EK, Erle DJ, Pulendran B, Nadeau MM, Hough Corry D, Kheradmand F, Ehrlich LIR, Melamed E, McComsey GA, Sekaly R, Diray-Arce J, Peters B, Augustine AD, Reed EF, Altman MC, Becker PM, Rouphael N, Ozonoff A, Schaenman J, Jayavelu N, Milliren C, Calfee C, Cairns C, Kraft M, Baden L, Shaw A, Krammer F, van Bakel H, Esserman D, Liu S, Sesma A, Simon V, Hafler D, Montgomery R, Kleinstein S, Levy O, Bime C, Haddad E, Erle D, Pulendran B, Nadeau K, Davis M, Hough C, Messer W, Higuita N, Metcalf J, Atkinson M, Brakenridge S, Corry D, Kheradmand F, Ehrlich L, Melamed E, McComsey G, Sekaly R, Diray-Arce J, Peters B, Augustine A, Reed E, McEnaney K, Barton B, Lentucci C, Saluvan M, Chang A, Hoch A, Albert M, Shaheen T, Kho A, Thomas S, Chen J, Murphy M, Cooney M, Presnell S, Fragiadakis G, Patel R, Guan L, Gygi J, Pawar S, Brito A, Khalil Z, Maguire C, Fourati S, Overton J, Vita R, Westendorf K, Salehi-Rad R, Leligdowicz A, Matthay M, Singer J, Kangelaris K, Hendrickson C, Krummel M, Langelier C, Woodruff P, Powell D, Kim J, Simmons B, Goonewardene I, Smith C, Martens M, Mosier J, Kimura H, Sherman A, Walsh S, Issa N, Dela Cruz C, Farhadian S, Iwasaki A, Ko A, Chinthrajah S, Ahuja N, Rogers A, Artandi M, Siegel S, Lu Z, Drevets D, Brown B, Anderson M, Guirgis F, Thyagarajan R, Rousseau J, Wylie D, Busch J, Gandhi S, Triplett T, Yendewa G, Giddings O, Anderson E, Mehta A, Sevransky J, Khor B, Rahman A, Stadlbauer D, Dutta J, Xie H, Kim-Schulze S, Gonzalez-Reiche A, van de Guchte A, Farrugia K, Khan Z, Maecker H, Elashoff D, Brook J, Ramires-Sanchez E, Llamas M, Rivera A, Perdomo C, Ward D, Magyar C, Fulcher J, Abe-Jones Y, Asthana S, Beagle S, Carrillo S, Chak S, Fragiadakis G, Ghale R, Gonzalez A, Jauregui A, Jones N, Lea T, Lee D, Lota R, Milush J, Nguyen V, Pierce L, Prasad P, Rao A, Samad B, Shaw C, Sigman A, Sinha P, Ward A, Willmore A, Zhan J, Rashid S, Rodriguez N, Tang K, Altamirano L, Betancourt L, Curiel C, Sutter N, Paz M, Tietje-Ulrich G, Leroux C, Connors J, Bernui M, Kutzler M, Edwards C, Lee E, Lin E, Croen B, Semenza N, Rogowski B, Melnyk N, Woloszczuk K, Cusimano G, Bell M, Furukawa S, McLin R, Marrero P, Sheidy J, Tegos G, Nagle C, Mege N, Ulring K, Seyfert-Margolis V, Conway M, Francisco D, Molzahn A, Erickson H, Wilson C, Schunk R, Sierra B, Hughes T, Smolen K, Desjardins M, van Haren S, Mitre X, Cauley J, Li X, Tong A, Evans B, Montesano C, Licona J, Krauss J, Chang J, Izaguirre O, Coppi A, Fournier J, Mohanty M, Ruff W, Salahuddin S, Schulz W, Vijayakumar P, Wang H, Wunder E, Young H, Zhao Y, Saksena M, Altman D, Kojic E, Srivastava K, Eaker L, Berm\u00fadez-Gonz\u00e1lez M, Beach K, Sominsky L, Azad A, Carre\u00f1o J, Singh G, Raskin J, Bielak D, Kawabata H, Mulder L, Kleiner G, Lee A, E, Fernandes A, Manohar M, Hagan T, Blish C, Din H, Roque J, Yang S, Brunton A, Sullivan P, Strnad M, Lyski Z, Coulter F, Booth J, Sinko L, Moldawer L, Borresen B, Roth-Manning B, Song L, Nelson E, Lewis-Smith M, Smith J, Tipan P, Siles N, Bazzi S, Geltman J, Hurley K, Gabriele G, Sieg S, Vaysman T, Bristow L, Hussaini L, Hellmeister K, Samaha H, Cheng A, Spainhour C, Scherer E, Johnson B, Bechnak A, Ciric C, Hewitt L, Carter E, Mcnair N, Panganiban B, Huerta C, Usher J, Ribeiro S, Altman M, Becker P, Rouphael N. Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from M. Fatty Acid Metabolism and T Cells in Multiple DiStasio M, Su G, Asashima H, Enninful A, Qin X, Deng Y, Bordignon P, Cassano M, Tomayko M, Xu M, Halene S, Craft J, Hafler D. Spatial-CITE-seq: spatially resolved receptors in human T cells](http://www.ncbi.nlm.nih.gov/pubmed/35301508)Sumida TS, Dulberg VK, Hafler DA. Type I interferon transcriptional network regulates expression of coinhibitory receptors in human of mouse and human brain](http://www.ncbi.nlm.nih.gov/pubmed/35260865)Marsh SE, Walker AJ, Kamath T, Dissing-Olesen L, Hammond TR, de Soysa TY, Young AMH, Murphy S, Abdulraouf A, Nadaf N, Dufort C, Walker AC, Lucca LE, Kozareva V, Vanderburg C, Hong S, Bulstrode H, Hutchinson PJ, Gaffney DJ, Hafler DA, Franklin RJM, Macosko EZ, Stevens B. Dissection of artifactual and confounding glial signatures by single-cell sequencing Daud AI, Hafler DA, Kluger HM, Raychaudhuri S, Sharpe AH. TCR-sequencing in cancer and adaptive immune system in progressive COVID-19](http://www.ncbi.nlm.nih.gov/pubmed/35064122)Unterman A, Sumida TS, Nouri N, Yan X, Zhao AY, Gasque V, Schupp JC, Asashima H, Liu Y, Cosme C, Deng W, Chen M, Raredon MSB, Hoehn KB, Wang G, Wang Z, DeIuliis G, Ravindra NG, Li N, Castaldi C, Wong P, Minasyan M, Mohanty S, Ruff WE, Cohen I, Raddassi K, Niklason L, Ko A, Montgomery R, Farhadian S, Iwasaki A, Shaw A, van Dijk D, Zhao H, Kleinstein S, Hafler D, Kaminski N, Dela Cruz C. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19 Nature Communications Kissel JT, Wolfe GI, Burns TM, Freimer ML, Nations S, Granit V, Smith AG, Richman DP, Ciafaloni E, Al-Lozi MT, Sams LA, Quan D, Ubogu E, Pearson B, Sharma A, Yankey JW, Uribe L, Shy M, Amato AA, Conwit R, O'Connor KC, Hafler DA, Cudkowicz ME, Barohn RJ, Team O. Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive LE. The double-edged sword: Harnessing imaging: Worth its salt for understanding multiple sclerosis Proceedings Of The National Academy Of Sciences Of The United States Of J, Kleinstein S, Altman M, Bosinger S, Eckalbar W, Guan L, Hough C, Krammer F, Langelier C, Levy O, McEnaney K, Peters B, Rahman A, Rajan J, Sigelman S, Steen H, van Bakel H, Ward A, Wilson M, Woodruff P, Zamecnik C, Augustine A, Ozonoff A, Reed E, Becker P, Higuita N, Altman M, Atkinson M, Baden L, Becker P, Bime C, Brakenridge S, Calfee C, Cairns C, Corry D, Davis M, Augustine A, Ehrlich L, Haddad E, Erle D, Fernandez-Sesma A, Hafler D, Hough C, Kheradmand F, Kleinstein S, Kraft M, Levy O, McComsey G, Melamed E, Messer W, Metcalf J, Montgomery R, Nadeau K, Ozonoff A, Peters B, Pulendran B, Reed E, Rouphael N, Sarwal M, Schaenman J, Sekaly R, Shaw A, Simon V. Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective Fleming I, Hoehn KB, Dardick KR, Belperron of the skin lesion erythema SC, Bukreyev A, Kleinstein SH. Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19 The of Coinhibitory Receptors in Human T cells.](http://www.ncbi.nlm.nih.gov/pubmed/34127967)Hafler D, Sumida Schupp M, Unterman A, Kaminski N, Madi A, Kuchroo V. Type I Interferon Transcriptional Network Regulates Expression of Coinhibitory Receptors in Human T differential or co-expression analysis AM. NEBULA is a fast negative binomial mixed model for differential or co-expression analysis of large-scale with autoimmune disorders and advanced malignancies (AIM-NIVO).](https://doi.org/10.1200/jco.2021.39.15_suppl.tps2676)Dumbrava E, Dougan M, Gupta S, Cappelli L, Katsumoto T, Rahma O, Painter J, Wang Y, Suarez-Almazor M, Reid P, Wesley S, Hafler D, Bingham C, Warner B, Chung L, Ott P, Kluger H, Khosroshahi A, Tawbi H, Sharon E. A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies Cells from Patients with COVID-19 and Idiopathic Pulmonary Fibrosis Demonstrates Dissimilar Cell Shifts and Gene Expression Profiles](https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4361)Zhao A, Unterman A, Schupp J, Adams T, Sumida T, Ryu C, DeIuliis G, Yan X, Hafler D, Dela Cruz C, Herzog E, Kaminski N. Comparative scRNA-seq Analysis of Peripheral Blood Mononuclear Cells from Patients with COVID-19 and Idiopathic Pulmonary Fibrosis Demonstrates Dissimilar Cell Shifts and Gene [DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4361](https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4361). M, Asashima Liu Y, Shah A, Ravindra NG, Bishai J, Khan A, Lau W, Sellers B, Bansal N, Guerrerio P, Unterman A, Habet V, Rice AJ, Catanzaro J, Chandnani H, Lopez M, Kaminski N, Dela Cruz CS, Tsang JS, Wang Z, Yan X, Kleinstein SH, van Dijk D, Pierce RW, Hafler DA, Lucas CL. Immune autoreactivity correlate with disease severity in M, Asashima Liu Y, Shah A, Ravindra NG, Bishai J, Khan A, Lau W, Sellers B, Bansal N, Guerrerio P, Unterman A, Habet V, Rice AJ, Catanzaro J, Chandnani H, Lopez M, Kaminski N, Dela Cruz CS, Tsang JS, Wang Z, Yan X, Kleinstein SH, van Dijk D, Pierce RW, Hafler DA, Lucas CL. Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity. MedRxiv : The Preprint Jessel S, Zhang L, Raddassi K, Zhang L, Olino K, Clune J, Singer M, Kluger HM, Hafler DA. Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells Journal Of Tumor-Associated CK, Zito CR, in Melanoma by Subcellular FOXP3 regulatory T cells from patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/33170805)Pompura SL, Wagner A, Kitz A, Laperche J, Yosef N, Dominguez-Villar M, acid restores suppressive defects in tissue-resident FOXP3 regulatory T cells from patients with multiple sclerosis Journal Of Clinical Investigation 2021, 131 Receptors in Human T N, A, Kuchroo VK, Hafler DA. Type I Interferon Transcriptional Network Regulates Expression of Coinhibitory Receptors in Human T cells. BioRxiv : The Preprint [Two genetic variants explain the association of European ancestry with multiple sclerosis risk in African-Americans](http://www.ncbi.nlm.nih.gov/pubmed/33037294)Nakatsuka N, Patterson N, Patsopoulos NA, Altemose N, Tandon A, Beecham AH, McCauley JL, N, Hauser S, De Jager PL, Hafler DA, Oksenberg JR, Reich D. Two genetic variants explain the association of European ancestry with multiple sclerosis risk in African-Americans Scientific fine-mapping: identification of causal Dijk D, Hafler DA. Transcriptomic and clonal characterization of T cells in the human central nervous system Science Immunology patients with autoimmune disorders and advanced malignancies (AIM-NIVO)](https://doi.org/10.1158/1538-7445.am2020-ct249)Ileana Dumbrava E, Suarez-Almazor M, Painter J, Johanns T, Dougan M, Cappelli L, Wang Y, Bingham C, Gupta S, Warner B, Rahma O, Naidoo J, Ott P, Hafler D, Kluger H, Khosroshahi A, Naqash R, Chung L, Katsumoto T, Kummar S, Tawbi H, Sharon E. Abstract CT249: A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO) Research 2020, Ib study of autoimmune disorders and advanced malignancies (AIM-NIVO).](https://doi.org/10.1200/jco.2020.38.15_suppl.tps3158)Ileana Dumbrava E, Suarez-Almazor M, Painter J, Johanns T, Dougan M, Cappelli L, Bingham C, Wang Y, Gupta S, Warner B, Rahma O, Naidoo J, Ott P, Hafler D, Kluger H, Khosroshahi A, Katsumoto T, Kummar S, Sharon E, Tawbi H. A phase Ib study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO). Journal Of Clinical Oncology 2020, 38: tps3158-tps3158. Lucca Harnett B, Kumar VP, Ponath G, Raddassi K, Huttner A, Hafler DA, Pitt D. Differential expression of the T-cell inhibitor TIGIT in D, van Dijk D. Disease state prediction from single-cell data using graph attention networks 2020, 121-130. [DOI: 10.1145/3368555.3384449](https://doi.org/10.1145/3368555.3384449). - Wesley S, Hafler D. Chapter 51 Sclerosis 2020, 961-986. [DOI: 10.1016/b978-0-12-812102-3.00051-8](https://doi.org/10.1016/b978-0-12-812102-3.00051-8). - Consortium I, Mitrovi M, Patsopoulos N, Beecham A, Dankowski T, Goris A, Dubois B, D'hooghe M, Lemmens R, Van Damme P, S\u00f8ndergaard H, Sellebjerg Sorensen Ullum C, Bayas A, Heesen C, K\u00fcmpfel T, Linker J, R, Duijn C, Teunissen C, Bos S, Myhr K, Celius E, Lie B, Spurkland A, Comabella M, Piehl F, Jeli I, Martin R, Sospedra M, Ban M, Hawkins C, Hysi P, Kalra S, Karpe F, Khadake J, Lachance G, Neville M, Santaniello A, Caillier S, Calabresi P, Cree B, Cross A, Davis M, Haines J, de Bakker P, Delgado S, Dembele M, Edwards K, Fitzgerald K, Hakonarson H, Konidari I, Lathi E, Manrique C, Pericak-Vance M, Piccio L, Schaefer C, McCabe C, Weiner H, Goldstein J, Olsson T, Hadjigeorgiou G, Taylor B, Tajouri L, Charlesworth J, Booth D, Harbo H, Ivinson A, Hauser S, Compston A, Stewart G, Zipp F, Barcellos L, Baranzini Hafler D, Cotsapas C. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis EE. CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome Journal Shoostari P, Cotsapas C, Wong G, Beecham A, James T, Replogle J, Vlachos I, McCabe C, Pers T, Brandes A, White C, Keenan B, Cimpean M, Winn P, Panteliadis I, Robbins A, Andlauer T, Zarzycki O, Dubois B, Goris A, S\u00f8ndergaard C, Grummel V, Hemmer B, Hoshi A, S, Mancini N, Zuccal\u00e0 M, Mescheriakova J, van Duijn C, Bos S, Celius Spurkland Comabella M, Piehl F, Jeli I, Martin R, Sospedra M, Baker A, Ban M, Hawkins C, Hysi P, Kalra S, Karpe F, Khadake J, Lachance M, Thorpe J, Bradshaw E, Caillier S, Calabresi P, Cree B, Cross A, Davis M, de Bakker P, Delgado S, Dembele M, Edwards K, Fitzgerald K, Frohlich I, Gourraud P, Haines J, Hakonarson H, Kimbrough D, Isobe N, Konidari I, Lathi E, Lee M, Li T, An D, Zimmer A, Madireddy L, Manrique C, Mitrovic M, Olah M, Patrick E, Pericak-Vance M, Piccio L, Schaefer C, Weiner H, Lage K, Compston A, Hafler D, Harbo H, Hauser S, Stewart G, D'Alfonso S, Hadjigeorgiou G, Taylor B, Barcellos L, Booth D, Hintzen R, Kockum I, Martinelli-Boneschi J, Oksenberg J, A, Sawcer S, Ivinson A, Olsson T, De Jager P. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in [PMID: 31604244](https://pubmed.ncbi.nlm.nih.gov/31604244), Multiple 2019, Dominguez-Villar M. AKT isoforms modulate Th1like Treg generation and function in human T cells links inflammatory environments to autoimmunity](http://www.ncbi.nlm.nih.gov/pubmed/31175348)Sumida T, Lincoln MR, Ukeje CM, Rodriguez DM, Akazawa H, Noda T, Naito AT, I, DA. Author Correction: Activated -catenin in Foxp3+ regulatory T cells links inflammatory 2019, Beecham A, Dankowski T, Goris A, Dubois B, D'hooghe M, Lemmens R, Van Damme P, S\u00f8ndergaard H, Sellebjerg Sorensen Ullum C, Bayas A, Heesen C, K\u00fcmpfel T, Linker J, R, Duijn C, Theunissen C, Bos S, Myhr K, Celius E, Lie B, Spurkland A, Comabella M, Piehl F, Jeli I, Martin R, Sospedra M, Ban M, Hawkins C, Hysi P, Kalra S, Karpe F, Khadake J, Lachance G, Neville M, Santaniello A, Caillier S, Calabresi P, Cree B, Cross A, Davis M, Haines J, de Bakker P, Delgado S, Dembele M, Edwards K, Fitzgerald K, Hakonarson H, Konidari I, Lathi E, Manrique C, Pericak-Vance M, Piccio L, Schaefer C, McCabe C, Weiner H, Goldstein J, Olsson T, Hadjigeorgiou G, Taylor B, Tajouri L, Charlesworth J, Booth D, Harbo H, Ivinson A, Hauser S, Compston A, Stewart G, Zipp F, Barcellos L, Baranzini Hafler D, Cotsapas C. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis to modulates [Yjaut Neurologic Antigens relatives of SLE and RA patients](http://www.ncbi.nlm.nih.gov/pubmed/30952617)James JA, Chen H, Young KA, MH, Keating RM, Gaffney PM, Kelly JA, Langefeld CD, Harley JB, Robinson W, Hafler DA, O'Connor KC, J, Norris disease-specific boundaries in at-risk first-degree relatives of T, Takahashi T, Grover JR, Iwasaki DA, Montgomery RR, Fikrig E. Aedes aegypti AgBR1 antibodies modulate early Zika virus infection of 2019, S, Spreafico R, Hafler DA, McKinney EF. From Big Data to Precision Medicine Frontiers In Medicine 2019, 6: Dominguez-Villar M, signaling restores suppressor 2 Genetics of Multiple Sclerosis 2019, 33-54. [DOI: 10.1039/9781788016070-00033](https://doi.org/10.1039/9781788016070-00033). - Ponath G, Lincoln MR, Levine-Ritterman M, Park C, Dahlawi S, Mubarak M, Sumida T, Airas L, Zhang S, Isitan C, Nguyen TD, Raine CS, Hafler DA, Pitt D. Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis Nature cells using multi-directional magnetic ratcheting](http://www.ncbi.nlm.nih.gov/pubmed/30420988)Murray C, Miwa H, Dhar M, Park DE, Pao E, Martinez J, Kaanumale S, Loghin E, Graf J, Raddassi K, Kwok WW, Hafler D, Puleo C, Di Carlo D. Correction: Unsupervised capture and profiling of rare immune cells using multi-directional magnetic ratcheting Lab On A Chip 2018, 18: 3703. 30420988](https://pubmed.ncbi.nlm.nih.gov/30420988), [DOI: 10.1039/c8lc90095g](https://doi.org/10.1039/c8lc90095g). Akazawa H, Noda T, Naito AT, I, Dominguez-Villar M, Hafler DA. Activated -catenin in Foxp3+ regulatory T cells links inflammatory environments Beecham A, Dankowski T, Goris A, Dubois B, D'hooghe M, Lemmens R, Van Damme P, S\u00f8ndergaard H, Sellebjerg Sorensen Ullum C, Bayas A, Heesen C, K\u00fcmpfel T, Linker J, R, Duijn C, Theunissen C, Bos S, Myhr K, Celius E, Lie B, Spurkland A, Comabella M, Piehl F, Jeli I, Martin R, Sospedra M, Ban M, Hawkins C, Hysi P, Kalra S, Karpe F, Khadake J, Lachance G, Neville M, Santaniello A, Caillier S, Calabresi P, Cree B, Cross A, Davis M, Haines J, de Bakker P, Delgado S, Dembele M, Edwards K, Fitzgerald K, Hakonarson H, Konidari I, Lathi E, Manrique C, Pericak-Vance M, Piccio L, Schaefer C, McCabe C, Weiner H, Goldstein J, Olsson T, Hadjigeorgiou G, Taylor B, Tajouri L, Charlesworth J, Booth D, Harbo H, Ivinson A, Hauser S, Compston A, Stewart G, Zipp F, Barcellos L, Baranzini Hafler D, Cotsapas C. Low-Frequency and Rare-Coding Variation Contributes to during virologically suppressed HIV](http://www.ncbi.nlm.nih.gov/pubmed/30232286)Farhadian SF, Mehta SS, Zografou C, Robertson K, Price RW, Pappalardo J, Chiarella DA, reveals cells in cerebrospinal fluid during DA. modulates cell phenotype and regulatory T Dhar M, Park DE, Pao E, Martinez J, Kaanumale S, Loghin E, Graf J, Rhaddassi K, Kwok WW, Hafler D, Puleo C, Di Carlo D. Unsupervised capture and profiling of rare immune cells using multi-directional magnetic ratcheting Lab On A D. Regulatory T Cells: From Discovery to Autoimmunity Cold Spring Harbor Perspectives Hafler DA. Podoplanin is a negative cells in healthy donors and patients with glioblastoma multiforme](http://www.ncbi.nlm.nih.gov/pubmed/28880903)Goods BA, Hernandez AL, Lowther DE, Lucca LE, Lerner BA, Gunel M, Raddassi K, Coric V, Hafler DA, Love JC. Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy R, Gottardo R, Khatri S, Kotliarov Y, Meng H, Sauteraud R, Shen-Orr S, Tsang J, Vallania F, Anguiano E, Baisch J, Baldwin N, Belshe R, Blevins T, Chaussabel D, Davis M, Fikrig E, Grill D, Hafler D, Henrich E, Joshi S, Kaech S, Kennedy R, Mohanty S, Montgomery R, Oberg A, Obermoser G, Ovsyannikova I, Palucka A, Pascual V, Poland G, Pulendran B, Reinherz E, Shaw A, Siconolfi B, Stuart K, Tsang S, Ueda I, Wilson J, Zapata H. Multicohort analysis reveals baseline transcriptional predictors of a glioma oncometabolite prevents CD8+ T cell in Patients After Intracerebral Hemorrhage](https://doi.org/10.1161/str.48.suppl_1.213)Askenase M, Goods B, Steinschneider A, Raddassi K, Beatty H, Hafler D, Love J, Sansing L. Abstract 213: Hematoma-infiltrating Macrophages Transition From Inflammatory to Reparative Programs Intracerebral Hemorrhage Stroke 2017, 48 [DOI: 10.1161/str.48.suppl_1.213](https://doi.org/10.1161/str.48.suppl_1.213). - Vodovotz A, Read EL, Bassaganya-Riera J, Hafler DA, Sontag E, Wang J, Tsang JS, Day JD, Kleinstein SH, Butte AJ, Altman MC, Hammond Chang CF, Goods BA, Hammond MD, Grory B, Ai Y, Steinschneider promotes Cell 2016, 27814519](https://pubmed.ncbi.nlm.nih.gov/27814519), [DOI: 10.1016/j.cell.2016.10.040](https://doi.org/10.1016/j.cell.2016.10.040). Baranzini S, Barcellos L, Barizzone N, Beecham A, Berge T, Bernardinelli L, Booth D, Bos S, Buck D, Butkiewicz M, Celius E, Comabella M, Compston A, Dedham K, Cotsapas C, Alfonso S, De Jager P, Dubois B, Duquette P, Fontaine B, Gasperi C, Gil E, Goris C, Gyllenberg A, Hadjigeorgiou G, Hafler D, Hribko D, Haines J, Harbo H, Hauser S, Warto S, Hawkins C, Hemmer B, Henry R, Hintzen R, Horakova D, Ivinson A, Howard M, Jelcic I, Kaskow B, Kira J, Kleinova P, Kockum I, Kucerova K, Lill C, Luessi F, Malhotra S, Martin R, Martinelli F, Matsushita T, McCabe C, McCauley J, Mescheriakkova J, Mitrovic M, Moen S, Montalban H, Sorensen P, Sospedra M, Spurkland A, Stewart G, Taylor B, Uitterlinden A, Van Duijn C, Zipp F. NR1H3 p.Arg415Gln Is Not Associated to to Clinical Phenotype in Multiple Sclerosis: In Search He J, Hernandez AL, Joe B, Karumanchi SA, Maric-Bilkan C, Mattson D, Mehta NN, Randolph G, Ryan M, Sandberg K, Titze J, Tolunay E, Toney GM, Harrison DG. National Heart, Lung, and Blood Institute Working Group Report on Salt in Human Health and Sickness Hypertension 2016, Dominguez-Villar M. AKT isoforms modulate Th1like Treg generation and function in human Liver-Transplanted Recipients with De Novo Autoimmune Hepatitis Is Enhanced and Induces TH1-like Regulatory T Cells](http://www.ncbi.nlm.nih.gov/pubmed/27183637)Arterbery AS, Osafo-Addo A, Avitzur Y, Ciarleglio Deng Proinflammatory Cytokines by Monocytes in Liver-Transplanted Recipients with De Novo Autoimmune Hepatitis Is Enhanced and Induces TH1-like Regulatory T Cells The Journal Lucca LE, Lerner BA, Raddassi K, van Dijk D, Hernandez AL, Duan X, Gunel M, Coric V, Krishnaswamy S, Love JC, Hafler DA. PD-1 marks dysfunctional regulatory T cells in malignant O'Connor KC. Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis New England Journal Of Medicine 2016, AH, Papinutto N, Shinohara RT, Stern W, Amann M, Bakshi R, Bischof A, Carriero A, Comabella M, Crane JC, D'Alfonso S, Demaerel P, Dubois B, Filippi M, Fleischer V, Fontaine B, Gaetano L, Goris BMJ, Villoslada P, Wattjes MP, Weiner H, Wuerfel J, Zimmer C, Zipp F, Consortium I, Hauser SL, Oksenberg JR, Henry RG. Power estimation Ponath G, Zabad R, VL, Vortmeyer AO, Hafler DA, D. demyelination Hafler DA. The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations. Current 17: 651-65. [PMID: 26844569](https://pubmed.ncbi.nlm.nih.gov/26844569), [DOI: 10.2174/1389450117666160201105934](https://doi.org/10.2174/1389450117666160201105934). [Investigating Nervous System-Derived Immunoglobulins](http://www.ncbi.nlm.nih.gov/pubmed/26648933)Willis SN, Stathopoulos P, Chastre A, Compton SD, Hafler DA, O'Connor K. Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins Frontiers IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE-143](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638710)Lowther Reap E, Vlahovic Sahebjam S, Baehring J, Voloschin A, Cloughesy T, Lim M, Coric V, Latek R, Simon J, Lerner B, Raddassi K, Hafler D, Sampson J. CBM-06IMMUNE BIOMARKER RESULTS FROM A TRIAL OF NIVOLUMAB \u00b1 IN COMBINATION WITH IPILIMUMAB IN RECURRENT GLIOBLASTOMA: UPDATED RESULTS FROM CHECKMATE-143](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638899)Sampson J, Omuro Vlahovic G, Sahebjam S, Baehring A, Simon J, Latek R, Coric V, Cloughesy T, Lim M, Reardon D. IMCT-03SAFETY AND ACTIVITY OF NIVOLUMAB MONOTHERAPY AND NIVOLUMAB IN COMBINATION WITH IPILIMUMAB IN Goods Lowther D, Hernandez A, Lerner B, Gunel M, Raddassi K, Simon J, Latek R, Coric V, Love J, Hafler D. CBM-04PD-1 EXPRESSION IDENTIFIES EXHAUSTED TUMOR INFILTRATING REGULATORY T EFFECTOR CELLS IN HEALTHY DONORS AND PATIENTS WITH GLIOBLASTOMA](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638709)Goods B, Lowther D, Lucca L, Hernandez A, Lerner B, Gunel M, Raddassi K, Simon J, Coric V, Love J, Hafler D. CBM-05FUNCTIONAL DIFFERENCES BETWEEN PD-1+ AND PD-1- CD4+ T EFFECTOR CELLS IN HEALTHY Kitz A, Wu C, Lowther DE, Rodriguez DM, Vudattu N, Deng S, Herold KC, Kuchroo VK, Kleinewietfeld M, DA. Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells Journal Of Reardon DA, Sampson JH. Prospects of immune checkpoint modulators in the treatment of to inflammatory stimuli](http://www.ncbi.nlm.nih.gov/pubmed/26062845)Housley WJ, Fernandez SD, Vera K, Murikinati SR, Mitrovic Cotsapas Hafler DA. Genetic variants associated with autoimmunity drive NFB signaling and responses to inflammatory stimuli with ipilimumab in recurrent glioblastoma J, Coric V, Cloughesy T, Lim M, Reardon D. Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma Hafler DA, Astier AL. Editorial: T Cell Regulation by the Environment Frontiers T cells from patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/25972006)Cao Y, Goods BA, Raddassi K, Nepom GT, Kwok WW, Love JC, Hafler DA. Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis Science Bilenky M, Yen A, Heravi-Moussavi A, Kheradpour P, Zhang Z, Wang J, Ziller M, Amin V, Whitaker J, Schultz M, Ward L, Sarkar A, Quon G, Sandstrom R, Eaton M, Wu Y, Pfenning A, Wang X, ClaussnitzerYaping Liu M, Coarfa C, Alan Harris R, Shoresh N, Epstein C, Gjoneska E, Leung D, Xie W, David Hawkins R, Lister R, Hong C, Gascard P, Mungall A, Moore R, Chuah E, Tam A, Canfield T, Scott Hansen R, Kaul R, Sabo P, Bansal M, Carles A, Dixon J, Farh K, Feizi S, Karlic R, Kim A, Kulkarni A, Li D, Lowdon R, Elliott G, Mercer T, Neph S, Onuchic V, Polak P, Rajagopal N, Ray P, Sallari R, Siebenthall K, Sinnott-Armstrong N, Stevens M, Thurman R, Wu J, Zhang B, Zhou X, Abdennur N, Adli M, Akerman M, Barrera L, Antosiewicz-Bourget J, Ballinger T, Barnes M, Bates D, Bell R, Bennett D, Bianco K, Bock C, Boyle P, Brinchmann J, Caballero-Campo P, Camahort R, Carrasco-Alfonso M, Charnecki T, Chen H, Chen Z, Cheng J, Cho S, Chu A, Chung W, Cowan C, Athena Deng Q, Deshpande V, Diegel M, Ding B, Durham T, Echipare L, Edsall L, Flowers D, Genbacev-Krtolica O, Gifford C, Gillespie S, Giste E, Glass I, Gnirke A, Gormley M, Gu H, Gu J, Hafler D, Hangauer M, Hariharan M, Hatan M, Haugen E, He Y, Heimfeld S, Herlofsen S, Hou Z, Humbert R, Issner R, Jackson A, Jia H, Jiang P, Johnson A, Kadlecek T, Kamoh B, Kapidzic M, Kent J, Kim A, Kleinewietfeld M, Klugman S, Krishnan J, Kuan S, Kutyavin T, Lee A, Lee K, Li J, Li N, Li Y, Ligon K, Lin S, Lin Y, Liu J, Liu Y, Luckey C, Ma Y, Maire C, Marson A, Mattick J, Mayo M, McMaster M, Metsky H, Mikkelsen T, Miller D, Miri M, Mukame E, Nagarajan R, Neri F, Nery J, Nguyen T, O'Geen H, Paithankar S, Papayannopoulou N, Raghuraman S, Raney B, Raubitschek A, Reynolds A, Richards H, Riehle K, Rinaudo P, Robinson J, Rockweiler N, Rosen E, Rynes E, Schein J, Sears R, Sejnowski T, Shafer A, Shen L, Shoemaker R, Sigaroudinia M, Slukvin I, Stehling-Sun S, Stewart R, Subramanian S, Suknuntha K, Swanson S, Tian S, Tilden H, Tsai L, Urich M, Vaughn I, Vierstra J, Vong S, Wagner U, Wang H, Wang T, Wang Y, Weiss A, Whitton H, Wildberg A, Witt H, Won K, Xie M, Xing X, Xu I, Xuan Z, Ye Z, Yen C, Yu P, Zhang X, Zhang X, Zhao J, Zhou Y, Zhu J, Zhu Y, Ziegler S, Beaudet A, Boyer L, De Jager P, Farnham P, Fisher S, Haussler D, Jones S, Li W, Marra M, McManus M, Sunyaev S, Thomson J, Tlsty T, Tsai L, Wang W, Waterland R, Zhang M, Chadwick L, Bernstein B, Costello J, Ecker J, Hirst M, Meissner A, Milosavljevic A, Ren B, Stamatoyannopoulos J, Wang T, Kellis M. Integrative analysis of 111 DA, Gimelbrant A, Chess A. Monoallelic expression of the human FOXP2 speech gene Proceedings Of The National Academy Of Sciences Of The United States Of America 2014, Hafler DA. TLR7 induces anergy Interleukin 10 After Influenza Vaccination in Older Adults](http://www.ncbi.nlm.nih.gov/pubmed/25367297)Mohanty S, Joshi SR, Ueda I, Wilson J, Blevins TP, Siconolfi B, Meng H, Devine L, SM, Proinflammatory Cytokine Production in Monocytes Modulated by Interleukin 10 After Influenza Vaccination in Older Adults The Journal Of Infectious Diseases 2014, 211: 1174-1184. Meng H, Wang X, You F, Devine L, Raddassi K, Garcia MN, Murray KO, Bolen SS, Hafler D, Fikrig E, Xavier R, Kleinstein SH, Montgomery RR. Systems Immunology Reveals Markers of Susceptibility to West Nile Virus MJ, Hafler DA, Bernstein BE. Genetic and epigenetic fine mapping of causal autoimmune disease BA, Vigneault F, Kleinstein SH, Hafler DA, O'Connor KC. B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes Science Translational C, Levkovich T, Perrotta A, Bhela S, Varian B, Ibrahim Y, Lakritz J, Kearney S, Chatzigiagkos A, Hafler D, Alm E, Obesity 2014, 17-43. [DOI: 10.1201/b17254-6](https://doi.org/10.1201/b17254-6). [Joint Modeling and Registration of Cell Populations in Cohorts of High-Dimensional Flow Cytometric Data](http://www.ncbi.nlm.nih.gov/pubmed/24983991)Pyne S, Lee SX, Wang K, Irish Tamayo P, Nazaire MD, Duong T, Ng SK, Hafler D, Levy R, Nolan GP, Mesirov J, McLachlan GJ. Joint Modeling and Registration of Cell Populations in Cohorts of High-Dimensional Flow Cytometric in Patients With De Novo Autoimmune Hepatitis.](https://doi.org/10.1097/00007890-201407151-02977)Ekong U, Hill M, Edmunds C, Han G, Bhela S, Hafler D, Kleinewietfeld M. Identification of Pathogenic IL-17 Producing FOXP3+ Tregs in Patients With De Novo Autoimmune Hepatitis. Transplantation 2014, 98: 872-873. [DOI: 10.1097/00007890-201407151-02977](https://doi.org/10.1097/00007890-201407151-02977). - Gautron A, Dominguez-Villar M, M, Hafler DA. Enhanced suppressor function of TIM3+FoxP3+ regulatory T cells European Journal Molecular Basis of Autoimmune Disease Annals Of The Rheumatic Diseases 2014, 73: 27. or in combination with ipilimumab versus bevacizumab in patients (pts) with recurrent glioblastoma (GBM).](https://doi.org/10.1200/jco.2014.32.15_suppl.tps2101)Sampson J, Vlahovic G, Desjardins A, Friedman H, Baehring J, Hafler D, Rollin L, Coric V, Perez S, phase IIb study of nivolumab (anti-PD-1; alone or in combination with ipilimumab versus bevacizumab in patients (pts) with recurrent glioblastoma Kuchroo VK, Hafler DA. Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cells Journal Of S, Ye C, Lee MN, Replogle JM, Feng T, Lee M, Asinovski N, Frohlich I, Imboywa S, Von Korff A, Okada Y, Patsopoulos NA, Davis S, McCabe C, Paik HI, Srivastava GP, Raychaudhuri S, Hafler A, N, Mathis D, Benoist C, Stranger BE, De Jager PL. Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles TW, Hafler DA, Toes RE. TLRmediated STAT3 and ERK activation controls IL10 secretion by human B cells European and Th17 Cell Responses](http://www.ncbi.nlm.nih.gov/pubmed/24745333)Joller N, Lozano E, Burkett PR, Patel B, Xiao S, Zhu C, Xia J, Tan TG, Sefik E, Yajnik V, Sharpe AH, Selectively Cell Transcriptional Network by Divergent Mechanisms](http://www.ncbi.nlm.nih.gov/pubmed/24745332)Xiao S, Yosef N, Yang J, Wang Y, Zhou L, Zhu C, Wu C, Baloglu E, Schmidt D, Ramesh R, Lobera M, Sundrud MS, Tsai PY, Xiang Z, Wang J, Xu Y, Lin X, Kretschmer K, Rahl PB, Young RA, Zhong Z, Hafler DA, A, Ghosh S, Marson A, Kuchroo VK. Small-Molecule RORt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms Heiden Uduman DA, SH. pRESTO: toolkit Raj T, Li W, Eisenhaure TM, Imboywa SH, Chipendo PI, Ran FA, Slowikowski K, Ward LD, Raddassi K, McCabe C, Lee MH, Frohlich IY, Hafler DA, Kellis M, Raychaudhuri S, Zhang F, BE, Benoist CO, De Jager PL, Regev A, Hacohen N. Common Genetic Variants Modulate Pathogen-Sensing Responses D. Chapter 52 Multiple Sclerosis 2014, 735-756. [DOI: 10.1016/b978-0-12-384929-8.00052-6](https://doi.org/10.1016/b978-0-12-384929-8.00052-6). - Bailey M, Hafler D, Pelletier D. and Acute Disseminated M. Role of \"Western Diet\" in Inflammatory Autoimmune Diseases Current Allergy And Asthma 14: 404. [PMID: 24338487](https://pubmed.ncbi.nlm.nih.gov/24338487), [PMCID: PMC4034518](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034518), Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA LF, Hintzen RQ, Noble Raj T, , , Gourraud PA, Stranger BE, Oksenberg J, Olsson T, BV, Sawcer S, Hafler DA, Carrington M, De Jager PL, de Bakker PI. Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and of human Treg and Th17 cells and its role Healy BC, Keenan BT, Xia Z, Chitnis T, Guttmann CR, Khoury SJ, Weiner HL, Hafler DA, De Jager PL. Clinical relevance and functional consequences of the TNFRSF1A CD226/CD155 Interaction Regulates the Proinflammatory (Th1/Th17)/Anti-Inflammatory (Th2) Balance in in MS 2013, 27-47. [DOI: 10.1007/978-1-4614-7953-6_2](https://doi.org/10.1007/978-1-4614-7953-6_2). - Querol L, Clark PL, Bailey MA, Cotsapas C, Cross AH, Hafler DA, Kleinstein SH, Lee JY, Yaari G, Willis SN, O'Connor KC. Protein array-based profiling of CSF identifies RBPJ as an autoantigen with GWAS Data from 15,000 Cases and 30,000 Controls](http://www.ncbi.nlm.nih.gov/pubmed/23731539)Consortium I, Baranzini S, Khankhanian P, Patsopoulos N, Li M, Stankovich J, Cotsapas C, S\u00f8ndergaard H, Ban M, Barizzone N, Bergamaschi L, Booth D, Buck D, Cavalla P, Celius E, Comabella M, Comi G, Compston A, Cournu-Rebeix I, D'alfonso S, Damotte V, Din L, Dubois B, Elovaara I, Esposito F, Fontaine B, Franke V, Martinelli-Boneschi F, McCauley J, Myhr K, Naldi M, Sellebjerg F, S\u00f8rensen P, Spurkland A, Stewart G, Taylor B, Tienari P, Winkelmann J, Consortium W, Zipp F, Ivinson A, Haines J, Sawcer S, DeJager P, Hauser S, Oksenberg J. Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls American Journal Of Human Genetics 2013, T, Lynch M, Preston-Hurlburt P, Herold KC, Hafler DA, O'Connor K, Meffre E. Specific peripheral B cell tolerance defects in patients with multiple sclerosis Journal Of Clinical Investigation lyoplate flow cytometry data (P3374)](https://doi.org/10.4049/jimmunol.190.supp.135.13)Scheuermann R, Finak G, Ramey J, Taghiyar J, Stanton R, Brandes A, De Jager P, Qiu P, McCoy J, Hafler D, Maecker H, Mosmann T, Brinkman R, Gottardo R. FlowCAP: comparison of automated and manual gating of standardized lyoplate flow cytometry data multiple Haren L, Robinson WH. Serum to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing- remitting multiple sclerosis Multiple sclerosis, type 1 diabetes and rheumatoid arthritis](http://www.ncbi.nlm.nih.gov/pubmed/23497938)Larman HB, Nigrovic PA, De Jager O'Connor KC, Elledge SJ. PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis Journal DN, DA. Sodium chloride drives autoimmune disease by the induction of pathogenic from Immunoglobulin Sequencing Data](http://www.ncbi.nlm.nih.gov/pubmed/24298272)Yaari G, Heiden J, Uduman Stern JN, O'Connor K, Hafler DA, Laserson U, Vigneault F, Kleinstein SH. Models of Somatic Hypermutation Targeting and Substitution Based on Synonymous Mutations from High-Throughput Immunoglobulin Sequencing Data JP, GJ, Khoury SJ, Hafler DA, Weiner HL, De Jager PL. An RNA Profile Identifies Two Subsets of Multiple Sclerosis Patients Differing in Disease Activity Science Translational Medicine 2012, 4: 153ra131. Yosef N, Quintana FJ, Xiao S, Peters A, Wu C, Kleinewietfeld M, Kunder S, Hafler DA, Sobel RA, Regev A, Kuchroo VK. Induction and molecular signature R, Hafler D, Muller D. Abstract 456: High Salt Induces Pathogenic Th17 Cells and Exacerbates Autoimmune Diseases Hypertension 2012, 60 [DOI: 10.1161/hyp.60.suppl_1.a456](https://doi.org/10.1161/hyp.60.suppl_1.a456). [Correction: The CD6 Multiple Sclerosis Susceptibility Allele Is Associated with Alterations in CD4+T Cell Proliferation](https://doi.org/10.4049/jimmunol.1290044)Kofler D, Severson C, Mousissian N, De Jager Hafler D. Correction: The CD6 Multiple Sclerosis Susceptibility Allele Is Associated with Alterations in CD4+T Cell Proliferation The Journal Of Immunology 2012, 189: 2063-2063. [DOI: 10.4049/jimmunol.1290044](https://doi.org/10.4049/jimmunol.1290044). [Erratum: Interferon regulatory factor gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis](https://doi.org/10.1038/gene.2012.18)Vosslamber S, van der Voort L, van den Elskamp I, Heijmans R, Aubin C, B, Killestein J, Polman C, Verweij C. Erratum: Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis Genes & Immunity 2012, 13: 443-443. [DOI: 10.1038/gene.2012.18](https://doi.org/10.1038/gene.2012.18). - Lowther DE, Hafler DA. Regulatory T cells in the central nervous system Immunological Reviews 2012, S, Hafler DA, Jabbour HN, Astier AL. Prostaglandin E2 Affects T Cell Responses through Modulation of CD46 Expression Stephen J, Hafler D, Jabbour H. Prostaglandin E2 affects T cell responses through modulation of CD46 expression. (178.8) The Journal Of 178.8-178.8. 10.4049/jimmunol.188.supp.178.8](https://doi.org/10.4049/jimmunol.188.supp.178.8). Kuchroo V, Linker R, Muller D, Hafler D. High salt induces pathogenic Th17 cells and exacerbates autoimmune diseases (60.13) The Journal Of 2012, Hafler DA. The TIGIT/CD226 Axis Regulates Human T Cell Function The Journal - Nylander A, Class II Self-Antigen Presentation in Fingolimod for Multiple Sclerosis New England Of Medicine 2012, 366: 339-347. [PMID: 22276823](https://pubmed.ncbi.nlm.nih.gov/22276823), [DOI: Hafler D, von Herrath M, Nestle FO. Unraveling the autoimmune translational research process layer by layer Nature J, Sandbrink R, Pohl C, Edan G, Kappos L, Miller D, Montalb\u00e1n J, Polman C, Freedman M, Hartung H, Arnason B, Comi G, Cook S, Filippi M, Goodin D, Jeffery D, O'Connor P, Ebers G, Langdon D, Reder A, Traboulsee A, Zipp S, Hillert J, Bahlo M, Booth D, Broadley S, Brown M, Browning B, Browning S, Butzkueven H, Carroll W, Chapman C, Foote S, Griffiths L, Kermode A, Kilpatrick T, Lechner-Scott J, Marriott M, Mason D, Moscato P, Heard R, Pender M, Perreau V, Perera D, Rubio J, Scott R, Slee M, Stankovich J, Stewart G, Taylor B, Tubridy N, Willoughby E, Wiley J, Matthews P, Boneschi F, Compston A, Haines J, Hauser S, McCauley J, Ivinson A, Oksenberg J, Pericak-Vance M, Sawcer S, Jager P, Hafler D, de Bakker P. Genomewide metaanalysis identifies novel multiple sclerosis susceptibility Hafler DA, Lauffenburger DA, Love JC. Polyfunctional responses by human T cells result from sequential release of cytokines Proceedings Of The National Academy Of Sciences Of The United States Of America Associated with Ventricular Dysfunction after Primary Coronary Artery Bypass Graft Surgery](http://www.ncbi.nlm.nih.gov/pubmed/21980348)Fox AA, Pretorius M, Liu KY, Collard CD, Perry TE, Shernan SK, De Jager PL, Hafler DA, Herman DS, DePalma SR, Roden DM, Muehlschlegel JD, Donahue BS, Darbar D, Seidman JG, Body SC, Seidman CE. Genome-Wide Assessment for Genetic Variants Associated with Ventricular Dysfunction after Primary Coronary Artery Bypass Graft Surgery with Alterations in CD4+ T Cell Proliferation](http://www.ncbi.nlm.nih.gov/pubmed/21849685)Kofler DM, Severson CA, Mousissian N, De Jager PL, Hafler DA. The CD6 Multiple Sclerosis Susceptibility Allele Is Associated with Alterations in CD4+ T Cell Proliferation The Journal Of BM, Wallace C, Abecasis GR, Barrett JC, Behrens T, Cho J, De Jager PL, Elder JT, Graham RR, Gregersen P, Klareskog L, Siminovitch KA, van Heel DA, Wijmenga C, Worthington J, Todd JA, Hafler DA, Rich SS, Daly MJ, . Pervasive Sharing of Genetic Effects in Autoimmune in Patients with Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/21653833)Raddassi K, Kent SC, Yang J, Bourcier V, Glycoprotein/MHC Class II-Binding CD4 Cells in Patients with chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex](http://www.ncbi.nlm.nih.gov/pubmed/21653641)Zuvich RL, WS, Hafler D, Hauser S, Sawcer S, Pericak-Vance M, Barcellos L, Mortlock D, Haines J. Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex Human Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease variants and pharmacological and clinical outcome of Interferon therapy in multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/21471993)Vosslamber S, van der Voort LF, Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferon therapy in multiple sclerosis Genes & Immunity 2011, 12: 466-472. [PMID: 21471993](https://pubmed.ncbi.nlm.nih.gov/21471993), [DOI: 10.1038/gene.2011.18](https://doi.org/10.1038/gene.2011.18). Human CD4+CD25hi Regulatory Cells in Patients with Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/21300823)Baecher-Allan CM, Costantino CM, Cvetanovich GL, M, DA. CD2 Costimulation Reveals Defective Activity by Human CD4+CD25hi Regulatory Cells in Patients with Multiple Sclerosis The Journal that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin](http://www.ncbi.nlm.nih.gov/pubmed/21353315)Obermeier B, Lovato L, Mentele R, Br\u00fcck W, H, Hohlfeld R, Hafler DA, O'Connor KC, Dornmair K. Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin L, Y, Polman CH, Hauser SL, Oksenberg J, Haines JL, Ritchie MD. A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility Genes & D, de Bakker PI, Kappos L, Polman CH, Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Chibnik LB, Hafler DA, Matthews PM, Hauser SL, Baranzini SE, Oksenberg JR. Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data Genome Medicine 2011, SE, Howell OW, Reynolds R, O'Connor K, Hafler DA. Related B cell clones populate the meninges and parenchyma of patients with multiple DRB1*1501 in the response of subjects with multiple sclerosis to first-line treatments](http://www.ncbi.nlm.nih.gov/pubmed/21115201)Gross R, Healy BC, Cepok B, Weiner HL, DA, De Jager PL. Population structure and HLA DRB1*1501 in the response of subjects with multiple sclerosis to first-line treatments Journal Of Amos M, Elliott J, Gaigalas A, Wang L, Aranda R, Banchereau J, Boshoff C, Braun J, Korin Y, Reed E, Cho J, Hafler D, Davis M, Fathman CG, Robinson W, Denny T, Weinhold K, Desai B, Diamond B, Gregersen P, Di Meglio P, Nestle FO, Peakman M, Villanova F, Ferbas J, Field E, Kantor A, Kawabata T, Komocsar H, O'Lone R, Phippard D, Plevy S, Rich S, Roederer M, Rotrosen D, Yeh JH. A model for harmonizing flow cytometry Human regulatory T cells in autoimmune diseases Current Opinion In ML. Droplet-based microfluidic With Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/20837847)Khoury SJ, Healy BC, Kivis\u00e4kk P, Viglietta V, CR, Wedgwood JF, Hafler DA, Weiner HL, Buckle G, Cook S, Reddy S. A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Glanz B, Wolfish L, R, sclerosis using supervised machine learning and meta-analysis in 12 566 individuals](http://www.ncbi.nlm.nih.gov/pubmed/20699326)Briggs FB, Bartlett SE, Goldstein BA, MA, Haines JL, Barcellos L. Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12 566 individuals Human Molecular gene signature is prevalent in the central nervous system of patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/20655601)Ligocki AJ, Lovato L, Xiang D, O'Connor KC, Monson NL. A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis Journal Of Independently HLA-DRB1*15:01](http://www.ncbi.nlm.nih.gov/pubmed/20593013)Cree BA, Rioux JD, McCauley JL, . A Major Histocompatibility Class I Locus Contributes to Multiple Sclerosis Susceptibility Independently from HLA-DRB1*15:01 sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/20574445)Ban M, McCauley JL, Zuvich R, Baker A, S, Guerini FR, J, Barcellos Ivinson AJ, Sexton SL, Haines J, Compston A, Sawcer S. A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis Genes Hafler DA. FOXP3+ regulatory T cells in the human immune system Nature Reviews Immunology 2010, DW, Driscoll Diederichs S, Haider K, Netravali I, Le S, Elia R, Dow E, Lee A, Freudenberg J, De Jager PL, Chretien Y, Varki A, MacDonald ME, Gillis T, Behrens TW, Bloch D, Collier D, Korzenik J, Podolsky DK, MA, Haines JL, Barcellos LF. Variation Within DNA Repair Pathway Genes and Risk of Multiple Sclerosis American Journal Of Epidemiology 2010, 172: 217-224. [PMID: M, Scott RJ, Lechner-Scott J, Goris Dobosi Dubois J, Kockum I, Olsson T, Hillert J, Ban M, Baker A, Kemppinen A, Sawcer S, Compston A, Robertson NP, JR, Hauser SL, Sexton D, Haines J. Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis. Nature Genetics and rates of cytokine secretion from single cells by quantitative microengraving](http://www.ncbi.nlm.nih.gov/pubmed/20376398)Han Q, Bradshaw EM, Nilsson B, Hafler DA, Love JC. Multidimensional analysis of the frequencies and rates of cytokine secretion from single cells by quantitative microengraving Lab and IL-10 and a Baecher-Allan C. CD4+CD45RA-CD25hiCD127low/neg regulatory T cells to secrete IFN and IL-10 and acquire a non-regulatory S, Oksenberg J, Barcellos L. CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis Human Molecular a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene](http://www.ncbi.nlm.nih.gov/pubmed/20159113)Jakkula E, Lepp\u00e4 Palotie A, Saarela J, Peltonen L. Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene American Journal Of Multiple Sclerosis Genetics Consortium, Aubin C, Cross AH, Piccio L, Aggarwal NT, Evans D, Hafler DA, Compston A, Hauser SL, Pericak-Vance MA, Haines JL. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility Human D, O'Connor K. Characterization of the Myelin Specific Autoantibodies in Acute 10.1016/j.clim.2010.03.243](https://doi.org/10.1016/j.clim.2010.03.243). T IFN and IL-10 and Acquire a Non-regulatory Effector D, Baecher-Allan C. IL-12 Induces CD4+CD45RA-CD25hiCD127low/neg Regulatory T Cells to Secrete IFN and IL-10 and Baecher-Allan C, Hafler D. IL-1 Receptor Expression on Human Regulatory T Cells and IL-1's Role in Reducing Suppression Clinical Immunology 2010, 135: s131. 10.1016/j.clim.2010.03.395](https://doi.org/10.1016/j.clim.2010.03.395). - Schubert Seth N, Raddassi K, Hafler D, Dustin M, Wucherpfennig K. Altered Synapse Formation by Self-reactive T Cells from MS Patients Clinical 2010, [DOI: 10.1016/j.clim.2010.03.227](https://doi.org/10.1016/j.clim.2010.03.227). Banwell B, Bates A, Ben-Hur T, Bowling A, Davis S, De Jager P, Dutta R, Edan G, Frohman E, Frohman T, Gold R, Hafler D, Jacob A, jeli I, Kaplin A, Kerr D, Kleinschnitz C, Kozubal D, Lemack G, Linker R, lucchinetti C, Marriott J, Martin R, Matiello M, Melzer N, Meuth S, Morrissey S, Munger K, O'Connor P, Amato M, Pirko I, Pittock S, Schr\u00f6der A, Shah A, Trapp B, Trecker C, Venkateswaran S, Voskuhl R, Weinshenker B, Wiendl H, Wingerchuk D, AUTHORS 2010, 35: xi-xvii. [DOI: 10.1016/b978-1-4160-6068-0.00024-3](https://doi.org/10.1016/b978-1-4160-6068-0.00024-3). [Monocytes from Patients with Type 1 Diabetes Have Increased Gene Expression of Pro-inflammatory Cytokines or IL-10](https://doi.org/10.1016/j.clim.2010.03.061)Bradshaw E, Elyaman W, Raddassi K, Mousissian N, Greer A, Orban T, Gottlieb P, Kent S, Hafler D. Monocytes from Patients with Type 1 Diabetes Have Increased Gene Expression of Pro-inflammatory Cytokines or Pyne S, Hu X, Wang K, Rossin E, Lin T, Maier L, Baecher-Allan C, McLachlan G, Tamayo P, Hafler D, De Jager P, Mesirov J. Automated C, Moya J, Bell D, Haider K, Taylor K, De Jager P, Behrens T, Hafler D, Sands B, Murali M, Gregersen P, Pillai S. Regulation of Immunological [Dissecting Functional Consequences of the Validated Multiple Sclerosis Susceptibility Allele in TNFRSF1A](https://doi.org/10.1016/j.clim.2010.03.351)Ottoboni L, Mousissian N, Castillo I, Hafler D, De Jager P. Dissecting the Functional Consequences of the Validated Multiple Sclerosis Susceptibility Allele in TNFRSF1A Clinical Immunology 2010, Pyrdol J, Raddassi K, Hafler D, Dustin M, Wucherpfennig K. Efficient Activation of Self-reactive T Cells from MS Patients with Altered Synapse Human Genetic and Immunologic Variation](https://doi.org/10.1016/j.clim.2010.03.355)Castillo I, Lui Q, Ottoboni L, Briskin R, Hafler D, De Jager P. The PhenoGenetic Project: A Living Biobank Enabling the Study of Human Genetic and Immunologic Immunology and Proinflammatory Cytokines and is Increased in Diabetes](https://doi.org/10.1016/j.clim.2010.03.089)Beriou Lozano E, Baecher-Allan C, Inducible by TGF- and Proinflammatory Cytokines and is Increased Diabetes Immunology 135: s29. [DOI: 10.1016/j.clim.2010.03.089](https://doi.org/10.1016/j.clim.2010.03.089). - De Jager P, Hafler D. Chapter 3 Uncovering the Genetic Architecture of Multiple Sclerosis 2010, 35: 43-56. [DOI: Hafler DA, Hacohen N. RNA Interference Screen in Primary Human T Cells Reveals FLT3 as a Modulator of IL-10 Levels Raddassi K, Nilsson B, Nepom GT, Hafler DA, Love JC. On-Chip Activation and Subsequent Detection of Individual Antigen-Specific T Cells study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci](http://www.ncbi.nlm.nih.gov/pubmed/20007504), , McCauley J, Zuvich R, Beecham A, De Jager P, Konidari I, Whitehead P, Aubin C, Ban M, Pobywajlo S, Briskin R, Romano S, Aggarwal N, Piccio L, McArdle W, Strachan D, Evans D, Cross A, Cree B, Rioux J, Barcellos L, Ivinson A, Compston A, Hafler D, Hauser S, Oksenberg J, Sawcer S, Pericak-Vance M, Haines J. Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci A-Chain of Human Insulin Using NMR Spectroscopy, Quantum Chemical Calculations, and Mass Spectrometry](http://www.ncbi.nlm.nih.gov/pubmed/19954153)Sharma AK, Ling Y, Greer AB, Hafler DA, Kent SC, Zhang Y, Rigby AC. Evaluating the Intrinsic Cysteine Redox-Dependent States of the A-Chain of Human Insulin Using NMR Spectroscopy, Quantum Chemical Calculations, and Mass Spectrometry The Journal Of Physical Chemistry L, Fernando M, Green T, De Jager P, Foisy S, Wang J, de Bakker P, Leslie S, McVean G, Padyukov L, Alfredsson L, Annese R, Sawcer S, Compston A, Cree B, Mirel D, Daly M, Behrens T, Klareskog L, Gregersen P, Oksenberg J, Hauser S. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases Proceedings Of The National Academy Of Sciences Of The United States Of America 2009, 106: KD. Engineered Interleukin-2 Antagonists for the Inhibition of Regulatory T Cells Journal into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score](http://www.ncbi.nlm.nih.gov/pubmed/19879194)De Jager PL, Chibnik LB, Cui J, Reischl J, Bauer D, Heubach JF, Sandbrink R, Tyblova M, Lelkova P, the steering committees of the BENEFIT B, Havrdova E, Pohl C, Horakova D, Ascherio A, Hafler D, Karlson E. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score Proinflammatory Cytokines Inducing Th17 Cells](http://www.ncbi.nlm.nih.gov/pubmed/19748982)Bradshaw EM, Raddassi Gottlieb PA, Kent SC, Hafler DA. Monocytes from Patients with Type 1 Diabetes Spontaneously Secrete Proinflammatory Cytokines Inducing Th17 Cells Franz B, Kennedy J, McArdel S, Kuhle J, Kappos L, Rostasy K, Pohl D, S, KC, V, Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis The Journal Greenfield EA, TB, Hafler DA, Kuchroo VK. TIM3 is expressed on activated CD4+ T cells and regulates Th1 and Th17 MM, Br\u00fcck W, Hafler DA, O'Connor K. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain Brain 2009, ME, De Jager PL, Hafler DA, Breitbart RE, Seidman JG, Seidman CE. De novo copy number variants identify new genes and loci in isolated sporadic Class II MHC Processing in Human CD4+ HLA-DR+ T Cells and TNFRSF1A as new multiple sclerosis susceptibility loci](http://www.ncbi.nlm.nih.gov/pubmed/19525953)De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Baranzini S, McCauley J, Pericak-Vance M, Haines J, Gibson R, Naeglin Y, Uitdehaag B, Matthews P, Kappos L, Polman C, McArdle W, Strachan D, Evans D, Cross A, Daly M, Compston A, Sawcer S, Weiner H, Hauser S, Hafler D, Oksenberg J. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis Lin TI, Maier LM, Baecher-Allan C, McLachlan GJ, Tamayo P, Hafler PL, Mesirov JP. Automated high-dimensional flow cytometric data analysis Proceedings Of The National Academy Of Sciences Of The United States Of America 2009, 106: J, Yelensky R, Price A, Leppa V, Patterson N, de Bakker PI, Tran D, Aubin C, Pobywajlo S, Rossin E, Hu CW, Choy E, Rioux JD, Pericak-Vance MA, Ivinson A, Booth DR, GJ, Peltonen L, Dubois B, Haines JL, Weiner HL, Compston A, Hauser SL, Daly MJ, Reich D, Oksenberg JR, Hafler DA. The role of the CD58 locus in multiple sclerosis Proceedings Of The National Academy Of Sciences Of The United States Of America 2009, 106: 5264-5269. [PMID: JL, Lassmann H, O'Connor KC, Ritchie AM, Shearer A, Lam C, Yu X, Birlea M, DuPree C, Williamson RA, Hafler DA, Burgoon MP, Gilden D. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid \u00c5, Baker A, Mihalova T, Ingram G, Booth DR, Heard RN, Stewart E, Dubois B, Harbo HF, Celius Spurkland Strange R, Hawkins C, NP, Dudbridge F, Wason J, De SL, Sexton D, Haines J, Sawcer S. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor European Journal Of Human Genetics 2009, A, Peltonen L, Saarela J. Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS Sclerosis Subjects and the Effect of Soluble IL-2RA on Immune Responses](http://www.ncbi.nlm.nih.gov/pubmed/19155502)Maier LM, Anderson DE, Severson CA, Wittrup KD, De Jager PL, Hafler DA. Soluble IL-2RA Levels in Multiple Sclerosis Subjects and the Effect of Soluble IL-2RA on Immune Responses The Journal Kuchroo VK, Baecher-Allan C, Hafler DA. IL-17-producing human peripheral regulatory Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production](http://www.ncbi.nlm.nih.gov/pubmed/19119414)Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE, Severson C, Clark PM, Healy B, Walker N, Aubin C, Oksenberg JR, Hauser SL, Compston A, Sawcer S, , De Jager PL, Wicker LS, Todd JA, Hafler DA. IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production PLOS Genetics Acute Necrotizing Encephalopathy Caused by Mutations in a Component of the Nuclear Pore, RANBP2](http://www.ncbi.nlm.nih.gov/pubmed/19118815)Neilson DE, Adams MD, Orr CM, Schelling DK, Eiben RM, Kerr DS, Anderson J, Bassuk AG, Bye AM, Childs AM, Clarke A, Crow YJ, Di Rocco M, Dohna-Schwake C, Dueckers G, Fasano A, Lentschig MG, Lopez-Laso J, Schmitt-Mechelke T, Servidei S, Skardoutsou Uldall P, van der MS, KC, Tefft DL, Aubin C, de Jager P, Hafler D, Warman ML. Infection-Triggered Familial or Recurrent Cases of Acute Necrotizing Encephalopathy Caused by Mutations in a Component of the Nuclear Pore, RANBP2 American Journal Of B Cell Repertoires Among Lesions and Normal Appearing White Matter in the Multiple Sclerosis Central Nervous System](https://doi.org/10.1016/j.clim.2009.03.055)Lovato L, Almendinger S, Willis S, Rodig S, Hafler D, O'Connor K. OR.43. Comparative Analysis of B Cell Repertoires Among Lesions and Normal Appearing White Matter in the Multiple Sclerosis Central Nervous System Clinical Immunology 2009, 131: s20-s21. [DOI: 10.1016/j.clim.2009.03.055](https://doi.org/10.1016/j.clim.2009.03.055). [F.89. Elucidating the Antigen Specificity of B Cells Present within the CNS Lesions of Patients with MS](https://doi.org/10.1016/j.clim.2009.03.346)Willis S, Almendinger S, Lovato L, Hafler D, O'Connor K. F.89. Elucidating the Antigen Specificity of B Cells Present within the CNS Lesions of Patients with MS Clinical Immunology 2009, 131: s117. [DOI: 10.1016/j.clim.2009.03.346](https://doi.org/10.1016/j.clim.2009.03.346). - Hastings Human S Regulates MHC Class II Processing Clinical Autoreactive B Cells in Pancreatic Draining Lymph Nodes from Type 1 Diabetes Subjects](https://doi.org/10.1016/j.clim.2009.03.051)Kent S, Bradshaw E, Han Q, Varadarajan N, Greer A, Love J, Hafler D. OR.39. Enumeration and Phenotype of Autoreactive B Cells in Pancreatic Draining Lymph Nodes from Type 1 Diabetes Subjects Clinical Immunology 2009, 131: s19. Differs Significantly Between Functionally Distinct Subpopulations of CD4+CD25high Human Regulatory T Cells](https://doi.org/10.1016/j.clim.2009.03.361)Cvetanovich G, Ashley C, Hafler D, Baecher-Allan C. F.108. DNA Methylation of the Human FoxP3 Locus Differs Significantly Between Functionally Distinct Subpopulations of CD4+CD25high Human Regulatory T Cells s122. Cells](https://doi.org/10.1016/j.clim.2009.03.011)Costantino Beriou D, Baecher-Allan C. Cellular Senescence in Terminally Differentiated and TNFRSF1A as Novel Multiple Sclerosis Susceptibility Loci](https://doi.org/10.1016/j.clim.2009.03.294)De Jager P, de Bakker P, Wang J, Ottoboni L, Consortium I, Hauser S, Oksenberg J, Hafler D. F.27. Meta-analysis of Genome Scans and Replication Identify CD6, ICSBP1, and TNFRSF1A as Novel Multiple CD4+Cells in the Peripheral Blood of Patients with Multiple Sclerosis using MHC Class II Tetramers](https://doi.org/10.1016/j.clim.2009.03.444)Raddassi K, Yang J, Kent S, Bradshaw E, Bourcier K, Seyfert-Margolis V, Detection of Myelin Reactive CD4+Cells in the Peripheral Blood of Patients with Multiple Sclerosis using MHC Class II Define Functionally Distinct Human Tregs- One Subsets Exhibits Decreased Activity in Multiple Sclerosis](https://doi.org/10.1016/j.clim.2009.03.487)Ashley C, Hafler D, Baecher-Allan C. S.119. CD127 and HLA DR Define Functionally Distinct Human Tregs- One Subsets Exhibits Decreased Activity in Multiple 2009, 131: s164-s165. [DOI: 10.1016/j.clim.2009.03.487](https://doi.org/10.1016/j.clim.2009.03.487). [T.22. Monocytes Pro-inflammatory Cytokines Inducing Th17 Cells](https://doi.org/10.1016/j.clim.2009.03.163)Bradshaw E, Raddassi K, Elyaman Gottlieb P, Kent S, Hafler D. T.22. Monocytes from Patients with Type 1 Diabetes Spontaneously Secrete Pro-inflammatory Cytokines Inducing [OR.55. Transforming Growth Factor-beta is Crucial for the Differentiation and Regulation of Interleukin 9-producing Human CD4+T Cells](https://doi.org/10.1016/j.clim.2009.03.067)Beriou G, Costantino C, Baecher-Allan C, Hafler D. OR.55. Transforming Growth Factor-beta is Crucial for the Differentiation and Regulation of Interleukin 9-producing Human CD4+T Cells Clinical D, Kuchroo V. TIMs: central regulators of immune responses Journal Of Cell Biology 2008, 183: i12-i12. [DOI: 10.1083/jcb1835oia12](https://doi.org/10.1083/jcb1835oia12). [Genetic Analysis of Human Traits In Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines](http://www.ncbi.nlm.nih.gov/pubmed/19043577)Choy E, Yelensky R, Bonakdar S, Hafler D, Daly MJ, Altshuler D. Genetic Analysis of Human Traits In Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines TIMs: central regulators of immune responses Journal Of Hafler DA, Love JC. Concurrent detection of secreted products from human lymphocytes by microengraving: Rusche JR, Hafler DA. Multiple Sclerosis and Regulatory T Cells Journal Of Hastings W, Anderson D, Kuchroo V, Hafler D. SY-23 Human CD4+CD25high natural [DOI: 10.1016/j.cyto.2008.07.340](https://doi.org/10.1016/j.cyto.2008.07.340). - Hutton J, Baecher-Allan C, Hafler D. Multiple Sclerosis and Regulatory T Cells 2008, 265-277. [DOI: 10.1007/978-0-387-77909-6_13](https://doi.org/10.1007/978-0-387-77909-6_13). [Pathology of an Islet Transplant for a Nonimmunological Loss](http://www.ncbi.nlm.nih.gov/pubmed/18622278)Smith RN, Kent Hafler DA, Auchincloss H, Orban T, Cagliero E. Pathology of an Islet Transplant 2 Years After Transplantation: Evidence for a Transplantation 2008, 86: 54-62. 18622278](https://pubmed.ncbi.nlm.nih.gov/18622278), [DOI: DA. TGF- are required for population structure and a reduction of CD8low cells](http://www.ncbi.nlm.nih.gov/pubmed/18567923)De Jager PL, Rossin E, Pyne V, Weiner M, Soler D, Izmailova E, Faron-Yowe L, O'Brien C, Freeman S, Granados S, Parker A, Roubenoff R, Mesirov JP, Khoury SJ, Hafler DA, Weiner HL. Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low DA. Human regulatory T cells and autoimmunity J, Hafler DA. Lack of TIM-3 Immunoregulation in Multiple Kassam N, Dardalhon V, Greenfield RA, DA, Strom TB, Kuchroo VK. TIM-4 Expressed on APCs Induces T Cell Expansion and Survival The Journal \"MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells\"](https://doi.org/10.4049/jimmunol.180.6.3626)Baecher-Allan C, Hafler D. Response to Comment on \"MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells\" The Journal Of to Initiate Invariant Chain Act Redundantly to Initiate Human Invariant Chain Degradation The cells upon CD46 activation in patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/18403025)Vaknin-Dembinsky A, Murugaiyan G, Hafler DA, Astier AL, Weiner IL-23 and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis Hafler DA. The developing mosaic of autoimmune disease risk Nature Genetics 2008, 40: 131-132. [PMID: 18227869](https://pubmed.ncbi.nlm.nih.gov/18227869), Kuhle J, Kappos K, Pohl D, Wong S, Tavakoli N, Tenembaum S, Franz B, O'Connor K, K. F.14. Autoantibodies to 10.1016/j.clim.2008.03.126](https://doi.org/10.1016/j.clim.2008.03.126). - Hastings W, Anderson D, Kuchroo V, Hafler D. Sa.102. Discovery and Characterization of Immunology 2008, M, Kuchroo V, Hafler D. OR.41. IL-21 and TGF- are Required for Differentiation Clinical 2008, Hacohen N. Flt3, a New Regulator of IL-10 Production by Human T Cells, Identified Using an RNAi Library Clinical Immunology 2008, 127: s29. [DOI: Sawcer S, Goris A, Saarela J, Barcellos L, Dubois B, Peltonen L, Palotie A, Weiner H, Booth D, Stewart G, Pericak-Vance M, Haines J, Rioux J, Hauser S, Daly M, Waliszewska A, Oksenberg J, Hafler D. OR.102. The CD58 Pathway is Implicated MS Clinical Immunology 2008, 127: s40-s41. [DOI: 10.1016/j.clim.2008.03.109](https://doi.org/10.1016/j.clim.2008.03.109). - Bradshaw E, Kent Greer Elyaman W, Raddassi K, Love J, Orban T, Hafler D. Sa.77. Ex Vivo Activated State of Immunology 2008, 127: s106. Baecher-Allan C. Differentiation of D. Sa.109. in the CD8dimCD4- Cell Population Parallel Disease Activity in Treated Multiple Sclerosis Subjects](https://doi.org/10.1016/j.clim.2008.03.146)De Jager P, Kivis\u00e4kk P, Hu X, Soler-Ferran D, Izmailova E, O'Brien C, Hafler D, Weiner H, Khoury S. F.34. Changes in the CD8dimCD4- Cell Population Parallel Disease Activity in Treated Multiple Sclerosis Subjects Clinical Immunology 2008, 127: s54. [DOI: 10.1016/j.clim.2008.03.146](https://doi.org/10.1016/j.clim.2008.03.146). P, Hafler D, Mesirov J, De Jager P. Su.86. Automated High-dimensional Granzyme Inhibits that Control the Expression of MHC Genes Do Not Affect Susceptibility to Multiple Sclerosis](https://doi.org/10.1016/j.clim.2008.03.145)Ottoboni L, Young E, Yelensky R, Hafler D, Daly M, De Jager P. F.33. Genetic Variants that Control the Expression of MHC Genes Do Not Affect Susceptibility to Multiple Sclerosis Clinical 2008, 127: (nTregs) Represent Effector nTregs, Precursor nTregs, and Induced nTregs](https://doi.org/10.1016/j.clim.2008.03.336)Baecher-Allan C, L, G, Ashley C, Hafler D. Sa.115. IL7R and HLA-Class II selected FoxP3+ T (nTregs) Represent Effector nTregs, - De Wicker LS, Hafler DA. Allelic variant in CTLA4 alters T cell phosphorylation patterns Proceedings Of The National Academy Of Sciences Of The United States Of America 2007, 104: 18607-18612. [PMID: 18000051](https://pubmed.ncbi.nlm.nih.gov/18000051), Hastings WD, Kassam N, Lei C, Chandwaskar R, Karman J, Su Hirashima M, Bruce JN, Kane LP, Kuchroo VK, Hafler DA. Promotion of Tissue Inflammation by the Immune Receptor Tim-3 Expressed on Innate Immune Cells Science 2007, 18006747](https://pubmed.ncbi.nlm.nih.gov/18006747), [DOI: 10.1126/science.1148536](https://doi.org/10.1126/science.1148536). - Plenge RM, L, Price AL, de Bakker PI, Maller J, Pe'er I, Burtt NP, Blumenstiel B, DeFelice M, Parkin M, Barry R, Winslow W, Healy C, Graham RR, Neale BM, Izmailova E, Roubenoff R, Parker AN, Glass R, Karlson EW, Maher N, Hafler DA, Lee DM, Seldin MF, Remmers EF, Lee AT, D. independent alleles at 6q23 associated with risk of rheumatoid Abnormal Tr1 differentiation in multiple sclerosis S, Lander E, Daly M, De Jager P, de Bakker P, Gabriel S, Mirel D, Ivinson A, Pericak-Vance M, Gregory S, Rioux J, McCauley J, Haines J, Barcellos L, Cree B, Oksenberg J, Hauser S. Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study New England Journal Of Medicine 2007, Sobel RA, Robinson WH, Steinman L. Protective and therapeutic role for B-crystallin Cohen C, RH, Podolsky DK, Louis E, Hafler DA, Rioux JD. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases Genes & Immunity 2007, 8: 387-397. F, Cohen IR, De Boer R, Garcia KC, Goldstein B, Greenspan R, Hafler D, Hodgkin P, Huseby ES, Krakauer DC, Nemazee AS, Pinilla C, Strong RK, Sercarz EE. Polyspecificity of T cell and B cell receptor recognition Seminars responses by T cells expanded by endogenous selfpeptide/MHC complexes PL, Hafler DA. New Therapeutic Approaches for Multiple Sclerosis Annual Review Of Medicine 2007, 58: 417-432. [PMID: 17217332](https://pubmed.ncbi.nlm.nih.gov/17217332), [DOI: 10.1146/annurev.med.58.071105.111552](https://doi.org/10.1146/annurev.med.58.071105.111552). - McLaughlin K. Detection of autoantibodies with self-assembling tetramers Exchange 2007 [DOI: TW, De Jager PL, Gregory SG, Barcellos LF, Walton A, Goris A, Fenoglio C, Ban M, Taylor CJ, Goodman RS, Walsh E, Wolfish CS, Horton R, Traherne J, Beck S, Trowsdale J, Caillier SJ, Ivinson AJ, Green T, Pobywajlo ES, Pericak-Vance MA, Haines JL, Daly MJ, S, . A second major histocompatibility complex susceptibility locus for multiple De Jager PL, Chitnis T, Bettelli E, Xu C, Robinson A, K, M, Amato AA, Hafler DA, Greenberg SA, O'Connor K. A Local Antigen-Driven Humoral Response Is Present in the Inflammatory Myopathies K, Anderson R, Anderson D, Bruce J, Hafler D, O'Connor K. Characterization of the B Cell Infiltrate Within Intracranial Germinomas Clinical Immunology 2007, Single B Cell Immunoglobulin Variable Region Genes Derived from Infiltrated Muscle Tissue of Subjects with Inflammatory Myopathies](https://doi.org/10.1016/j.clim.2007.03.072)Bradshaw E, Orihuela A, McArdel S, Hafler D, Amato A, O'Connor K. Characterization of Single B Cell Immunoglobulin Variable Region Genes Derived from Infiltrated Muscle Tissue of Subjects with Inflammatory Myopathies Clinical Immunology 2007, 123: s152. [DOI: 10.1016/j.clim.2007.03.072](https://doi.org/10.1016/j.clim.2007.03.072). - O'Connor K, Cherry S, Hafler D. How B Cells Contribute to Multiple Sclerosis Pathology 2007, 66-86. [DOI: 10.1007/978-0-387-36003-4_5](https://doi.org/10.1007/978-0-387-36003-4_5). - Manzanet R, Hartt-Meyers J, Slavik J, Dardalhon V, Kassam N, Greenfield E, Sobel R, Strom T, Hafler D, Kuchroo V. Tim-4 Expressed on Antigen-presenting Cells Induces T Cell Expansion and Survival Clinical Immunology 2007, 123: s124-s125. [DOI: 10.1016/j.clim.2007.03.533](https://doi.org/10.1016/j.clim.2007.03.533). - Yang L, Anderson D, Kuchroo V, Hafler D. Defect in TIM-3 Regulation of CD4+ T Cells in a Human Autoimmune Disease Clinical Immunology 2007, 123: s139-s140. [DOI: 10.1016/j.clim.2007.03.035](https://doi.org/10.1016/j.clim.2007.03.035). - Hastings W, Greer A, Kuchroo V, Hafler D, Kent S, Anderson D. Dysregulation of the TIM-3-Galectin-9 Pathway in Type I Diabetic T Cells Clinical Immunology 123: s21. [DOI: 10.1016/j.clim.2007.03.228](https://doi.org/10.1016/j.clim.2007.03.228). [Haplotype-specific the Class II MHC Peptide Repertoire but Does Not Impair Invariant Chain Degradation in Human Antigen Presenting Cells](https://doi.org/10.1016/j.clim.2007.03.330)Costanti-England C, Hang H, Hafler D, Ploegh H. Haplotype-specific Use of Lysosomal Proteases Can Modulate the Class II MHC Peptide Repertoire but Does Not Impair Invariant Chain Degradation in Human Antigen Presenting Cells Clinical Immunology 2007, 123: s53. [DOI: 10.1016/j.clim.2007.03.330](https://doi.org/10.1016/j.clim.2007.03.330). - IL-10 Both Inhibits Treg Suppressive Activity and is a Survival Factor for Human Natural Tregs Clinical Immunology 2007, 123: P, Hafler D, Reich D. Admixture Mapping, a New Tool for Disease Gene Finding in Autoimmune and Other Diseases Clinical Immunology 2007, 123: s122. [DOI: 10.1016/j.clim.2007.03.526](https://doi.org/10.1016/j.clim.2007.03.526). - J, O'Conner K, Wawrousek E, Hafler D, Sobel R, Robinson W, Steinman L. Protective and Therapeutic Role for B-Crystallin in Autoimmune Clinical V, Hafler D. Improving Elispot to Detect Antigen Specific Immunology 2007, s154. [DOI: 10.1016/j.clim.2007.03.078](https://doi.org/10.1016/j.clim.2007.03.078). [A of Immunologically Relevant Cell Surface Markers](https://doi.org/10.1016/j.clim.2007.03.076)De Jager P, Yelensky R, Rossin Bonadkar S, Daly M, Altshuler D, Hafler D. A Genome-wide Screen for Genetic Variants Affecting the Expression of Immunologically Relevant Cell Surface Markers Clinical Immunology 2007, D. Elifacs: A Multiplex Assay to Detect Antigen Specific T Cells and to Monitor the Immune Response Clinical Immunology 2007, 123: s126. [DOI: 10.1016/j.clim.2007.03.538](https://doi.org/10.1016/j.clim.2007.03.538). - Mesirov J, Tamayo P, Hafler D. Novel Computational Methods to Enhance the Uncovers Population Structure in Untreated MS Subjects and Highlights the Role of NK Cells](https://doi.org/10.1016/j.clim.2007.03.068)Rossin E, Viglietta V, Soler-Ferran D, Parker A, Weiner M, Buckle G, Khoury S, Hafler D, Weiner H, De Jager P. Large Scale Immunoprofiling Uncovers Population Structure in Untreated MS Subjects and Highlights the Role of NK Cells Apoptosis Resistant, DR+ Tregs](https://doi.org/10.1016/j.clim.2007.03.507)Ashley C, Anderson R, Bruce J, D, Hafler D, Baecher-Allan C. Human Glioblastoma Multiforme (GBM) Kassam N, Hafler D. TIM-3 is a Negative Regulator of Clinical Immunology 2007, 123: s154. Susceptibility Locus CTLA4 and Alterations in Proximal TCR Signaling in Healthy Human Volunteers](https://doi.org/10.1016/j.clim.2007.03.023)Maier L, Anderson D, de Jager P, Hafler D, Wicker L. An Association Between the Autoimmune Susceptibility Locus CTLA4 and Alterations in Proximal TCR Signaling in Healthy Clinical Immunology s135. the Current Understanding of Putative Biomarkers](http://www.ncbi.nlm.nih.gov/pubmed/17124343)O'Connor K, Roy SM, Becker CH, Hafler DA, Comprehensive Phenotyping in Multiple Sclerosis: Discovery Based Proteomics and the Current Understanding of S, Hafler DA. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis Journal Of Clinical Investigation for disease association studies in the extended human MHC](http://www.ncbi.nlm.nih.gov/pubmed/16998491)de Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J, Ke X, Monsuur AJ, Whittaker P, Delgado M, Morrison J, Richardson A, Walsh EC, Gao X, Galver L, Hart J, Hafler DA, Pericak-Vance M, Todd JA, Daly MJ, Trowsdale J, Wijmenga C, Vyse TJ, Beck S, Murray SS, Carrington M, Gregory S, Deloukas P, Rioux JD. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC Nature Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response](http://www.ncbi.nlm.nih.gov/pubmed/16951385)Karni A, Abraham M, Monsonego A, Cai G, Freeman GJ, Hafler D, Khoury HL. Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response The Journal Of Hafler DA. Human regulatory T cells and their role in autoimmune disease Immunological Reviews 2006, 212: 203-216. [PMID: 16903916](https://pubmed.ncbi.nlm.nih.gov/16903916), [DOI: 10.1111/j.0105-2896.2006.00417.x](https://doi.org/10.1111/j.0105-2896.2006.00417.x). O'Connor KC, Kuchroo VK, Hafler DA. Dysregulated T cell expression of TIM3 in multiple sclerosis Journal Of Experimental loci in multiple sclerosis and systemic lupus erythematosus](http://www.ncbi.nlm.nih.gov/pubmed/16642031)De Jager PL, Graham R, Farwell L, Sawcer Behrens TW, DA, Kere J, Vyse TJ, Rioux JD. The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus Hafler DA. MHC Class II Expression Identifies Functionally Distinct Human Regulatory T Cells The Journal Of Immunology 2006, The Purification and Functional Analysis of Human CD4+CD25high Regulatory T Cells Current Protocols Variable Region Genes Derived from Muscle Tissue of Subjects with Inflammatory Myopathies](https://doi.org/10.1016/j.clim.2006.04.262)Bradshaw E, Orihuela A, Amato A, Hafler D, Greenberg S, O'Connor K. Sa.30. Characterization of B-Cell Immunoglobulin Variable Region Genes Derived from Muscle Tissue of Subjects with Inflammatory Myopathies Clinical Immunology 2006, 119: s115. [DOI: 10.1016/j.clim.2006.04.262](https://doi.org/10.1016/j.clim.2006.04.262). - O'Connor K, McArdel S, Bradshaw E, Anderson D, Moore N, Brady M, Hafler D. Sa.9. Examination of the B-Cell Repertoire in the CNS of Patients with MS Clinical Immunology 2006, 119: s108. [DOI: 10.1016/j.clim.2006.04.241](https://doi.org/10.1016/j.clim.2006.04.241). - Hastings W, Kuchroo V, Hafler D. Analysis of Autoreactive T-Cells in Khoury S, D. Sa.25. In Vitro Correlates of in Vivo Rapamycin Therapy in Patients with Multiple Sclerosis Clinical Immunology 2006, 119: s113. [DOI: 10.1016/j.clim.2006.04.257](https://doi.org/10.1016/j.clim.2006.04.257). - BRASS S, WEINER H, HAFLER CHAPTER 46 Multiple Sclerosis 2006, 615-632. [DOI: 10.1016/b978-012595961-2/50049-4](https://doi.org/10.1016/b978-012595961-2/50049-4). [Sa.13. Function of TIM3 May Be Compromised in Human CD4 T-Cells of Untreated Patients with Multiple Sclerosis](https://doi.org/10.1016/j.clim.2006.04.245)Yang L, Anderson D, Hafler D. Sa.13. Function of TIM3 May Be Compromised in Human CD4 T-Cells of Untreated Patients with Multiple Sclerosis Clinical Immunology 119: s109. [DOI: 10.1016/j.clim.2006.04.245](https://doi.org/10.1016/j.clim.2006.04.245). [OR.80. Identifying Regulators Using a Lentiviral N. OR.80. Identifying Regulators of Cytokine Production in Primary Human T-Cells Using a Il-10 Plays a Contrasting Role in Suppression By Functionally Distinct, Dr+ and Dr Human Natural Regulatory T-Cells](https://doi.org/10.1016/j.clim.2006.04.011)Baecher-Allan C, Ashley C, Hafler D. OR.9. Il-10 Plays a Contrasting Role in Suppression By Functionally Distinct, Dr+ and Dr Human Natural Regulatory T-Cells Clinical Immunology 2006, 119: s7. [DOI: 10.1016/j.clim.2006.04.011](https://doi.org/10.1016/j.clim.2006.04.011). [OR.72. of Insulin a Chain 1-15 By Expanded T-Cell Clones from Human Type 1 Diabetic (T1D) Pancreatic Draining Lymph Nodes](https://doi.org/10.1016/j.clim.2006.04.228)Kent S, Hafler D. OR.72. Enhanced Recognition of Insulin a Chain 1-15 By Expanded T-Cell Clones from Human Type 1 Diabetic (T1D) Pancreatic Draining Nodes Clinical Immunology 2006, [Sa.43. Role of the HLA DRB1*1501 Haplotype in the Expression of Clinical and Radiographic Phenotypes of Multiple Sclerosis](https://doi.org/10.1016/j.clim.2006.04.275)De Jager P, Charles G, Wolfish C, Holland C, Alkasab T, Parker A, Roubenoff R, Khoury S, Hafler D, Weiner H. Sa.43. Role of the HLA DRB1*1501 Risk Haplotype in the Expression of Clinical and Radiographic Phenotypes of Pathway Alleles Associated with Risk of Inflammatory Bowel Disease](https://doi.org/10.1016/j.clim.2006.04.259)Waliszewska A, De Jager P, Franchimont D, Hafler Epistasis Analyses of Toll-Like Receptor Pathway Alleles Associated with Risk of Inflammatory Bowel Disease Clinical Immunology 2006, 119: s114. [DOI: 10.1016/j.clim.2006.04.259](https://doi.org/10.1016/j.clim.2006.04.259). [OR.22. Dissection of the Admixture Multiple Locus On Chromosome 1 in An African-American Population](https://doi.org/10.1016/j.clim.2006.04.024)De Jager P, Patterson N, McDonald G, Waliszewska A, Cree B, Wolfish C, Hauser S, Oksenberg J, Reich D, Hafler D. OR.22. Dissection of the Admixture Multiple Sclerosis Susceptibility Locus On Chromosome 1 in An African-American Population Clinical Immunology 119: Cohen L, Goris A, Libioulle C, Jani N, Dassopoulos T, Gillian B, Dubois B, Cho J, Brant S, Duerr R, Yang H, Rotter J, Silverberg M, Steinhart H, Daly M, Louis E, Hafler D, Rioux J. Sa.137. Toll-Like Receptor Pathway Polymorphisms and Association to Inflammatory Bowel Disease Clinical Immunology 2006, 119: s154. 2006, 119: s151. [DOI: 10.1016/j.clim.2006.04.362](https://doi.org/10.1016/j.clim.2006.04.362). [Sa.128. Comparison of Two Methods to Isolate Mononuclear Cells from Peripheral Blood On Viability and Function of Freshly and Cryopreserved PBMCS](https://doi.org/10.1016/j.clim.2006.04.360)Raddassi K, Estevam J, Bourcier K, Gisler T, Hafler D, Seyfert-Margolis V. Sa.128. Comparison of Two Methods to Isolate Mononuclear Cells from Peripheral Blood On Viability and Function of Freshly and Cryopreserved PBMCS Clinical Immunology 2006, Sawcer S, Waliszewska A, Farwell L, Wild Cohen A, D, Bitton A, Compston A, Hafler DA, Rioux JD. of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosis European Human Genetics 2005, 14: 317-321. [PMID: 16391555](https://pubmed.ncbi.nlm.nih.gov/16391555), [DOI: 10.1038/sj.ejhg.5201548](https://doi.org/10.1038/sj.ejhg.5201548). Bregoli L, Clemmings S, Hering B, Kenyon N, Ricordi C. Insulin auto-antigenicity in type 1 diabetes (Reply) Nature 2005, 438: e5-e6. [DOI: 10.1038/nature04424](https://doi.org/10.1038/nature04424). - Baecher-Allan CM, Hafler DA. Immunology 117: 192. [PMID: Kenyon NS, Ricordi C, Hering B, Hafler DA. Loss of IL-4 Secretion from Human Type 1a Diabetic Pancreatic Draining Lymph Node NKT Cells 175: 4458-4464. [DOI: McDonald GJ, Waliszewska A, Tandon A, Lincoln C, Fruhan SA, Cabre P, Bera O, Semana G, Kelly MA, Francis DA, Ardlie K, Khan O, Cree BA, Hauser SL, Oksenberg JR, Hafler DA. A whole-genome admixture scan finds a candidate locus for multiple sclerosis Genetics 16186815](https://pubmed.ncbi.nlm.nih.gov/16186815), [DOI: Myelin Oligodendrocyte Glycoprotein](http://www.ncbi.nlm.nih.gov/pubmed/16034142)O'Connor K, Appel H, Bregoli L, Call ME, Catz I, Chan JA, Moore NH, Warren KG, Wong SJ, Hafler DA, Wucherpfennig KW. Antibodies from Inflamed Central Nervous Tissue Recognize Compston A, Kirby A, Daly MJ, Jager Walsh Lander ES, Rioux JD, Hafler DA, Ivinson A, Rimmler J, Gregory Pericak-Vance MA, Akesson E, Hillert J, Datta HF, Spurkland A, Myhr KM, Laaksonen M, Booth D, Heard R, Stewart G, Lincoln R, Barcellos LF, Hauser SL, Oksenberg JR, Kenealy SJ, Haines JL. A High-Density Screen for Linkage in Multiple Sclerosis American Journal Of Trollmo C, Kessler B, Hekking B, Merritt D, Meyer AL, Kwok B, Ploegh H, Huber BT, Hafler DA. Characterization of in vivo expanded OspA-specific from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope](http://www.ncbi.nlm.nih.gov/pubmed/15889096)Kent SC, Chen Y, Bregoli Hering BJ, Hafler DA. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope Nature 2005, 435: 224-228. populations of human regulatory CD4+CD25+ T cells](http://www.ncbi.nlm.nih.gov/pubmed/15870015)Baecher-Allan C, Wolf E, Hafler DA. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T KC, De Jager P, BaecherAllan Jutton M, Price DA, Hafler DA, Kuchroo VK, Altmann DM. High Incidence of Spontaneous Disease in an HLA-DR15 and TCR Transgenic Multiple Sclerosis Model The Journal Of 2005, Jager P. Applying a new generation of genetic maps to understand human inflammatory disease Nature Reviews Immunology 2005, 5: 83-91. [PMID: 15630431](https://pubmed.ncbi.nlm.nih.gov/15630431), [DOI: 10.1038/nri1532](https://doi.org/10.1038/nri1532). [The potential for targeting CD4+CD25+ regulatory T cells in the treatment of multiple sclerosis in humans](https://doi.org/10.1007/3-7643-7301-6_8)Baecher-Allan C, Viglietta V, Hafler D. The potential for targeting CD4+CD25+ regulatory T cells in the treatment of multiple sclerosis in humans 2005, 133-151. [DOI: 10.1007/3-7643-7301-6_8](https://doi.org/10.1007/3-7643-7301-6_8). [PD-1 ligands, negative regulators for activation of na\u00efve, memory, and recently activated human CD4+ T cells](http://www.ncbi.nlm.nih.gov/pubmed/15598424)Cai G, Karni A, Oliveira EM, Weiner HL, Hafler DA, Freeman GJ. PD-1 ligands, negative regulators for activation of na\u00efve, memory, and recently activated human CD4+ T Self Antigens Presented by Different MHC Class II Molecules The Immunology [PMID: Hafler DA. Re: GAMES issue study: Are 5-6. [PMID: 15334748](https://pubmed.ncbi.nlm.nih.gov/15334748). - Baecher-Allan C, Hafler DA. Suppressor T Cells in Human Diseases Journal Of Experimental Medicine 2004, De Jager PL, Gabriel S, Hafler DA, Ivinson AJ, Lander ES, Rioux JD, Walsh E, Gregory SG, Schmidt S, Pericak-Vance MA, Barcellos L, Hauser SL, Oksenberg JR, Kenealy SJ, Haines JL. Enhancing linkage analysis of complex disorders: an evaluation of cell receptor transgenic model of multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/15214032)Ellmerich S, Takacs K, Mycko M, Waldner H, Wahid Altmann DM. Diseaserelated epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis European Journal Of Immunology Differentially and Th2 Cells and in Cerebrospinal Fluid-Derived Mononuclear M, Takazawa N, Baecher-Allan C, Brundin L, J, Martin C, Harris RA, Hafler DA, Kuchroo VK, Olsson T, Piehl Mucin-Domain-Containing Molecule-3 and Molecules Are Differentially and Th2 Cells and in Cerebrospinal Fluid-Derived Mononuclear Cells in Multiple Signals Negatively in T Cells](http://www.ncbi.nlm.nih.gov/pubmed/15142525)Vijayakrishnan L, Slavik JM, Ill\u00e9s Z, Greenwald RJ, Rainbow D, Greve B, Peterson LB, Hafler DA, Freeman GJ, Sharpe AH, Wicker LS, Kuchroo An Autoimmune Disease-Associated CTLA-4 Splice Variant Lacking the B7 Binding Domain Signals Negatively in T Cells Immunity 2004, 20: 563-575. [PMID: 15142525](https://pubmed.ncbi.nlm.nih.gov/15142525), [DOI: 10.1016/s1074-7613(04)00110-4](https://doi.org/10.1016/s1074-7613(04)00110-4). - DA. Gene expression profiling in MS: what is the clinical relevance? The Lancet Neurology 2004, 269. [PMID: 15099539](https://pubmed.ncbi.nlm.nih.gov/15099539), B, Lohmueller KE, Hafler DA, Oksenberg JR, Hauser SL, Smith MW, O'Brien S, Altshuler D, Daly MJ, Reich D. Methods for High-Density Admixture Mapping of Disease Genes American Journal Of 74: Jager PL, Mignault AA, Yi Z, de Th\u00e9 G, Essex M, Sankal\u00e9 J, Moore JH, Poku D, Williams Tishkoff SA, Winkler CA, De La Vega FM, Woodage T, Sninsky JJ, Hafler DA, Altshuler D, Gilbert DA, O'Brien S, Reich D. A High-Density Admixture Map for Disease Gene Discovery in African Americans American Journal Of Human Genetics 2004, Hafler DA. Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis Journal Of Experimental Medicine 2004, Hafler A, Gottlieb P. Regulatory T cells in type 1 diabetes mellitus Current Opinion In Endocrinology Diabetes And Obesity 2004, 11: 85-90. [DOI: 10.1097/01.med.0000129641.34639.2e](https://doi.org/10.1097/01.med.0000129641.34639.2e). - Hafler D. Multiple 113: 1070-1070. [PMCID: PMC380239](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC380239), [DOI: 10.1172/jci200421357c](https://doi.org/10.1172/jci200421357c). - Hafler in Multiple Sclerosis kip1 Down-regulation and bcl-xL p27 kip1 Down-regulation and bcl-xL Inhibitor of Phosphoinositide Hafler DA, Rioux JD. Genetic analysis Induce Atypical Partial Agonistic CD8+ T and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions](http://www.ncbi.nlm.nih.gov/pubmed/12620653)O'Connor KC, Chitnis T, Griffin the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions Journal of glatiramer acetate induces hyporesponsive T cells in patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/12706402)Schmied M, Duda PW, Krieger JI, Trollmo C, Hafler DA. In vitro evidence that subcutaneous administration of glatiramer acetate induces hyporesponsive T cells in patients with multiple Clinical Immunology DA. Activated CD8+ T cells in myelin basic protein reactive T cells may distinguish patients with multiple sclerosis from healthy controls](http://www.ncbi.nlm.nih.gov/pubmed/12604314)Oliveira EM, Bar-Or A, Waliszewska AI, Cai G, Anderson DE, Krieger JI, Hafler DA. CTLA-4 dysregulation in the activation of myelin basic protein reactive T cells may distinguish patients with multiple sclerosis from healthy controls Journal Of Autoimmunity 2003, 20: 71-81. [PMID: characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis](http://www.ncbi.nlm.nih.gov/pubmed/12594850)Cao D, Malmstr\u00f6m V, BaecherAllan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis European Journal Of DA, Weinshenker BG. CTLA4 is associated with susceptibility to 2003, 134: 133-141. [PMID: GJ, Hafler DA. CD4+CD25+ Regulatory Cells from Human Peripheral Blood Express Very High Levels of CD25 Ex DA. Inhibition of Human CD4+CD25+high Regulatory T Cell Function 6210-6217. T, Hafler D. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes Journal Of Clinical Investigation 2002, 109: 1511-1511. [DOI: 10.1172/jci14114c1](https://doi.org/10.1172/jci14114c1). - Lim DG, H\u00f6llsberg P, Hafler DA. Strength of prior stimuli determines the magnitude of secondary responsiveness in CD8+ T cells Cellular Hafler DA. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes Journal Of Clinical opposed to specificity, in immunotherapy Journal Expressing Costimulatory Molecules in the Resting State](http://www.ncbi.nlm.nih.gov/pubmed/11698439)Bar-Or A, Oliveira E, Anderson D, Krieger J, Duddy M, O'Connor K, Hafler D. Immunological Memory: Contribution of Memory B Cells Expressing Costimulatory Molecules in the Resting State The Journal Of Immunology 2001, 167: 5669-5677. [Conserved CDR3 Regions CD8+T Cells That Recognize the Tax11-19/HLA-A*0201 Complex in a Subject Infected with Human T-Cell Leukemia Virus Type 1: Relationship of T-Cell Fine Specificity and Major Histocompatibility Complex/Peptide/TCR Crystal Structure](http://www.ncbi.nlm.nih.gov/pubmed/11559817)Bourcier K, Lim D, Ding Y, Smith K, Wucherpfennig K, Hafler D. Conserved CDR3 Regions in T-Cell Receptor (TCR) CD8+T Cells That Recognize the Tax11-19/HLA-A*0201 Complex in a Subject Infected with Human T-Cell Leukemia Virus Type 1: Relationship of T-Cell Fine Specificity and Major Histocompatibility Complex/Peptide/TCR Crystal Structure of contaminating mouse IgG; techniques for producing Ig-free MOG](http://www.ncbi.nlm.nih.gov/pubmed/11498254)Ohashi T, Yukitake M, Slavin A, Krieger J, Hafler D. In vitro evidence that immunuaffinity-purified MOG contains immunogenic quantities of contaminating mouse IgG; techniques for producing Freeman G, Hafler D. CD4+CD25high Regulatory Cells in Human Peripheral Blood The the Single Cell Level: LFA-1L Is a Partial Agonist for Outer Surface Protein A-Reactive T Cells](http://www.ncbi.nlm.nih.gov/pubmed/11290815)Trollmo C, Meyer A, Steere A, Hafler D, Huber B. Molecular Mimicry in Lyme Arthritis Demonstrated at the Single Cell Level: LFA-1L Is a Partial Agonist for Outer Surface Protein A-Reactive T Cells The and B Lymphocytes in Immunopathogenesis](http://www.ncbi.nlm.nih.gov/pubmed/11332657)O'connor K, Bar-Or A, Hafler D. The Neuroimmunology of Multiple Sclerosis: Possible Roles of T and B Lymphocytes in Immunopathogenesis Hafler D, Hartung H. Enhanced B7 Costimulatory Molecule Expression In Inflammatory Human Sural Nerve Biopsies Journal Of The Peripheral Nervous System 2001, 6: 64-64. [DOI: 10.1046/j.1529-8027.2001.01008-15.x](https://doi.org/10.1046/j.1529-8027.2001.01008-15.x). [Decreases in Interleukin-4 Secretion by Invariant T Cells in Peripheral Blood of Patients with Relapsing-Remitting Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/11141321)Gausling R, Trollmo C, Hafler D. Decreases in Interleukin-4 Secretion by Invariant CD4CD8V24JQ T Cells in Peripheral Blood of Patients with Relapsing-Remitting Multiple Sclerosis in Human Type 1 Diabetes Mellitus Before Clinical Onset](http://www.ncbi.nlm.nih.gov/pubmed/11905851)Orban T, Kent SC, Malik P, Milner JD, Schuster K, Jackson RA, Hafler DA. Heterophile Antibodies Indicate Progression of Autoimmunity in Human Type 1 Diabetes Mellitus Before 2001, 10.3109/08916930109014694](https://doi.org/10.3109/08916930109014694). - Anderson D, Hafler System Antigen: Recognition of the Synthetic Random Polypeptide Glatiramer Acetate](http://www.ncbi.nlm.nih.gov/pubmed/11120865)Duda P, Krieger J, Human and Murine CD4 T Cell Reactivity to a Complex Antigen: Recognition of the Synthetic Random Polypeptide Glatiramer Acetate Hafler Antigen-specific therapy for autoimmune disease Current Humans Using MHC Class I Tetramers: Similar Cytotoxicity but Variable Proliferation and Cytokine Production Among Different Clonal CD8+ T Cells Specific to a Single Viral Epitope](http://www.ncbi.nlm.nih.gov/pubmed/11086055)Lim D, Bourcier K, Freeman G, Hafler D. Examination of CD8+ T Cell Function in Humans Using MHC Class I Tetramers: Similar Cytotoxicity but Variable Proliferation and Cytokine Production Among Different Clonal CD8+ T Cells Specific to a Single Viral Epitope Of Immunology 2000, Marrack P, Steere A, Huber B, Kappler J, Hafler D. Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers Proceedings Of The National Academy Of Sciences Of The United States Of America 2000, Hafler DA, Hartung HP. Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies Journal Of Neurology Neurosurgery cells producing intracellular IL4 is decreased in patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/10940899)Kipp B, BarOr A, Gausling R, Oliveira E, Fruhan S, Stuart W, Hafler D. A novel population of B71+ T cells producing intracellular IL4 is decreased in patients with multiple sclerosis European Immunology 2000, 30: 2092-2100. [PMID: 10940899](https://pubmed.ncbi.nlm.nih.gov/10940899), gene expression in regulatory V24JQ T cells from identical twins discordant for type I diabetes](http://www.ncbi.nlm.nih.gov/pubmed/10840051)Wilson S, Kent S, Horton H, Hill A, Bollyky P, Hafler D, Strominger J, Byrne M. Multiple differences in gene expression in regulatory V24JQ T cells from identical twins discordant for type I diabetes Proceedings Of The National Academy Of Sciences Of The United States Of America in patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/10749576)Duda PW, Schmied MC, Cook SL, Krieger JI, Hafler DA. Glatiramer acetate (Copaxone\u00ae) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis Journal Of Clinical Investigation M, Hafler D. T-cell function in response to CTLA-4 blockade; heterogeneity within the [PMID: 10655112](https://pubmed.ncbi.nlm.nih.gov/10655112), with pulse cyclophosphamidel methylprednisolone: Response to therapy is linked to the duration of progressive disease](http://www.ncbi.nlm.nih.gov/pubmed/10618696)Hohol M, Olek M, Orav E, Stazzone L, Hafler D, Khoury S, Dawson D, Weiner H. Treatment of progressive multiple sclerosis with pulse cyclophosphamidel methylprednisolone: Response to therapy is linked to the duration of progressive disease Multiple Sclerosis Journal 1999, 5: 403-409. [PMID: 10618696](https://pubmed.ncbi.nlm.nih.gov/10618696), [DOI: 10.1177/135245859900500i606](https://doi.org/10.1177/135245859900500i606). - What is the turning point? Editorial overview Immunology 1999, 11: 635-637. 10631547](https://pubmed.ncbi.nlm.nih.gov/10631547), [DOI: D. The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system Current Opinion In Immunology 1999, D, Hafler D. Molecular pathogenesis of multiple CDR3 region amino acid substitutions are restricted by CD1d](http://www.ncbi.nlm.nih.gov/pubmed/10600006)Kent S, Hafler D, Strominger J, Wilson S. Noncanonical V24JQ T cells with conservative chain CDR3 region amino acid substitutions are restricted Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone.](http://www.ncbi.nlm.nih.gov/pubmed/10452989)Milner J, Kent S, Ashley T, Wilson S, Strominger J, Hafler D. Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to blurs between an autoimmune versus microbial hypothesis in multiple sclerosis Journal Of Clinical in families and are associated with protection from type 1 diabetes](http://www.ncbi.nlm.nih.gov/pubmed/10393957)She J, Ellis T, Wilson S, Wasserfall C, Marron M, Reimsneider S, Kent S, Hafler D, Neuberg D, Muir A, Strominger J, Atkinson M. Heterophile antibodies segregate in families and are associated with protection from type 1 diabetes Proceedings Of The National Academy Of Sciences Of The United States Of America 1999, D. T cell Autoreactivity to Proinsulin Epitopes in Diabetic Patients and Healthy 12: 259-267. [PMID: 10330297](https://pubmed.ncbi.nlm.nih.gov/10330297), multiple sclerosis with pulse cyclophosphamide/methylprednisolone: Response to therapy is linked to the duration of progressive disease](https://doi.org/10.1191/135245899678846492)Hohol M, Olek M, John Orav E, Stazzone L, Hafler D, Khoury S, Dawson D, Weiner H. Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: Response to therapy is linked to the duration of progressive disease Multiple Sclerosis Journal 1999, 5: 403-409. [DOI: 10.1191/135245899678846492](https://doi.org/10.1191/135245899678846492). - Wilson S, Kent S, Patton K, Orban T, Jackson R, Exley M, Porcelli S, Schatz D, Atkinson M, Balk S, Strominger J, Hafler D. Erratum: Extreme Th1 bias of invariant V24JQ T cells in type 1 diabetes Nature 1999, 399: 84-84. [DOI: 10.1038/20007](https://doi.org/10.1038/20007). - Smith D, Buckle G, Hafler D, Frank D, H\u00f6llsberg P. HTLV-I-Infected T Cells Evade the Antiproliferative Not in Borrelial Encephalomyelitis](http://www.ncbi.nlm.nih.gov/pubmed/10357888)Pohl-Koppe A, E, burgdorferi and Myelin Protein-Specific Cells Clones Specific for Altered Peptide with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy.](http://www.ncbi.nlm.nih.gov/pubmed/9973440)Bieganowska K, Hollsberg P, Buckle G, Lim D, Greten T, Schneck J, Altman J, Jacobson S, Ledis S, Hanchard B, Chin J, Morgan O, Roth P, Hafler D. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic Reingold S, Hafler D. T helper cell differentiation in multiple sclerosis and autoimmunity Trends In DA. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis Journal Of 1998, Myelin basic protein reactive Th2 T cells are found in acute disseminated Neuroimmunology 1998, P. Increased expression of CDIIb (mac-1) on CD8+ T cells in patients with Of Neuroimmunology 1998, 90: IL-4 secretion by invariant V24JQT cells in peripheral blood of patients with multiple sclerosis (MS)](https://doi.org/10.1016/s0165-5728(98)91612-5)Gausling R, Trollmo T, Hafler D. Decreases in IL-4 secretion by invariant V24JQT cells in peripheral blood of patients with multiple sclerosis (MS) Journal Of Neuroimmunology 1998, 90: 72. [DOI: 10.1016/s0165-5728(98)91612-5](https://doi.org/10.1016/s0165-5728(98)91612-5). - Anderson D, Bieganowska K, Bar-Or A, Hafler D. CTLA4 engagement can have both positive and negative effects on human T cell activation Journal Of Neuroimmunology 1998, 90: 14. [DOI: 10.1016/s0165-5728(98)91262-0](https://doi.org/10.1016/s0165-5728(98)91262-0). - Bieganowska K, Anderson D, Bar-Or A, Hafler D. Effect of CD28/CTLA4 signaling on function of MBP reactive T cells Journal Of Neuroimmunology 1998, 90: 15. 10.1016/s0165-5728(98)91267-x](https://doi.org/10.1016/s0165-5728(98)91267-x). - Bar-Or A, CTLA4 blockade B7-2 dependent Duda P, Krieger J, Hafler D. In vitro analysis of T-cell responses to Copaxone\u00ae Of Multiple Sclerosis Patients](http://www.ncbi.nlm.nih.gov/pubmed/9683547)Takashima H, Smith D, Fukaura H, Khoury S, Hafler D, Weiner H. Pulse Cyclophosphamide Plus Methylprednisolone Induces Myelin-Antigen-Specific IL-4-Secreting T Cells in 28-34. [PMID: receptors interferon secretion from T cells and natural killer cells](http://www.ncbi.nlm.nih.gov/pubmed/9520447)Mandelboim O, Kent S, Davis D, Wilson S, Okazaki T, Jackson R, Hafler D, Strominger J. Natural killer activating receptors trigger interferon secretion from T cells and natural killer cells Proceedings Of The National Academy Of Sciences Of The United States Of America of both IFN-gamma and IL-10 secretion in K, Steere A, Logigian E, Hafler D. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia is independent of exogenous B7 costimulation.](http://www.ncbi.nlm.nih.gov/pubmed/9570577)Scholz C, Patton K, Anderson D, Freeman G, Hafler D. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. from PHA-Activated Immune Cells](http://www.ncbi.nlm.nih.gov/pubmed/9464271)Dangond J, Randall J, Kojima R, Utku N, Gullans S. Differential Display Cloning Novel Histone (HDAC3) cDNA from Wilson K, Orban T, Jackson R, Exley M, Porcelli S, Schatz D, Atkinson M, Balk S, Strominger J, Hafler D. Extreme Th1 bias of invariant V24JQ T cells in type T Cells in Patients with Multiple Sclerosisa](http://www.ncbi.nlm.nih.gov/pubmed/9616767)HAFLER D, KENT S, PIETRUSEWICZ M, KHOURY S, WEINER H, FUKAURA H. Oral Administration of Myelin Induces Antigenspecific TGF1 Secreting T Cells in Patients with Multiple Sclerosisa Annals Of The New York Academy Of Sciences 1997, 120-131. [PMID: CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4.](http://www.ncbi.nlm.nih.gov/pubmed/9366404)H\u00f6llsberg P, Scholz C, Anderson DE, Greenfield EA, VK, Freeman GJ, DA. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4. The enhanced agonist response induced by altered ligands.](http://www.ncbi.nlm.nih.gov/pubmed/9366420)Dressel A, Gausling DA. by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands of myelin sclerosis: Increased interleukin4 production and associated eosinophilia](http://www.ncbi.nlm.nih.gov/pubmed/9307252)Smith D, Balashov K, Hafler D, Khoury S, Weiner H. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin4 production and T cell reveal functional differences in B7-1 and B7-2 costimulation of human T cell clones. and its relevance to CNS autoimmunity](http://www.ncbi.nlm.nih.gov/pubmed/9184642)Dangond F, Windhagen A, Groves C, Hafler D. Constitutive expression of costimulatory molecules by human microglia and its relevance to Cells in Human Autoimmune Disease](http://www.ncbi.nlm.nih.gov/pubmed/9151896)Bieganowska K, Ausubel L, Modabber Y, Slovik E, Messersmith W, D. Direct Ex Vivo Analysis of Activated, Fas-sensitive Autoreactive T Cells in Human Autoimmune Disease Journal Of blood-derived T-cell clones infected with human T-cell leukemia virus type I.](http://www.ncbi.nlm.nih.gov/pubmed/9129036)Richardson JH, Hollsberg P, Windhagen A, Child LA, Hafler DA, Lever A. Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia [DOI: Antigens: Results of a Phase I/II Randomized Masked Trial](http://www.ncbi.nlm.nih.gov/pubmed/9152063)Nussenblatt R, Gery I, Weiner H, Ferris F, Shiloach J, Remaley N, Perry C, Caspi R, Hafler D, Foster C, Whitcup S. Treatment of Uveitis by Oral Administration of Retinal Antigens: Results of a Phase I/II Randomized Masked Trial Multiple Sclerosis Patientsa](http://www.ncbi.nlm.nih.gov/pubmed/9186687)KENT S, FUKAURA H, PIETRUSEWICZ M, KHOURY S, WEINER H, HAFLER D. Oral Administration of Myelin Induces Antigenspecific TGF1secreting T Cells in Multiple Sclerosis Patientsa Annals Of The New York Academy Of Sciences 1997, 815: 412-422. [PMID: 9186687](https://pubmed.ncbi.nlm.nih.gov/9186687), [DOI: 10.1111/j.1749-6632.1997.tb52092.x](https://doi.org/10.1111/j.1749-6632.1997.tb52092.x). induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.](http://www.ncbi.nlm.nih.gov/pubmed/9036945)Greenfield EA, Howard E, Paradis T, Nguyen K, Benazzo F, McLean P, H\u00f6llsberg P, Davis G, Hafler DA, Sharpe AH, Freeman GJ, Kuchroo VK. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors. The 158: 2025-34. [PMID: 9036945](https://pubmed.ncbi.nlm.nih.gov/9036945), Induction by activated CD4+ T cells via CD40 ligand](http://www.ncbi.nlm.nih.gov/pubmed/9012830)Balashov K, Smith D, Khoury S, Hafler D, Weiner H. Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4+ T cells via CD40 ligand Proceedings Of The National Academy Of Sciences Of The United States Of America C, Sette A, V, Hafler D. Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones Proceedings Of The National Academy Of Sciences Of The United States Of America 1996, Induction of anergy in CD8 T cells by B cell presentation of antigen. The Journal Of Immunology 1996, How to know thy self CD4+ T cells via CD40 ligand](https://doi.org/10.1177/135245859600200519)Weiner H, Balashov K, Smith D, Khoury S, Hafler D. Increased IL-12 production in progressive multiple sclerosis: Induction by activated CD4+ T cells via CD40 Sclerosis Journal 1996, 2: 253-253. [DOI: 10.1177/135245859600200519](https://doi.org/10.1177/135245859600200519). [Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation.](http://www.ncbi.nlm.nih.gov/pubmed/8816399)Scholz C, Freeman GJ, Greenfield EA, Hafler DA, H\u00f6llsberg P. Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 of C, Hafler H\u00f6llsberg P. of IL10 secretion and enhanced antigenpresenting abilities following HTLVI infection of T cells Journal Characterization of Autoreactive T-cells in Acute Disseminated Encephalomyelitis 199 Pediatric Research 1996, 548-548. [DOI: 10.1203/00006450-199609000-00222](https://doi.org/10.1203/00006450-199609000-00222). - Windhagen A, Anderson DE, Carrizosa A, Williams RE, Hafler DA. IL-12 induces human T cells secreting IL-10 protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in sclerosis patients.](http://www.ncbi.nlm.nih.gov/pubmed/8690806)Fukaura and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. Journal Of Clinical Milford E, Steinman L. TCR usage in human and experimental demyelinating disease In V, Hafler D. Role of Th1 and 10.1159/000319485](https://doi.org/10.1159/000319485). - MATSUI M, HAFLER D, WEINER Pilot Study of Oral Tolerance to Keyhole Limpet Hemocyanin in Humans. Annals Of The New York Sciences 1996, 778: 398-404. [PMID: 8611003](https://pubmed.ncbi.nlm.nih.gov/8611003), [DOI: 10.1111/j.1749-6632.1996.tb21156.x](https://doi.org/10.1111/j.1749-6632.1996.tb21156.x). Oral Tolerization with Myelin Antigens in Multiple Sclerosis and Design of a Phase III Pivotal Trial](http://www.ncbi.nlm.nih.gov/pubmed/8610977)HOHOL M, KHOURY S, COOK S, ORAV E, HAFLER D, WEINER H. Threeyear Open Protocol Continuation Study of Oral Tolerization with Myelin Antigens in Multiple Sclerosis and Design of a Phase III Pivotal Trial Annals Of The New York Academy Of Sciences 1996, 778: 243-250. [PMID: 8610977](https://pubmed.ncbi.nlm.nih.gov/8610977), H, D. Antigenspecific TGF1 Secretion with Bovine Myelin Oral Tolerization in Multiple Sclerosis Annals Of The New York Academy Of Sciences 1996, 778: 251-257. activation. JAIDS Journal D, Weiner H. Antigen-specific therapies for the treatment of autoimmune diseases 1996, B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. Journal Of Experimental McNeely B, Hafler D, Hedley-Whyte E. Case 37-1995 \u2014 A 6-year-old boy with a rash, meningismus, and diplegia New England [DOI: immunodominant myelin basic protein Strominger specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes. Proceedings Of The National Academy Of Sciences Of The United States Of America 1995, S, Sette A, Kuchroo VK, of immunodominant and cryptic proteolipid protein epitopes in Sclerosis: Clonal Expansion and Persistence of Human TCells Specific for an Immunodominant Myelin Basic Protein Peptidea](http://www.ncbi.nlm.nih.gov/pubmed/7544075)WUCHERPFENNIG K, HAFLER D. A Review of TCell Receptors in Multiple Sclerosis: Clonal Expansion and Persistence of Human TCells Specific for an Immunodominant Myelin Basic Protein Peptidea Annals Of The New York Of Sciences 1995, 756: 241-258. [PMID: 7544075](https://pubmed.ncbi.nlm.nih.gov/7544075), [DOI: 10.1111/j.1749-6632.1995.tb44522.x](https://doi.org/10.1111/j.1749-6632.1995.tb44522.x). - Hafler D, Weiner H. Antigen-specific therapies for the treatment of autoimmune diseases Seminars 1995, 17: 61-76. [PMID: 7482227](https://pubmed.ncbi.nlm.nih.gov/7482227), [DOI: 10.1007/bf00194100](https://doi.org/10.1007/bf00194100). [Correlation of Magnetic Resonance Imaging With Immune and Clinical Measures in 45 MS Patients Receiving 20 to 24 MRI Scans Each Over a 1 -Year Period: 1](https://doi.org/10.1212/wnl.45.7.1416)Weiner H, Guttman C, Khoury S, Hohol M, Hafler D, Orav E, Hsu L, Ahn S, Kikinis R, Jolesz F. Correlation of Magnetic Resonance Imaging With Immune and Clinical Measures in 45 MS Patients Receiving 20 to 24 MRI Scans Each Over a 1 -Year Period: 1 Neurology 1995, 45: 1416-1416. [DOI: 10.1212/wnl.45.7.1416](https://doi.org/10.1212/wnl.45.7.1416). [Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis.](http://www.ncbi.nlm.nih.gov/pubmed/7769110)Balashov KE, Khoury SJ, Hafler DA, Weiner HL. Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis. Journal Of Clinical Investigation delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements.](http://www.ncbi.nlm.nih.gov/pubmed/7722338)Stinissen P, Vandevyver C, Medaer R, Vandegaer L, Nies J, Tuyls L, Hafler DA, Raus J, Zhang J. Increased frequency of gamma delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements. T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand.](http://www.ncbi.nlm.nih.gov/pubmed/7732026)H\u00f6llsberg P, Weber WE, Dangond F, Batra V, Sette A, Hafler DA. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proceedings Of The National Academy Of Sciences Of The United States Of America human autoreactive T cell clones by a single amino acid substitution of their peptide ligand](http://www.ncbi.nlm.nih.gov/pubmed/7536622)Windhagen A, Schooz C, H\u00f6llsberg D. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand Immunity 1995, 2: 373-380. HAFLER D, WEINER H. Immunologic Mechanisms and Therapy in Multiple Immunological Hafler DA. Tropical spastic paraparesis on the Caribbean coast of Colombia. American Journal Of Tropical Medicine And Hygiene 1995, 52: 155-8. of normal T-cell lines to MBP isolated from normal and multiple sclerosis white matter Journal Of The Neurological Sciences 1995, 128: 205-211. [PMID: 7537795](https://pubmed.ncbi.nlm.nih.gov/7537795), [DOI: 10.1016/0022-510x(94)00224-c](https://doi.org/10.1016/0022-510x(94)00224-c). Khoury S, Dawson D, Hafler D. Therapy for Weiner HL. Antigen specific therapies for the treatment of autoimmune diseases. 1995, 47: 59-77. Immunosuppression: Oral Tolerance for the 1995, 60: 126-149. [PMID: 7857525](https://pubmed.ncbi.nlm.nih.gov/7857525), [DOI: 10.1159/000423974](https://doi.org/10.1159/000423974). Kent S, Orav J, Khoury S, Hafler D. Treatment of multiple sclerosis and other autoimmune diseases by oral tolerance to autoantigens Journal Of Neuroimmunology 1995, 56: 14. Scholz C, Fukaura H, H\u00f6llsberg P. Modification of immune responses to myelin basic protein (MBP) using altered peptide ligands Journal Of T-cell receptors. Proceedings Of The National Academy Of Sciences Of The United States Of America the Treatment of Autoimmune Disease (Part 2 of 2)](https://doi.org/10.1159/000319270)Hafler D, Weiner H. Antigen-Specific Immunosuppression: Oral Tolerance for the Treatment of Autoimmune Disease (Part 2 of 2) 1994, 60: 138-149. [DOI: 10.1159/000319270](https://doi.org/10.1159/000319270). [Antigen-Specific Immunosuppression: Oral Tolerance for the Treatment of Autoimmune Disease (Part 1 of 2)](https://doi.org/10.1159/000319269)Hafler D, Weiner H. Antigen-Specific Immunosuppression: Oral Tolerance for the Treatment of Autoimmune Disease (Part 1 of 2) 1994, 60: 126-137. [DOI: 10.1159/000319269](https://doi.org/10.1159/000319269). Kuchroo V, D. cell recognition of immunodominant and cryptic proteolipid protein epitopes in 179. [DOI: proliferation in HTLV-I tax-reactive CD8 T cells by a single amino acid substitution in a T cell receptor contact residue of the peptide antigen](https://doi.org/10.1016/0165-5728(94)90360-3)H\u00f6llsberg P, Weber W, Dangond F, Batra V, Sette A, Hafler D. Differential activation of cytolysis and proliferation in HTLV-I tax-reactive CD8 T cells by a single amino acid substitution in a T cell receptor contact residue of the peptide antigen Journal Of Neuroimmunology 1994, 54: 168. [DOI: 10.1016/0165-5728(94)90360-3](https://doi.org/10.1016/0165-5728(94)90360-3). Zhang J, Hafler Raus J. In vivo clonal depletion of human myelin basic protein-reactive T cells by T cell vaccination Journal Of Neuroimmunology 1994, 54: 208. [DOI: 10.1016/0165-5728(94)90597-5](https://doi.org/10.1016/0165-5728(94)90597-5). [Switch of autoreactive human from a TH2 to a TGF1 secreting phenotype with low Scholz C, Fukaura H, Sette A, Hafler D. Switch of autoreactive human T cell clones from a TH2 to a TGF1 secreting phenotype with low affinity T-cell receptor stimulating Journal Of Neuroimmunology 1994, 54: 206. [DOI: 10.1016/0165-5728(94)90586-x](https://doi.org/10.1016/0165-5728(94)90586-x). - Chen Y, Kuchroo V, Inobe J, Hafler D, Weiner H. Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune to TGF-beta 1-induced suppression.](http://www.ncbi.nlm.nih.gov/pubmed/8021495)H\u00f6llsberg P, Ausubel LJ, Hafler DA. Human T cell lymphotropic virus type I-induced T cell activation. Resistance to TGF-beta 1-induced suppression. Hafler DA, Boeri E, Lever A, Bernardi G. Regional specificity of HTLV-I pro viral integration in the human 155-163. [PMID: 8206368](https://pubmed.ncbi.nlm.nih.gov/8206368), [DOI: 10.1016/0378-1119(94)90091-4](https://doi.org/10.1016/0378-1119(94)90091-4). [Clonal expansion and human T cells specific for an immunodominant myelin basic protein peptide.](http://www.ncbi.nlm.nih.gov/pubmed/7514641)Wucherpfennig KW, Zhang J, Witek M, Modabber Y, Ota K, Hafler DA. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. [T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR V beta 8.2 transgenic mice.](http://www.ncbi.nlm.nih.gov/pubmed/8163944)Kuchroo VK, Collins M, al-Sabbagh A, Sobel RA, Whitters MJ, SS, Dorf ME, Hafler DA, Seidman JG, Weiner HL. T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR V beta 8.2 transgenic mice. Journal Of Experimental Medicine of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens](http://www.ncbi.nlm.nih.gov/pubmed/8011298)Weiner HL, Friedman A, Miller A, Khoury SJ, al-Sabbagh L, Sayegh DE, Hafler DA. Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens Annual cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.](http://www.ncbi.nlm.nih.gov/pubmed/7509366)Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. Journal Of Experimental 1994, 179: 973-984. basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.](http://www.ncbi.nlm.nih.gov/pubmed/7505801)Wucherpfennig KW, Sette DA. Structural requirements for binding an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. Journal Of Experimental Medicine 1994, D, Lorenzo C, Sewell K, Hafler D, Weiner H. Effects of Oral Administration of Type II Collagen on Rheumatoid Arthritis Science 1993, 261: 1727-1730. Raus J. MHC-Restricted Depletion of Human Myelin Basic Protein-Reactive T Cells by T Cell 261: 1451-1454. [PMID: 7690157](https://pubmed.ncbi.nlm.nih.gov/7690157), [DOI: 10.1126/science.7690157](https://doi.org/10.1126/science.7690157). [T-cell proliferation and anergy induction. Differential superantigen and autoantigen.](http://www.ncbi.nlm.nih.gov/pubmed/7687620)LaSalle Saadeh M, Golan DE, Taber R, Hafler DA. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen D, Hafler D. Increased Protein Kinase C Activity in Human Memory T Cells progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.](http://www.ncbi.nlm.nih.gov/pubmed/8388090)Weiner HL, Mackin GA, Orav Herndon R, Lehrich JR, Hauser SL, Turel A, Fisher M, Birnbaum G, McArthur J, Butler R, Moore M, Sigsbee B, Safran A. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group. Neurology 1993, Z, LaSalle J, Weiner H, Hafler D. Biological activity of recombinant human myelin basic protein Of Neuroimmunology 1993, Hafler D. Pathogenesis of Diseases Induced by Human Lymphotropic Virus Type I Infection New England Journal Of Medicine 1993, 328: 1173-1182. [PMID: 8455685](https://pubmed.ncbi.nlm.nih.gov/8455685), E, Khoury S, Dawson D, Hafler D. Double-Blind Pilot Trial of Oral Tolerization with Myelin 10.1126/science.7680493](https://doi.org/10.1126/science.7680493). cells predominantly use unusual rearrangements of the T cell receptor delta and gamma loci expressed on both CD4+CD8- and JL. Human fetal liver gamma/delta T cells predominantly use unusual rearrangements of the T cell receptor delta and gamma loci expressed on both CD4+CD8- and CD4-CD8- gamma/delta T cells. specific therapies for autoimmune diseases; investigations in multiple sclerosis as a paradigm for rheumatoid arthritis.](http://www.ncbi.nlm.nih.gov/pubmed/7686832)Hafler DA, Zhang JW, LaSalle J, Donnelly C, Weiner HL, Wucherpfeffnig K. The development of antigen specific therapies for autoimmune diseases; investigations in multiple sclerosis as a paradigm for rheumatoid arthritis. Clinical And Experimental Rheumatology 1993, 11 Suppl 8: s39-40. [PMID: 7686832](https://pubmed.ncbi.nlm.nih.gov/7686832). - Weiner Miller S, Zhang Z, Al-Sabbagh A, Brod S, Lider O, Higgins P, Sobel R, Matsui M, Sayegh M, Carpenter C, Eisenbarth G, Nussenblatt R, Hafler D. Suppression of Organ-Specific Autoimmune Diseases by Oral Administration Autoantigens 10.1007/978-3-642-51479-1_81](https://doi.org/10.1007/978-3-642-51479-1_81). [CTLA-4 and CD28 mRNA are in cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate Lombard and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine Thrombolytic Streptokinase in Elderly Patients with Suspected Acute Myocardial Infarction](http://www.ncbi.nlm.nih.gov/pubmed/1598117)Krumholz H, Pasternak R, Weinstein M, Friesinger G, Ridker P, Tosteson A, Goldman L. Cost Effectiveness of Thrombolytic Therapy with Streptokinase in Elderly Patients with Suspected Acute Myocardial Infarction New England Journal Of Medicine LM, Hafler DA. Early signaling defects in human T cells anergized by T cell presentation of autoantigen. Journal Of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells. The Cuzner ML, Hafler DA. Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. Proceedings Of The National Academy Of Sciences Of The United States Of America beta repertoire and cytokine gene expression in active multiple sclerosis lesions.](http://www.ncbi.nlm.nih.gov/pubmed/1348083)Wucherpfennig KW, Newcombe J, Li H, Keddy C, Cuzner ML, Hafler DA. T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions. Journal Of Experimental Medicine 1992, DA. by autologous human T-cell leukemia virus type I-infected T-cell clones. Proceedings Of The National Academy Of Sciences Of The United States Of America 1992, Cohen I, Benjamin D, Weiner H. T cell vaccination in multiple sclerosis: A preliminary report Clinical Immunology 1992, Hafler D, Weiner H. Immunotherapy in autoimmune diseases Current Biology 1992, 2: 74. [DOI: 10.1016/0960-9822(92)90205-o](https://doi.org/10.1016/0960-9822(92)90205-o). - Zhang J, Weiner H, Hafler D. Autoreactive T Cells in Multiple Sclerosis International Weiner H. Experimental Approaches to Specific Immunotherapy in Multiple Sclerosis 1992, 301-307. [DOI: 10.1007/978-1-4471-3184-7_15](https://doi.org/10.1007/978-1-4471-3184-7_15). - Mackin G, Dawson D, Hafler D, Weiner H. Treatment of Multiple Sclerosis with Cyclophosphamide 1992, 199-216. [DOI: 10.1007/978-1-4471-3184-7_9](https://doi.org/10.1007/978-1-4471-3184-7_9). [The Potential of Restricted T Cell Recognition of Myelin Basic Protein Epitopes in the Therapy of Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/1724362)HAFLER D, MATSUI M, WUCHERPFENNIG K, OTA K, WEINER H. The Potential of Restricted T Cell Recognition of Myelin Basic Protein Epitopes in the Therapy of Multiple Sclerosis Annals Of The New York Academy Of Sciences 1991, 636: 251-265. [PMID: 1724362](https://pubmed.ncbi.nlm.nih.gov/1724362), [DOI: 10.1111/j.1749-6632.1991.tb33456.x](https://doi.org/10.1111/j.1749-6632.1991.tb33456.x). - Miller A, Hafler D, Weiner H. Immunotherapy in autoimmune diseases Current Opinion In Immunology 1991, 3: 936-940. [PMID: 1793539](https://pubmed.ncbi.nlm.nih.gov/1793539), [DOI: 10.1016/s0952-7915(05)80017-2](https://doi.org/10.1016/s0952-7915(05)80017-2). - WEINER ZHANG S, MILLER A, ALSABBAGH A, BROD S, LIDER O, HIGGINS P, SOBEL R, NUSSENBLATT R, HAFLER D. AntigenDriven Peripheral Immune Tolerance Annals Of The New York Academy Of Sciences 1991, 636: 227-232. [PMID: 1793212](https://pubmed.ncbi.nlm.nih.gov/1793212), [DOI: of CD45RA and CD45RO isoforms on T cells during the S/G2/M stages of Cellular Annals Neurology 1991, 30: 624-624. [DOI: 10.1002/ana.410300422](https://doi.org/10.1002/ana.410300422). - LaSalle JM, Ota K, Hafler DA. Presentation of autoantigen by human T cells. The Of 774-80. DA. Restricted T cell expression of IL-2/IFN-gamma mRNA in human inflammatory disease. The 810-5. T-cell recognition of myelin autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases](http://www.ncbi.nlm.nih.gov/pubmed/1868980)Miller A, Hafler D, Weiner H. Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases The 1991, 5: [PMID: 1868980](https://pubmed.ncbi.nlm.nih.gov/1868980), [DOI: 10.1096/fasebj.5.11.1868980](https://doi.org/10.1096/fasebj.5.11.1868980). administration of myelin antigens: IV. Suppression of chronic relapsing disease in the lewis rat and strain 13 guinea pig](http://www.ncbi.nlm.nih.gov/pubmed/1716432)Brod S, alSabbagh A, Sobel R, Hafler D, Weiner H. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the lewis rat and strain 13 guinea pig Annals Of Neurology 1991, progressive multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/1672870)Hafler D, Orav J, Gertz R, Stazzone L, Weiner H. Immunologic effects of cyclophosphamide/ACTH in patients with chronic progressive multiple sclerosis Journal Of 1991, Mcquillen Hoffmann R, Weiner H, Hauser S, Dawson D, Hafler D, Mackin G, Orav E, Currier R, Haerer A, Files J, Morrison F. Cyclophosphamide and plasma exchange in multiple sclerosis The 1033-1034. [PMID: T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/1847614)Lee S, Wucherpfennig K, Brod S, Benjamin D, Weiner H, Hafler D. Common Tcell receptor V usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis Annals Of Neurology 1991, H. Interleukin-1 corrects the defective autologous mixed lymphocyte response in HTLV-1 induced spontaneous T cell clonal proliferation is rapamycin sensitive Journal Of Neuroimmunology 1991, [DOI: 10.1016/0165-5728(91)91225-2](https://doi.org/10.1016/0165-5728(91)91225-2). Wucherpfennig Cuzner L, Li H, Keddy C, Hafler D. Analysis of and T cell receptors in multiple sclerosis plaques Journal Of Neuroimmunology 1991, 35: 28. [DOI: 10.1016/0165-5728(91)90882-8](https://doi.org/10.1016/0165-5728(91)90882-8). - Matsui M, Miller Weiner H. Oral toleralization to keyhole limpet hemocyanin 10.1016/0165-5728(91)90995-j](https://doi.org/10.1016/0165-5728(91)90995-j). [Case 42-1990 \u2014 A Previously Healthy 41-Year-Old Man with Meningoencephalitis and the Rapid Development of Coma](http://www.ncbi.nlm.nih.gov/pubmed/2215581)Cabot R, Scully R, Mark E, McNeely W, McNeely B, Hafler D, Sobel R. Case 42-1990 \u2014 A Previously Healthy 41-Year-Old Man with Meningoencephalitis and the Rapid Development of Coma New England Journal Of Medicine 1990, 323: 1123-1135. [PMID: 2215581](https://pubmed.ncbi.nlm.nih.gov/2215581), Benjamin D, Hafler D. TT cell interactions are mediated by adhesion molecules European Journal Of Immunology 1990, Mackin G, Weiner H, Hafler D. T-cell recognition of an immuno-dominant myelin basic protein 10.1038/346183a0](https://doi.org/10.1038/346183a0). N, Seidman JG, Rosenzweig A, Weiner H, Hafler D. Shared Human T Cell Receptor V Usage to Immunodominant Regions of Myelin Basic Protein 1693015](https://pubmed.ncbi.nlm.nih.gov/1693015), [DOI: - 27: 447-448. [DOI: 10.1002/ana.410270417](https://doi.org/10.1002/ana.410270417). - Brod S, Benjamin D, Hafler D. Frequency analysis of CD4+CD8+ T cells cloned with Cellular Immunology 1990, FcR-mediated crosslinking of Ta1 Review of immunology. Proceedings Of The Association For Research In Nervous And Mental Disease 1990, 68: 23-35. [PMID: 2183313](https://pubmed.ncbi.nlm.nih.gov/2183313). DA. Lymphokine regulation of CD45R expression on human T cell clones. Journal Of Experimental 1989, 170: 2147-2152. Dalgleish A, Hafler D. In Reply: PCR Analysis of DNA from Multiple Sclerosis Patients for the Presence of HTLV-I Science 1989, 246: 821-823. [DOI: 10.1126/science.246.4931.821-a](https://doi.org/10.1126/science.246.4931.821-a). P, Dalgleish A, Hafler D. PCR Analysis of DNA from Multiple Sclerosis Patients for the Presence of HTLV-I Science 1989, 246: 821-823. [DOI: 10.1126/science.246.4931.821.b](https://doi.org/10.1126/science.246.4931.821.b). - Hafler D. Book Review Medicine 1989, 321: 1347-1347. [DOI: 10.1056/nejm198911093211921](https://doi.org/10.1056/nejm198911093211921). [Inflammatory cerebrospinal fluid t cells requirements characteristic of cd4+cd45ra t cells](http://www.ncbi.nlm.nih.gov/pubmed/2479560)Chofflon M, Gonz\u00e1lez V, Weiner H, Hafler D. Inflammatory cerebrospinal fluid t cells have activation requirements characteristic of cd4+cd45ra t cells European Journal Of D. Decrease of suppressor inducer (cd4+ 2h4+) t cells in multiple sclerosis CD3 phosphorylation correlates with Ta1 (CDw26) expression.](http://www.ncbi.nlm.nih.gov/pubmed/2564857)Hafler DA, Chofflon M, Benjamin D, Dang NH, Breitmeyer J. Mechanisms of immune memory. T cell activation and CD3 phosphorylation correlates with Ta1 (CDw26) expression. fluid of a patient with varicella zoster viral meningoencephalitis](http://www.ncbi.nlm.nih.gov/pubmed/2465314)Duby A, Weiner H, Benjamin D, Seidman JG, Hafler D. Sequestration of virus-specific T cells in the cerebrospinal fluid of a patient with varicella zoster a CNS and systematic autoimmune Borst J, Ang S, Hafler D, Seidman J. Cytolytic Potential of CD3+4-8- T Cells with Differently Organized T Cell Receptor Y Chains 1988, 493-498. [DOI: 10.1515/9783110850253-073](https://doi.org/10.1515/9783110850253-073). [Immunohistochemical Analysis of SuppressorInducer and HelperInducer T Cells in Multiple Sclerosis Brain Tissue](http://www.ncbi.nlm.nih.gov/pubmed/2905121)SOBEL R, HAFLER D, CASTRO E, MORIMOTO C, WEINER H. Immunohistochemical Analysis of SuppressorInducer and HelperInducer T Cells in Multiple Sclerosis Brain Tissue Annals Of The New York Academy Of Sciences 1988, 540: 306-308. [PMID: 2905121](https://pubmed.ncbi.nlm.nih.gov/2905121), [DOI: 10.1111/j.1749-6632.1988.tb27082.x](https://doi.org/10.1111/j.1749-6632.1988.tb27082.x). [Loss of Linked to Decreases in Circulating SuppressorInducer (CD4+2H4+) T Cells in Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/2905122)CHOFFLON M, WEINER H, HAFLER D. Loss of Functional Suppression Is Linked to Decreases in Circulating SuppressorInducer (CD4+2H4+) T Cells in Multiple Sclerosis Annals Of The New York Academy Of Sciences 1988, Multiple Sclerosis Immunosuppressive Effects and Human Antimouse Responses](http://www.ncbi.nlm.nih.gov/pubmed/2905125)HAFLER D, WEINER H. AntiCD4 and AntiCD2 Monoclonal Antibody Infusions in Subjects with Multiple Sclerosis Immunosuppressive Effects and Human Antimouse Responses Annals Of The New York Academy Of Sciences 1988, 540: in Chronic Progressive Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/2849902)CARTER J, DAWSON D, HAFLER D, FALLIS R, STAZZONE L, ORAV J, WEINER H. Cumulative Experience with HighDose Intravenous Cyclophosphamide and ACTH Therapy in Chronic Progressive Multiple Sclerosis Annals Of The New York Academy Of Sciences 1988, 540: 535-536. [PMID: 2849902](https://pubmed.ncbi.nlm.nih.gov/2849902), [DOI: 10.1111/j.1749-6632.1988.tb27163.x](https://doi.org/10.1111/j.1749-6632.1988.tb27163.x). [Loss of functional to decreases in circulating suppressor inducer (CD4 + 2H4 +) T Cells in multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/2972249)Chofflon M, Weiner H, Morimoto C, Hafler D. Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4 + 2H4 +) T Cells in multiple multiple sclerosis. Immunosuppressive effects and human anti-mouse responses.](http://www.ncbi.nlm.nih.gov/pubmed/2454256)Hafler DA, Ritz J, Weiner HL. Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses. The in 164 patients.](http://www.ncbi.nlm.nih.gov/pubmed/2838768)Carter JL, Hafler in Neurology 42-7. [PMID: 3260356](https://pubmed.ncbi.nlm.nih.gov/3260356). [Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody.](http://www.ncbi.nlm.nih.gov/pubmed/2966845)Borst J, van Dongen JJ, Bolhuis RL, Peters PJ, Hafler DA, de Vries E, van de Griend RJ. Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody. Journal Of Experimental Morimoto C, Weiner HL. The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions. The Journal Of Immunology 1988, D, Seidman JG, Weiner HL. Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis. Journal Of Experimental 1988, 167: 1313-1322. CD8 molecules. Anti-CD4 can mediate two distinct inhibitory activities.](http://www.ncbi.nlm.nih.gov/pubmed/2891768)Blue ML, Hafler DA, Daley JF, Levine H, Craig KA, Breitmeyer JB, Schlossman SF. Regulation of T cell clone function via CD4 and CD8 molecules. Anti-CD4 can mediate two distinct inhibitory ISBN O + 531 pages) ISBN O 9: 243-244. [DOI: 10.1016/0167-5699(88)91225-x](https://doi.org/10.1016/0167-5699(88)91225-x). - Blue ML, Hafler Craig Levine H, Schlossman SF. Phosphorylation of CD4 and CD8 molecules following T cell triggering. 139: 3949-54. [PMID: 2961801](https://pubmed.ncbi.nlm.nih.gov/2961801), [DOI: 10.4049/jimmunol.139.12.3949](https://doi.org/10.4049/jimmunol.139.12.3949). - Hafler D, Weiner H. T Cells in Multiple Sclerosis and Inflammatory Central Nervous System Diseases Immunological Reviews 1987, 100: 307-332. [PMID: 3326824](https://pubmed.ncbi.nlm.nih.gov/3326824), [DOI: 10.1111/j.1600-065x.1987.tb00537.x](https://doi.org/10.1111/j.1600-065x.1987.tb00537.x). - Hafler D, Fox D, Benjamin D, Blue M, Weiner H. Secondary immune amplification following live poliovirus immunization in [DOI: 10.1016/0090-1229(87)90076-6](https://doi.org/10.1016/0090-1229(87)90076-6). [Loss linked to decreases in circulating suppressor-inducer (CD4+2H4+) T cells in multiple sclerosis](https://doi.org/10.1016/0165-5728(87)90177-9)Chofflon M, Weiner H, Hafler D. Loss of functional suppression is linked to decreases in circulating suppressor-inducer (CD4+2H4+) T cells in multiple sclerosis Journal Of Neuroimmunology 1987, 16: 33. [DOI: 10.1016/0165-5728(87)90177-9](https://doi.org/10.1016/0165-5728(87)90177-9). [Oligocllonal T lymphocytes in the cerebrospinal fluid (CSF) of patients with chronic progressive multiple sclerosis](https://doi.org/10.1016/0165-5728(87)90234-7)Hafler D, Duby A, Lee S, Seidman D, Weiner H. Oligocllonal T lymphocytes in the cerebrospinal fluid (CSF) of patients with chronic progressive multiple sclerosis Journal Of Neuroimmunology 1987, 16: and in multiple sclerosis Cumulative experience in 100 patients](https://doi.org/10.1016/0165-5728(87)90173-1)Carter J, Az S, Dawson D, Fallis R, Hafler H. Immunosuppression with high-dose I.V. cyclophosphamide and acth in progressive multiple sclerosis Cumulative experience in 100 patients Journal Of Neuroimmunology 1987, 16: 29. [DOI: 10.1016/0165-5728(87)90173-1](https://doi.org/10.1016/0165-5728(87)90173-1). - Lee S, Benjamin D, Duby A, Ang S, Seidman J, Hafler D. T-cell receptor--chain clones with natural killer-like activity in the cerebrospinal Journal Of Neuroimmunology 1987, 103. [DOI: 10.1016/0165-5728(87)90287-6](https://doi.org/10.1016/0165-5728(87)90287-6). [Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue](https://doi.org/10.1016/0165-5728(87)90382-1)Sobel R, Castro E, Hafler D, Morimoto C, Schlossman S, Weiner H. Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue Journal Of 1987, infusions in multiple Immunosuppressive and Of Neuroimmunology 16: 180. [DOI: of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis.](http://www.ncbi.nlm.nih.gov/pubmed/2438352)Hafler DA, Benjamin DS, Burks J, Weiner HL. Myelin and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious In vivo labeling of blood T cells: Rapid traffic into cerebrospinal fluid in multiple sclerosis natural killer-like T cell clones.](http://www.ncbi.nlm.nih.gov/pubmed/3106557)Ang SL, Seidman JG, Peterman GM, Duby AD, Benjamin D, Lee SJ, Hafler DA. Functional gamma chain-associated T cell receptors on cerebrospinal fluid-derived natural killer-like T cell clones. Journal Letvin N, Hagan M, Daley J, Schlossman S. Selective Loss of the Suppressor-Inducer T-Cell Subset in Progressive Multiple Sclerosis New England 1987, 316: 67-72. [PMID: 2946956](https://pubmed.ncbi.nlm.nih.gov/2946956), [DOI: 10.1056/nejm198701083160202](https://doi.org/10.1056/nejm198701083160202). cyclophosphamide and monoclonal antibodies.](http://www.ncbi.nlm.nih.gov/pubmed/3039645)Dawson DM, Carter JL, Hafler DA, Weiner HL. Immunosuppression in progressive multiple sclerosis high dose intravenous in Cerebrospinal Fluid and Blood of Patients with Multiple Sclerosis](https://doi.org/10.1007/978-1-4899-5348-3_31)Hafler D, Weiner H. Activated T-Cells and Antigen Reactivity in the Cerebrospinal Fluid and Blood of Patients with Multiple Sclerosis 1987, 261-272. [DOI: 10.1007/978-1-4899-5348-3_31](https://doi.org/10.1007/978-1-4899-5348-3_31). [Cell-mediated immunity to myelin-associated protein in multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/2428837)Johnson D, Hafler D, Fallis R, Lees M, Brady R, Quarles R, Weiner H. Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in 99-108. [PMID: 2428837](https://pubmed.ncbi.nlm.nih.gov/2428837), [DOI: Benjamin D, Weiner HL. Antigen reactive memory T cells are defined by Ta1. The Journal Immunology 1986, 137: 414-8. [PMID: 3013990](https://pubmed.ncbi.nlm.nih.gov/3013990), [DOI: 10.4049/jimmunol.137.2.414](https://doi.org/10.4049/jimmunol.137.2.414). [Immunologic with an anti-T-cell monoclonal antibody, anti-T12.](http://www.ncbi.nlm.nih.gov/pubmed/3486383)Hafler DA, Fallis Reinherz EL, Weiner HL. Immunologic responses of progressive multiple sclerosis patients treated with DA, Johnson D, JJ, Panitch H, Kyle HL. Monoclonal vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases](http://www.ncbi.nlm.nih.gov/pubmed/3930113)Hafler DA, Hemler ME, Christenson L, Williams JM, Shapiro HM, TB, Strominger JL, Weiner HL. Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases Clinical Immunology 1985, 37: 163-171. [PMID: 3930113](https://pubmed.ncbi.nlm.nih.gov/3930113), [DOI: 10.1016/0090-1229(85)90147-3](https://doi.org/10.1016/0090-1229(85)90147-3). [Phenotypic and functional analysis of T cells cloned directly from the blood and cerebrospinal fluid of patients with multiple sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/2416267)Hafler D, Buchsbaum M, Johnson D, Weiner H. Phenotypic and functional analysis of T cells cloned directly from the blood and cerebrospinal fluid of patients with multiple sclerosis Annals the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple Sclerosis](http://www.ncbi.nlm.nih.gov/pubmed/2985995)Hafler D, Fox D, Manning M, Schlossman S, Reinherz E, Weiner H. In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple Sclerosis New England Journal Of Medicine 1985, 312: 1405-1411. [PMID: 2985995](https://pubmed.ncbi.nlm.nih.gov/2985995), [DOI: H. Decreased autologous mixed lymphocyte reaction in multiple sclerosis 9: 339-347. [PMID: 2931449](https://pubmed.ncbi.nlm.nih.gov/2931449), HAFLER D, FALLIS R, LEHRICH J, DAWSON D. The Use of Cyclophosphamide in the Treatment of Multiple Sclerosisa Annals Of The New York Academy Of Sciences 1984, 436: 373-381. [PMID: 6099707](https://pubmed.ncbi.nlm.nih.gov/6099707), [DOI: 10.1111/j.1749-6632.1984.tb14808.x](https://doi.org/10.1111/j.1749-6632.1984.tb14808.x). FALLIS R, JOHNSON D, AULT K, HAUSER S. T Cell Subsets in Patients with Multiple Sclerosis: An Overviewa Annals Of The New York Academy Of Sciences 1984, 436: 281-290. [PMID: 6152384](https://pubmed.ncbi.nlm.nih.gov/6152384), [DOI: 10.1111/j.1749-6632.1984.tb14800.x](https://doi.org/10.1111/j.1749-6632.1984.tb14800.x). Fallis R, Johnson D, Ault K, Hauser S. Altered blood T-cell subsets in patients with multiple sclerosis of monoclonal antibodies against normal tissue following infection of mice with reovirus and demonstration of shared antigenicity between virus and lymphocytes](http://www.ncbi.nlm.nih.gov/pubmed/6329771)Tardieu M, Powers M, Hafler D, Hauser S, Weiner H. Autoimmunity following viral infection: demonstration of monoclonal antibodies against normal tissue following infection of mice with reovirus and demonstration of shared antigenicity between virus and lymphocytes Hafler DA, Victor J. Embarrassment as the aura of a complex partial seizure. Neurology 1982, R, Reichert W. Spinal Subarachnoid Hematoma \u2014 A Hazard of Lumbar Puncture Resulting in Reversible Paraplegia New England Journal Of Prolonged benzodiazepine coma. New State Journal Of Medicine 1981, 81: 776-7. [PMID: 6111773](https://pubmed.ncbi.nlm.nih.gov/6111773). - Panitch H, Hafler D, Johnson K. Antibodies to Myelin Basic Protein in Cerebrospinal Fluid of Patients with Multiple Sclerosis 1980, 98-105. [DOI: 10.1007/978-3-642-67554-6_17](https://doi.org/10.1007/978-3-642-67554-6_17). - "}